ALINORM 08/31/26

JOINT FAO/WHO FOOD STANDARDS PROGRAMME

CODEX ALIMENTARIUS COMMISSION

Thirty first Session

Geneva, Switzerland, 30 June - 5 July 2008

REPORT OF THE 29th SESSION

OF THE CODEX COMMITTEE ON NUTRITION AND FOODS

FOR SPECIAL DIETARY USES

Bad Neuenahr-Ahrweiler, Germany

12 - 16 November 2007

Note: This report includes Circular Letter CL 2007/43-NFSDU

 - iii

CX 5/20.2 CL 2007/43-NFSDU
November 2007

TO: Codex Contact Points

Interested International Organizations

FROM: Secretary,
Codex Alimentarius Commission,
Joint FAO/WHO Food Standards Programme, FAO,
Viale delle Terme di Caracalla,
00153 Rome, Italy

SUBJECT: Distribution of the Report of the 29th Session of the Codex Committee on Nutrition and
Foods for Special Dietary Uses (ALINORM 08/31/26)

A. REQUEST FOR COMMENTS AND INFORMATION AT STEP 8 OF THE PROCEDURE:

1. Draft Revised Codex Standard for Foods for Special Dietary Use for Persons Intolerant to
Gluten (ALINORM 08/31/26 para. 64 and Appendix III)
Governments and international organizations wishing to comment on the above text should do so in writing,
preferably by email to: the Secretary, Codex Alimentarius Commission, Viale delle Terme di Caracalla,
00153 Rome, Italy (fax: +39 06 5705 4593, e-mail: codex@fao.org ) before 1 April 2008.
2. Draft Advisory Lists of Nutrient Compounds for Use in Foods for Special Dietary Uses
Intended for Infants and Young Children (ALINORM 08/31/26, para. 78 and Appendix IV)
Governments and international organizations wishing to comment on the above text should do so in writing,
preferably by email to: the Secretary, Codex Alimentarius Commission, Viale delle Terme di Caracalla,
00153 Rome, Italy (fax: +39 06 5705 4593, e-mail: codex@fao.org ) before 1 April 2008.

B. REQUEST FOR COMMENTS AND INFORMATION AT STEP 5 OF THE PROCEDURE:

Establishment and Application of Risk Analysis Principles by the Codex Committee on Nutrition and
Foods for Special Dietary Uses (ALINORM 08/31/26 para. 121 and Appendix VI)
Governments and international organizations are invited to comment on the above text and should do so in
writing, preferably by email to the Secretary, Codex Alimentarius Commission, Viale delle Terme di
Caracalla, 00153 Rome, Italy (fax: +39 06 5705 4593, e-mail: codex@fao.org), with a copy to: Dr Rolf
Grossklaus, Director and Professor, Federal Institute for Risk Assessment, P.O. Box 33 00 13, 14191 Berlin,
Germany, Fax: +49 1888 529 – 49 65, e-mail: ccnfsdu@bmelv.bund.de before 1 April 2007;
 - iv ­

C. REQUEST FOR COMMENTS AND INFORMATION AT STEP 6 OF THE PROCEDURE:

1. Guidelines for Use of Nutrition Claims: Draft Table of Contents for Nutrient Contents (Part B
Containing Provisions on Dietary Fibre) (ALINORM 08/31/6, para. 41 and Appendix II)
While considering this matter, the Committee agreed that it was not possible to progress further on the
document at this stage, as it was preferable to allow more time for consultations at the national level, as the
scientific papers had only been available shortly before the meeting. The Committee also agreed to ask
comments as to how the FAO/WHO scientific update applied to the definition proposed for dietary fibre and
its applicability for conditions for claims (for details of consideration see paras 22-41).
Governments and international organizations are invited to comment on the above text and should do so in
writing, preferably by email to: Dr Rolf Grossklaus, Director and Professor, Federal Institute for Risk
Assessment, P.O. Box 33 00 13, 14191 Berlin, Germany, Fax: +49 1888 5 29 – 49 65, e-mail:
ccnfsdu@bmelv.bund.de with a copy to the Secretary, Codex Alimentarius Commission, Viale delle Terme
di Caracalla, 00153 Rome, Italy (fax: +39 06 5705 4593, e-mail: codex@fao.org) before 1 April 2008;
2. Draft Advisory List of Nutrient Compounds for Use in Foods for Special Dietary Uses Intende
for Infants and Young Children: Part D Advisory List of Food Additives for Special Nutrient Forms:
Provisions on gum arabic (gum acacia) (ALINORM 08/31/26, paras 75-78 and Appendix V)
While considering the level of gum arabic that should be included in the list as there had been no consensus
at the last session on the levels of 10 or 100 mg/kg, the Committee could not come to a conclusion and
agreed to retain the two levels of 10 and 100 mg/kg in square brackets (for details of consideration see paras
75-78).
Governments and international organizations are invited to comment on the above text and should do so in
writing, preferably by email to: Dr Rolf Grossklaus, Director and Professor, Federal Institute for Risk
Assessment, P.O. Box 33 00 13, 14191 Berlin, Germany, Fax: +49 1888 5 29 – 49 65, e-mail:
ccnfsdu@bmelv.bund.de with a copy to the Secretary, Codex Alimentarius Commission, Viale delle Terme
di Caracalla, 00153 Rome, Italy (fax: +39 06 5705 4593, e-mail: codex@fao.org) before 1 April 2008.
 -v-

SUMMARY AND CONCLUSIONS

The 29th Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses
reached the following conclusions:
MATTERS FOR FINAL ADOPTION BY THE 31ST SESSION OF THE CODEX ALIMENTARIUS
COMMISSION:

The Committee:
- agreed to forward to the Commission the Draft Revised Codex Standard for Foods for Special
Dietary Use for Persons Intolerant to Gluten for final adoption at Step 8 (ALINORM 08/31/26 para.
64 and Appendix III);
- agreed to forward to the Commission the Draft Advisory List of Nutrient Compounds for Use in
Foods for Special Dietary Uses Intende for Infants and Young Children for final adoption at Step 8
(ALINORM 08/31/26, para. 78 and Appendix IV)

MATTERS FOR PROVISIONAL ADOPTION BY THE 31ST SESSION OF THE CODEX

ALIMENTARIUS COMMISSION:

The Committee:
- agreed to forward to the Commission the Establishment and Application of Risk Analysis Principles
by the Codex Committee on Nutrition and Foods for Special Dietary Uses for adoption at Step 5
(ALINORM 08/31/26 para. 121 and Appendix VI).

MATTERS FOR ACTION BY THE 31ST SESSION OF THE COMMISSION

NEW WORK

The Committee:
- Agreed to ask, through the 61st Session of the Executive Committee, the 31st Session of the
Commission to approve new work on the Revision of Nutrient Reference Values for Labelling
Purposes. The Project Document is attached as Appendix VII (paras 122-133).

MATTERS OF INTEREST TO THE 31ST SESSION OF THE COMMISSION

The Committee:
- agreed to return the draft Table of Conditions for Nutrient Content (Part B containing provisions on
dietary fibre) to Step 6 and to ask comments in the Circular Letter as to how the FAO/WHO scientific
update applied to the definition proposed for dietary fibre and its applicability for conditions for
claims (paras 22-41);
- agreed to cease the consideration of the Discussion Paper on the Production and Processing
Standards Regarding the Nutritional Quality and Safety of Foods as these matters were already
covered by the General Principles for the Addition of Essential Nutrients to Foods and the Proposed
Draft Risk Analysis Principles Applied by the Committee on Nutrition and Foods for Special Dietary
Uses being elaborated by the Committee (paras 134-140).

Intergovernmental Task Force on Foods Derived from Biotechnology (CTFBT)

- following the established Procedures between General Committees and Commodity Committees, the
Committee noted that the proposed Annex on Food safety assessment of foods derived from
 - vi ­

recombinant-DNA plants modified for nutritional or health benefits was considerably debated by the
Itergovernmental Task Force on Foods derived from Biotechnology and after some discussion agreed
to endorse the text as proposed by the Task Force (paras 16-21).

MATTERS REFERRED TO OTHER COMMITTEES

Codex Committee on Food Additives (CCFA)

The Committee noted the clarification of the Secretariat of JECFA regarding the applicability of ADI
concept for infants below 12 weeks of age as presented in CRD 12 and agreed that there was no need
to consider the food additives provisions at the Committee before JECFA and CCFA conclude their
work on remaining food additive issues posed by the 28th Session of the Committee (para.15).

Codex Committee on Methods of Analysis and Sampling (CCMAS)

Following the established Procedures between Commodity Committees and General Committees, the
CCNFSDU refers some responses to the questions on several methods in the standard for Infant Formula
and Formulass for Special Medical Purposes Intended for Infants (paras 149-159).

Codex Committee on Food Labelling (CCFL)

Following the established Procedures between Commodity Committees and General Committees, the
CCNFSDU refers the Section of Food Labelling of the Draft Revised Codex Standard for Foods for
Special Dietary Use for Persons Intolerant to Gluten for endorsement by the CCFL (see paras 59-60
and Appendix III).
 - vii ­

TABLE OF CONTENTS
Paragraphs
INTRODUCTION ..................................................................................................................................................1

OPENING OF THE SESSION .............................................................................................................................. 2-3

ADOPTION OF THE AGENDA ........................................................................................................................... 4-7

MATTERS REFERRED BY THE CODEX ALIMENTARIUS COMMISSION AND/OR OTHER

CODEX COMMITTEES: .................................................................................................................................. 8-21

TRANS FATTY ACIDS .............................................................................................................................9

PRIORITIZATION OF WORK ..................................................................................................................10

PROJECT DOCUMENTS .........................................................................................................................11

METHODS OF ANALYSIS IN THE CODEX STANDARD FOR INFANT FORMULA ................................ 12-13

REVIEW OF CODEX COMMITTEE STRUCTURE AND MANDATES OF THE CODEX

COMMITTEES AND TASK FORCES ........................................................................................................14

FOOD ADDITIVES IN INFANT FORMULA ...............................................................................................15

FOOD SAFETY ASSESSMENT OF FOODS DERIVED FROM RECOMBINANT-DNA

PLANTS MODIFIED FOR NUTRITIONAL OR HEALTH BENEFITS ....................................................... 16-21

GUIDELINES FOR THE USE OF NUTRITION CLAIMS: DRAFT TABLE OF CONDITIONS FOR

NUTRIENT CONTENTS (PART B CONTAINING PROVISIONS ON DIETARY FIBRE) AT STEP 7 ....................... 22-41

DRAFT REVISED STANDARD FOR GLUTEN-FREE FOODS AT STEP 7 ........................................................... 42-64

DRAFT ADVISORY LIST OF NUTRIENT COMPOUNDS FOR USE IN FOODS FOR SPECIAL

DIETARY USES INTENDED FOR INFANTS AND YOUNG CHILDREN AT STEP 7 ............................................. 65-78

PROPOSED DRAFT RECOMMENDATIONS ON THE SCIENTIFIC BASIS OF HEALTH CLAIMS

AT STEP 4 .................................................................................................................................................... 79-97

PROPOSED DRAFT RISK ANALYSIS PRINCIPLES AND GUIDELINES FOR APPLICATION TO

THE WORK OF THE COMMITTEE ON NUTRITION AND FOODS FOR SPECIAL DIETYARY

USES AT STEP 4......................................................................................................................................... 98-121

DISCUSSION PAPER ON THE PROPOSALS FOR ADDITIONAL OR REVISED NUTRIENT

REFERENCE VALUES FOR LABELLING PURPOSES ................................................................................... 122-133

DISCUSSION PAPER ON THE PRODUCTION AND PROCESSING STANDARDS REGARDING

THE NUTRITIONAL QUALITY AND SAFETY OF FOODS ............................................................................. 134-140

DISCUSSION PAPER ON THE PROPOSAL FOR NEW WORK TO AMEND THE CODEX

GENERAL PRINCIPLES FOR THE ADDITION OF ESSENTIAL NUTRIENTS TO FOODS

(CAC/GL 09-1987)................................................................................................................................. 141-148

OTHER BUSINESS AND FUTURE WORK ................................................................................................... 149-179

METHODS OF ANALYSIS IN THE REVISED INFANT FORMULA STANDARD ................................. 149-159

PROPOSAL FOR NEW WORK TO ESTABLISH A STANDARD FOR PROCESSED

CEREAL-BASED FOODS FOR UNDERWEIGHT INFANT AND YOUNG CHILDREN .......................... 160-169

INFORMATION FROM THE COMMITTEE ON FOOD LABELLING.................................................... 170-178

CORRECTION OF REPORT OF THE 28TH SESSION OF THE COMMITTEE ................................................179

DATE AND PLACE OF THE NEXT SESSION .......................................................................................................180

 - viii ­

LIST OF APPENDICES
Page
APPENDIX I LIST OF PARTICIPANTS ................................................................................................... 21
APPENDIX II GUIDELINES FOR THE USE OF NUTRITION CLAIMS: DRAFT TABLE OF
CONDITIONS FOR NUTRIENT CONTENTS (PART B CONTAQINING
PROVISIONS ON DIETARY FIBRE ..................................................................................... 47
APPENDIX III DRAFT REVISED STANDARD FOR FOODS FOR SPECIAL DIETARY USE
FOR PERSONS INTOLERANT TO GLUTEN AT STEP 8......................................................... 50
APPENDIX IV ADVISORY LIST OF NUTRIENT COMPOUNDS FOR USE IN FOODS FOR
SPECIAL DIETARY USES INTENDED FOR THE USE OF INFANTS AND
YOUNG CHILDREN .......................................................................................................... 52
APPENDIX V PROPOSEDDRAFT ADVISORY LIST OF NUTRIENT COMPOUNDS FOR
USE IN FOODS FOR SPECIAL DIETARY USES INTENDED INTENDED
FOR INFANTS AND YOUNG CHILDREN ............................................................................ 72
APPENDIX VI PROPOSED DRAFT NUTRITIONAL RISK ANALYSIS PRINCIPLES AND
GUIDELINES FOR APPLICATION TO THE WORK OF THE COMMITTEE
ON NUTRITION AND FOODS FOR SPECIAL DIETARY USES .............................................. 73
APPENDIX VII PROJECT DOCUMENT OF A PROPOSAL FOR NEW WORK TO REVISE
NUTRIENT REFERENCE VALUES OF VITAMINS AND MINERALS
(CAC/GL 2-1985)........................................................................................................... 79
ALINORM 08/31/26 1

INTRODUCTION
1. The Twenty-ninth Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses
(CCNFSDU) was held in Bad-Neuenahr-Ahrweiler, Germany from 12 to 19 November 2007 at the kind
invitation of the Government of Germany. Dr Rolf Grossklaus, Director and Professor of the Federal
Institute for Risk Assessment, Berlin chaired the Session. The Committee was attended by 278 delegates,
observers and advisors representing 71 member countries, one member organization and 26 international
organizations.
OPENING OF THE SESSION
2. Mr Gert Lindemann, State Secretary of the Federal Ministry of Food, Agriculture and Consumer
Protection, Germany welcomed the participants and noted the importance of the work of the Committee in
ensuring the highest standards worldwide to protect the health of consumers, especially infants and children
while ensuring fair practices of food trade. Mr Lindemann pointed out the importance of the Committee’s
work in implementing the WHO Global Strategy on Diet Physical Activity and Health and in such diverse
areas as reducing malnutrition and obesity in countries around the world. While referring to the Provisional
Agenda for this session of the Committee, Mr Lindemann encouraged the delegates to finalize the Draft
Revised Standard for Gluten Free Foods and the Advisory List of Nutrient Compounds for the Use in Foods
for Special Dietary Uses Intended for Infants and Young Children in order to ensure the protection of such
vulnerable populations. Mr Lindemann indicated that it was very important to progress with the work on
Substantiation of Health Claims and on the Application of Risk Analysis Principles by the Committee on
Nutrition and Foods for Special Dietary Uses and decide on the work for Nutrient Reference Values for Food
Labelling Purposes as these items were very important for the protection of consumers from deceptive and
misleading claims and for choosing products on the basis of appropriate information. In conclusion, Mr
Lindemann pointed out the importance of arriving at consensus with the work and wished all success to the
delegates in their important work.
3. Following Rule II.5 of the Rules of Procedure of the Codex Alimentarius Commission the Committee
was informed about CRD 2 on the division of competence between the European Community (EC) and its
Member States and noted that 19 Member States of the EC were present at the current session.
ADOPTION OF THE AGENDA (Agenda Item 1)1
4. The Committee noted the proposal of the delegation of Canada that the delegates might benefit from the
presence of the Chairperson of the Codex Committee on Food Labelling and agreed to consider information
from the Committee on Food Labelling on the consideration of the WHO Global Strategy on Diet, Physical
Activity and Health under Agenda Item 11 “Other Business and Future Work”.
5. The Committee also noted that the Delegation of India had prepared a document (CRD 9) containing the
proposal for new work on the elaboration of a standard for “Processed Cereal Based Foods for Underweight
Infants and Young Children” and agreed to discuss this matter on Agenda Item 11 “Other Business and
Future Work”.
6. The Delegation of Republic of Korea drew the attention of the Committee to the fact that sufficient time
should be allocated to discuss Item 8 in order to have a clear guidance from the Committee regarding further
work on this issue.
7. With these modifications the Committee adopted the Provisional Agenda as the Agenda for the 29th
Session of the Committee.

1
CX/NFSDU 07/26/1; CRD 2 (Annotated Provisional Agenda on the Division of Competence between the European
community and its Member States according to Rule II paragraph 5 of the Codex Alimentarius Commission; CRD 15
(comments of India).
ALINORM 08/31/26 2

MATTERS REFERRED BY THE CODEX ALIMENTARIUS COMMISSION AND/OR OTHER

CODEX COMMITTEES (Agenda Item 2)2
8. The Committee noted that most of the matters referred by the 30th session of the Commission were for
information purposes while others would be discussed in more detail under relevant Agenda items. The
Committee also noted that assignments given by the Commission in relation to the implementation of the
Strategic Plan 2008-2013 of the Codex Alimentarius Commission such as the review and development of
Codex standards and related texts for food safety was ongoing work and that Activity 2.2 Review of risk
analysis principles would be taken on Item 7 while considering the elaboration of application of risk analysis
principles by the Committee on Nutrition and Foods for Special Dietary Uses. In addition, the Committee
noted matters referred as follows:
Trans fatty acids
9. The Representative of WHO informed the Committee about the Scientific Update on trans fatty acids
(TFA) which was led by WHO. The Representative indicated that the Scientific Update reviewed the health
effects of TFA from both epidemiological and experimental perspectives, as well as the feasibility of
alternative replacements and pointed out that the expert group reviewed scientific background papers
prepared and further agreed to prepare six scientific review papers. These include: 1) General historical
background of the work related to TFA and the Global Strategy; 2) Risk assessment on TFA:
epidemiological/experimental; 3) Quantification of consequences/model to assess alternatives to TFA; 4)
Feasibility for replacement of TFA; 5) Assessing approaches to removing TFA in the food supply in
industrialized countries and in developing countries; and 6) Summary and conclusions of the scientific
update. The Representative indicated that the final papers would be published most likely in the European
Journal of Clinical Nutrition in early 2008.
Prioritization of work
10. The Committee noted that the General Criteria for Prioritization of Work presented in the Codex
Procedural Manual sufficiently covered needs of the Committee and therefore there was no need to develop
additional criteria for the prioritization of work by the Committee.
Project documents
11. With regard to project documents for new work, the Committee noted that the 30th Session of the CAC
was of the view that some project documents were not of sufficient quality, not addressing all criteria with
sufficient explanation/justification and that the CAC had requested that in future all documents should be
prepared in accordance with provisions set forth in the Codex Procedural Manual.
Methods of Analysis in the Codex Standard for Infant Formula
12. The Committee recalled that the 30th Session of the Commission had adopted the draft Standard for
Infant Formula and Formulas for Special Medical Purposes Intended for Infants with the understanding that
the Section on Methods of Analysis would be reviewed by the CCNFSDU with a view to its submission to
CCMAS for endorsement. The Committee noted that some proposals relevant to questions posed by the 28th
session of the Codex Committee on Methods of Analysis and Sampling were contained in CRD 10 prepared
by the United States and agreed to establish an inter-session working group to review issues related to
methods of analysis and sampling in the Standard for Infant Formula and Formulas for Special Medical
Purposes Intended for Infants and Young Children.
13. Some delegations drew the attention of the Committee to the fact that CRD 10 contained some
provisions which were not acceptable to all members and expressed their view that more work on methods of
analysis and sampling for all foods for special dietary uses was necessary. CRD 15 prepared by the EC was
also made available. It was proposed that the work on this matter be extended between the current and
subsequent sessions and that an electronic working group could do it (see also Item 11).

2
CX/NFSDU 07/26/2; CX/NFSDU 07/29/2-Add.1 (matters referred from the Intergovernmental Task Force on
Biotechnology); CRD 3 (information from WHO); CRD 15 (comments of India).
ALINORM 08/31/26 3

Review of Codex Committee structure and mandates of Codex Committees and Task Forces
14. The Delegation of Australia drew the attention of the delegates to the fact that the last session of the
Commission due to time constraints was not able to finalize discussions and provide conclusions on Proposal
No 10 regarding the work of the Committee and encouraged the Executive Committee and the Commission
to finalize this discussion which would provide clear direction for future work to be undertaken by the
CCNFSDU.
Food additives in infant formula
15. The Committee noted the clarification of the Secretariat of JECFA regarding the applicability of ADI
concept for infants below 12 weeks of age as presented in CRD 12 and agreed that there was no need to
consider the food additives provisions at the Committee before JECFA and CCFA conclude their work on
remaining food additive issues posed by the 28th Session of the Committee.
Food safety assessment of foods derived from recombinant-DNA plants modified for nutritional or
health benefits3
16. The Committee recalled that the 7th session of the Codex ad hoc Intergovernmental Task Force invited
the 29th Session of the Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) to review
the annex on Food safety assessment of foods derived from recombinant DNA plants modified for nutritional
or health benefits and provide comments if necessary as an annex contained references to certain concepts
related to nutrition.
17. The Chairperson of the Task Force Dr H. Yoshikura briefly introduced this Annex and explained that
while developing it, the Task Force tried to ensure its consistency with other Codex texts developed by the
Committees on Nutrition and Food Labelling by making references to appropriate texts elaborated by the
above Committees and indicated that the wording contained in annex was reached after a careful
consideration.
18. The Delegation of Norway while agreeing in principle with the content of the document proposed to
amend last sentences of paragraphs 14 and 17 for clarification purposes.
19. The Delegation of Thailand drew the attention of the Committee to the fact that in document in the
definition section only the definition of “nutrient” was included, however in the text the “upper level of
intake” and “bioavailability” was used, therefore was of the view that these terms should be also defined. The
Delegation also indicated that “bioavailability” in humans was required for both nutrients and undesirable
substances in the document and was of the view that it would be inappropriate to allow an evaluation of
undesirable substances in humans therefore in vitro or animal studies for them should be allowed.
20. Some delegations pointed out that this annex contained relevant references to the texts elaborated by the
CCNFSDU, therefore proposed to endorse the document without additional changes.
21. The Committee noted that the proposed Annex was considerably debated by the Task Force and after
some discussion agreed to endorse the text as proposed by the Task Force.
GUIDELINES FOR THE USE OF NUTRITION CLAIMS: DRAFT TABLE OF CONDITIONS FOR
NUTRIENT CONTENTS (PART B CONTAINING PROVISIONS ON DIETARY FIBRE) AT STEP
7 (Agenda Item 3)4
22. The Committee recalled that its last session had agreed to return the Draft Table of Conditions for
Claims (dietary fibre) to Step 6 with a Circular Letter asking comments and additional input on the definition
and other provisions for dietary fibre in the light of the results of the FAO/WHO scientific update of

3
ALINORM 08/31/34, Appendix III.
4
CL 2007/3-NFSDU, CX/NFSDU 07/29/3 (comments of Argentina, Australia, Costa Rica, Dominican Republic,
Guatemala, Japan, Mexico, New Zealand, Philippines, United States of America, INFOODS, AAC, AIDGUM, EDA,
IACST, IADSA, ICBA, ICGMA, IDF, IFAC, IFT, ILSI, IUNS), CX/NFSDU 07/29/3- Add.1 (comments of Brazil),
CRD 1 (Report of the Working Group on the Revision of the Standard for Gluten Free Foods), CRD 3 (comments of
India, Indonesia, Philippines), CRD 13 (comments of CIAA)
ALINORM 08/31/26 4

carbohydrates in human nutrition, including the definition of dietary fibre, which had been presented at the
last session of the Committee.
23. The Representative of WHO informed the Committee that FAO and WHO had agreed to undertake a
scientific update on some of the key issues related to carbohydrates in human nutrition in 2005. This
Scientific Update of existing knowledge and evidence relating to the current recommendations was viewed
as essential in the process leading up to an eventual expert consultation on carbohydrates in human nutrition.
A meeting of the authors of the scientific background papers, together with several other expert peer-
reviewers, was held in July 2006. At this meeting, the experts also reviewed issues related to dietary fibre,
among various other issues, and proposed a definition of dietary fibre.
24. The Representative also informed the Committee about the availability of all the papers prepared for the
Joint FAO/WHO Scientific Update on Carbohydrates in Human Nutrition as a supplement of the European
Journal of Clinical Nutrition (Volume 61, Supplement 1, December 2007), which was also distributed to
Codex Contact Points.
25. The brief rationale used by the experts for defining dietary fibre as "intrinsic plant cell wall
polysaccharides" was provided by the Representative of WHO at the 28th Session of CCNFSDU. However,
the Committee requested additional information regarding the work of the expert group and the issues and
approaches employed by the expert group in reaching the conclusions. Therefore, WHO requested Professor
J. Cummings, as a member of the expert group which undertook the scientific update for FAO and WHO, to
participate and further inform the Committee. This information is presented in paragraphs 27 to 35.
26. Professor Cummings highlighted that the Joint FAO/WHO Scientific Update concerned the whole of
carbohydrates, not just fibre. New evidence of the importance to health regarding glycaemic index and
glycaemic load, sugars in relation to obesity, resistant starch, the concept of whole grains and of prebiotic
oligosaccharides was considered. Most of these encroach upon the traditional area of fibre, and therefore, it
is necessary in considering any definition of fibre to place it in the context of carbohydrates as a whole.
27. The expert group reviewed the classification of carbohydrates, based on their chemistry and dividing
them into sugars, oligosaccharides and polysaccharides. The classification of the 1997 Joint FAO/WHO
Expert Consultation was endorsed by the expert group. For all food components, it was agreed that they
should be defined first by their chemistry. This was felt to be essential for good methods of measurement,
labelling, health claims and enforcement.
28. In this context the definition of fibre was discussed. The importance of fibre to general health was
accepted, in that a high fibre diet based on whole grain foods, fruits and vegetables was well established as
being protective against various chronic diseases, such as diabetes, coronary heart disease and some cancers.
The question of how to characterise fibre continues to present some difficulty. Existing definitions were
considered, including that being proposed by the CCNFSDU. After considerable discussion, the expert group
decided to define fibre as “intrinsic plant cell wall polysaccharides”.
29. A physiological basis for the definition, such as “non digestibility”, was considered inappropriate.
Inclusion of “non digestibility” poses many problems as there is no agreement on the definition of
digestibility and no method to measure nor validate it, without extensive difficult studies in humans.
Digestion of food components in the gut is affected by many factors, such as gut transit time, the nature of
the microflora, history of antibiotic use, other components of the diet and the amount consumed. Food
processing, storage conditions, cooking and physical treatments such as grinding, also affect digestibility.
30. The expert group agreed that a food component should be defined in the first instance by its chemistry,
not its function. The expert group was also unconvinced that the definition should include “properties” of
fibre, such as effects on transit time, fermentation and lipid metabolism. These were not consistent effects of
fibre and were felt to be the province of health claims. Many factors contributed to their control other than
fibre.
31. The inclusion of carbohydrates, such as resistant starch and the prebiotic oligosaccharides in the
definition of fibre was considered to be potentially misleading for the consumer. These carbohydrates, while
having important properties in their own right, cannot be said to confer the benefits of fibre as originally
ALINORM 08/31/26 5

proposed. “There is no good evidence of protection against cardiovascular disease and diabetes when various
oligosaccharides or isolated components of whole-grains, fruits, vegetables and legumes are added to
functional and manufactured foods.”
32. Professor Cummings further provided responses to some of the written comments made on the new
proposed definition as the outcome of the Joint FAO/WHO Scientific Update. One was the issue related to
"intrinsic". There are two reasons for the inclusion of the term “intrinsic” in the proposed new definition.
Firstly the Institute of Medicine of the USA makes the distinction between intrinsic and other types of fibre,
which the expert group found to be a reasonable concept. Secondly, as stated already, there is no evidence
that diets high in resistant starch, isolated and purified cell wall material, plant gums and oligosaccharides
confer the health benefits traditionally ascribed to fibre.
33. To the question regarding the exclusion of lignin, Prof Cummings clarified that lignin was not included
in the proposed definition because true lignin is very difficult to measure. What is normally reported as lignin
in the fibre method is Klasson lignin, which is an impure mixture of often unidentified substances. If true
lignin is found to be important to health, it should be measured separately.
34. Finally, the Committee was urged to take a broader view of carbohydrates, into which a definition of
fibre can be fitted. The newly discovered properties of the carbohydrate components of the diet can only be
exploited by the food industry with benefit to the consumer if these are defined and measured separately.
Fibre represents a unique component that does not encroach on the other clearly defined classes of
carbohydrates.
35. The Chair invited the Committee to provide general comments or questions on the scientific update and
to consider whether the discussion on the Draft Table should be deferred until the next session in order to
allow delegates to consider carefully the provisions for dietary fibre in the light of the scientific update.
36. The Committee had an opportunity to ask questions regarding the scientific update and considered in
particular the following questions: the difference between intrinsic and other fibre; the substances which
were not included in the definition of fibre, such as resistant starch; and analytical issues.
37. As regards the non-inclusion of resistant starch in the definition of fibre, Prof Cummings noted that there
was always a possibility of declaring the presence of resistant starch as a health claim if adequate scientific
justification existed. Other added nutrients could also be declared in the list of ingredients or as part of
nutrition labelling.
38. The Delegation of the EC pointed out that the purpose of the Table of Conditions was to define
nutritional claims. Therefore, some clarification was needed as to how the scientific update could affect the
definition of fibre in this context.
39. The Observer from IUNS drew the attention of the Committee to the problems related to methodology
and indicated that IUNS was currently working with IUPAC on the analytical methodology for the
determination of fibre and that this work would be completed in 2008.
40. Several delegations expressed the view that they would need more time to consider the results of the
scientific update. The Committee agreed that it was not possible at this stage to progress further on the
document, as it was preferable to allow more time for consultations at the national level, as the scientific
papers had only been available shortly before the meeting. It was noted that if the document was retained at
Step 7 no comments would be requested and several delegations indicated that they would prefer to submit
comments. After some discussion, the Committee agreed to return the current document to Step 6 and to ask
comments in the Circular Letter as to how the FAO/WHO scientific update applied to the definition proposed
for dietary fibre and its applicability for conditions for claims.
Status of the Guidelines for the Use of Nutrition Claims: Draft Table of Conditions for Nutrient
Contents (Part B Containing Provisions on Dietary Fibre)
41. The Committee agreed to return the Draft Table (Provisions on Dietary Fibre) to Step 6 for further
comments and consideration at the next session (see Appendix II).
ALINORM 08/31/26 6

DRAFT REVISED STANDARD FOR GLUTEN-FREE FOODS AT STEP 7 (Agenda Item 4)5
42. The Committee recalled that at its 28th session it had agreed to return the Draft Revised Standard for
Gluten-Free Foods to Step 6 for further comments and that a physical working group chaired by Sweden and
co-chaired by Canada would meet before the current Session of the Committee to review the comments
received and to prepare proposals in order to assist the Plenary in finalizing the Standard.
43. The Co-chairs from Sweden and Canada introduced CRD 1 and explained all changes that were
proposed in the title and other sections of the Standard, which was presented in Appendix to the CRD 1.
44. The Committee expressed its appreciation to the Working Group for their excellent work and decided to
consider the Standard based on the document prepared by the Working Group and presented in the Appendix
to CRD 1. The Committee agreed to concentrate discussion only on those sections comments were received
and square brackets existed. In addition to editorial and formatting corrections the Committee made the
following changes and recommendations on the following sections.
Title
45. The Committee agreed to rename the title to Standard for Foods for Special Dietary Use for Persons
Intolerant to Gluten.
Scope
46. After some discussion, the Committee accepted the second option for the scope proposed by the Working
Group. It also clarified in the second paragraph that foods were for “general” rather than “normal”
consumption and that foods that by their nature were “gluten-free” could also be represented for use by
persons intolerant to gluten.
Section 2.1.1 Gluten-free foods and Section 2.1.2 Foods specially processed to reduce gluten content to
levels above 20 up to 100 mg/kg
47. The Committee had a lengthy discussion regarding the definition for gluten-free foods described in this
section and how to address labelling issues related to gluten-free foods and foods specially processed to
reduce gluten.
48. A number of delegations were of the view that the term “gluten-free” sho uld be reserved only for
products that contain not more than 20 mg gluten per kg as sold or distributed to consumers or products
gluten-free by nature containing no more than 20 mg gluten per kg and preferred to have only this group of
products in the standard and pointed out that the Committee should help celiac patients to reduce the amount
of gluten in their diet as low as possible.
49. A number of other delegations preferred to have two groups of foods: one for gluten free foods with a
level not exceeding 20 mg/kg and another for products such as specially processed wheat starch based
products with reduced gluten content above 20 to at a level of 100 mg/kg. They drew the attention of the
Committee to the fact that products containing those levels of gluten were on the market and had been used
as gluten free foods for a long time without any negative consequence and that the removal of these products
would limit consumers’ choice for their diets.
50. Some delegations indicated that there was significant variation in the sensitivity to gluten among celiac
patients and not all countries have those products on their markets. However, it was important to convey a
message to consumers about the true nature of the products.
51. The Committee noted that this matter was also discussed at length at the Working Group which, as a
compromise solution, inserted a footnote that starch at levels above 20mg gluten per kg could not be labelled
as “gluten free” but can be as ingredient in a gluten-free product provided that the final product contained

5
ALINORM 07/30/26, Appendix IV; CX/NFSDU 07/29/4 (comments from Argentina, Australia, Canada, Costa Rica,
Guatemala, Mexico, United States of America, AAC, ISDI, IWGA, WGPAT); CX/NFSDU 07/29/4-Add.1 (comments
from Brazil, AOECS); CX/NFSDU 07/29/4-Add.2 (comments from Cuba, Ghana); CRD 1 (Report of the Working
Group); CRD 4 (comments from India, Philippines); CRD 11 (comments from AAC); CRD 16 (comments from South
Africa).
ALINORM 08/31/26 7

lesson more than 20 mg gluten per kg. The Committee inserted Section 2.1.2 for foods with gluten content
above 20 mg/km to 100 mg/kg.
52. After some discussion, the Committee agreed that matters presented in the Description Section regarding
gluten free foods and other foods with reduced gluten content should be addressed in conjunction with
Section 4 on Labelling.
53. The Committee made some amendments to sections 2.1.1 a) and b) and 2.1.2 for clarification purposes
and clarified a footnote regarding the tolerance to oats. The Committee agreed to specify that the allowance
of oats that are not contaminated with wheat, rye or barley in foods covered by the standard may be
determined at national level.
54. The Committee noted that the terms “very low gluten foods” or “low gluten foods’ or ‘gluten-reduced
foods” presented in the title and text of Section 2.1.2 might create confusion among consumers in different
countries and after some discussion decided to rename this section to Foods Specially Processed to Reduce
Gluten Content to level above 20 up to 100 mg/kg with consequential amendments in the text to that effect.
The Committee also made some editorial amendments to the first paragraph of this section and deleted the
square brackets around the level of 100 mg/kg.
55. The Committee agreed to insert the provision that decisions on marketing of products described in this
section may be determined at national level.
56. The Delegation of Spain expressed their reservation on the decision to include Section 2.1.2 defining
products from 20 to 100 mg gluten per kg.
57. In view of these changes, the Committee agreed to delete a footnote 2 from section 2.1.1 b) containing
provisions for starch at levels above 20 to 100 mg gluten per kg as this was already covered by Section 2.1.2.
Section 3 Essential composition and quality factors
58. The Committee agreed to delete the square brackets around 100mg/kg in section 3.2 in view of its
decision on section 2.1.2.
Section 4 Labelling
59. In section 4.1, the Committee clarified that the use of term “gluten-free” was for products described in
Section 2.1.1.
60. Different proposals were put forward for section 4.2 in order to describe how foods processed to reduce
gluten content to a level above 20 up to 100 mg/kg should be labelled. After some discussion the Committee
agreed to use the second option of section 4.2 proposed by the working group with the addition of
clarification that labeling of products described in Section 2.1.2 may be determined at the national level and
that these products must not be called “gluten-free” and that labelling terms for such products should indicate
the true nature of the food.
Section 5 Methods of analysis and sampling
61. The Committee agreed to the proposal of the Observer from WGPAT to rearrange section 5.1 for clarity
and in order to provide more logic for the text and clarified that for qualitative analysis the presence of gluten
shall be based on relevant methods e.g. ELISA or DNA.
62. The Committee agreed to emphasize that methods should be validated against a certified reference
material and clarified that the detection limit should be at 10 mg gluten per kg or below. The Committee also
deleted the reference to “traceability” and “internationally accepted standards” in the second paragraph.
63. To the concern expressed by the Delegation of Canada that the ELISA R5 Mendez method does not meet
the definition of a Type I method and the request to ask the Committee on Methods of Analysis and
Sampling to reconsider the status of this method, the Secretariat clarified that this matter had been
substantively considered by the CCMAS at its 26th and 27th sessions and that the Committee came to a
conclusion that a Type I should be allocated to this method. The Secretariat also recalled that new methods
ALINORM 08/31/26 8

could be proposed as they are available and meet criteria presented in Codex Procedural Manual, considered
by the Committee and forwarded to the CCMAS for endorsement.
Status of the draft revised Standard for Gluten-Free Foods
64. The Committee agreed to forward the renamed draft revised Standard for Foods for Special Dietary Uses
for Persons Intolerant to Gluten to the 31st Session of the Commission for final adoption at Step 8 (see
Appendix III).
DRAFT ADVISORY LIST OF NUTRIENTS COMPOUNDS FOR USE IN FOODS FOR SPECIAL
DIETARY USES INTENDED FOR INFANTS AND YOUNG CHILDREN AT STEP 7 (Agenda Item
5)6
65. The Committee recalled that the Draft Advisory List had been adopted at Step 5 by the 29th Session of
the Commission and circulated for comments at Step 6. The Committee considered the text section by
section and made the following amendments and comments.
66. The Committee agreed with the proposal of the Delegation of the United States to add a new section on
optional ingredients, as Codex standards on foods for infants and young children do not identify all optional
ingredients. It was agreed that optional ingredients should met the criteria specified in section 2.1, and the
provisions in relevant Codex standards.
67. The Delegation of Mexico expressed the view that Hydrogen reduced iron had a low bioavailabilty and
therefore should not be included in the advisory list. The Committee however retained this substance, noting
that it was of an advisory nature and that countries could select the nutrient source that was most suitable at
the national level.
68. The Delegation of India, referring to its written comments, proposed to include Sodium Iron EDTA as a
source of iron. The Committee agreed that in order to consider the inclusion of additional substances,
relevant data should be provided in accordance with the criteria set out in section 2.1.
69. Some editorial corrections were made throughout the text, including the references to the use of some
substances in Codex standards and to the relevant Pharmacopoeia.
70. It was clarified in footnote 7 that the last column referred to foods for special medical purposes other
than infant formula, as infant formula for special medical purposes intended for infants were included in a
specific column.
71. In section 4. Sources of Sodium, the references to the use of sodium sulphate in Codex Standards were
corrected. The Committee agreed with the proposal of the Delegation of the EC to delete Sodium Tartrate
due to the possibility of exceeding the ADI and the contribution to sodium intake resulting from its use.
72. Following some discussion, the Committee clarified that in section 10. Folic Acid, Calcium-L-methyl­
folate was suitable only in foods for special medical purposes and section B of the Standard for Infant
Formula.
73. In Part C, the Committee agreed to include Calcium-L-methyl pholate in Part B on the basis of available
purity requirements and to delete 4.6 Lecithin as it is an additive. In section 6. Nucleotides, the square
brackets were deleted and all substances listed were retained.
74. The Committee agreed to delete the entire section listing the substances that lack official purity
requirements as no additional information had been provided on these substances.
75. In Part D. Advisory List of the Committee recalled that the Committee on Food Additives had endorsed
the additives in Part B with some amendments. The Committee discussed the level of gum arabic that should
be included in the list as there had been no consensus at the last session on the levels of 10 or 100 mg/kg.

6
ALINORM 07/29/26, Appendix V, CL CX/NFSDU 07/29/05 (comments of Brazil, Costa Rica, Cuba, Dominican
Republic, Ghana. Guatemala, United States), CRD 5 (comments of European Community, India, Indonesia, Philippines)
ALINORM 08/31/26 9

76. The Delegation of the European Community expressed the view that the level of gum arabic should be
10 mg/kg as there was no justification for a higher level. The Delegation of the United States pointed out that
the level in the current Advisory List was 100 mg/kg and that it should be retained as no new information
had been provided to justify a lower level. The Observer from AIDGUM supported this position and
proposed to provide additional information on technological justification why higher levels should be used.
77. The Committee could not come to a conclusion and agreed to retain the two levels of 10 and 100 mg/kg
in square brackets for further consideration. However, it was agreed that this should not delay the progress of
the Draft Revised Advisory List as all other issues had been addressed, including the other additives in part
D.
Status of the Draft Advisory List of Nutrients Compounds for Use in Foods for Special Dietary Uses
Intended for Infants and Young Children
78. The Committee agreed to advance the Draft Advisory List to Step 8 for adoption by the 31st Session of
the Codex Alimentarius Commission (See Appendix IV), with the exception of the level of gum Arabic in
Part D, which was returned to Step 6 for further comments and consideration at the next session (see
Appendix V).
PROPOSED DRAFT RECOMMENDATIONS ON THE SCIENTIFIC BASIS OF HEALTH
CLAIMS AT STEP 4 (Agenda Item 6)7
79. The Committee recalled that its 28th session had not been able to consider this item in detail due to time
constraints and had agreed to retain the Proposed Draft Recommendations at Step 4 for consideration at its
next session.
80. The Delegation of France recalled the background of the development of the recommendations and noted
that the text had been redrafted for the last session in the light of the comments received and the guidance
provided by the Committee at previous sessions. The Delegation stressed the importance of the nature of
scientific evidence as addressed in section 4 and noted that special cases were addressed separately. Some
issues remained to be clarified, such as the scope, since the Committee had taken different views at different
sessions as to whether claims should refer to total diets. The question of reevaluation of health claims also
required further consideration as two approaches were possible: reevaluation on a regular basis or only when
new substantial scientific evidence became available.
81. The Committee expressed its thanks to the Delegation of France and the drafting group for their excellent
work on complex issues and had a general discussion on the main sections in the document.
Preamble
82. The Committee agreed that the Proposed Draft Recommendations, when finalized would be included as
an Annex in the Guidelines for Use of Nutrition and Health Claims. The Committee therefore agreed to
delete the Preamble as no additional reference to other Codex texts would be required as the
recommendations would be part of the Guidelines.
Scope
83. The Delegation of India, referring to its written comments, proposed to add new provisions concerning
the application of health claims under various circumstances. The Committee however agreed that the
purpose of the Recommendations was to define the scientific basis of health claims and that other issues
concerning health claims were addressed in the adopted Guidelines, which were not under consideration.
84. The Committee discussed the need to include additional food safety considerations. After some
discussion, it was agreed to retain the current paragraph on food safety with an editorial amendment for
clarification purposes.

7
CX/NFSDU 07/29/6 (previously CX/NFSDU 06/28/7) CX/NFSDU 27/29/6-Add.1 (comments of Argentina, Australia,
Bolivia, Brazil, Guatemala, Kenya, New Zealand, United States, CIAA, IASDA, ISDI, WSRO), CRD 6 (comments of
Australia, Cuba, European Community, India, Indonesia, Malaysia, Philippines, United States)
ALINORM 08/31/26 10

Definition
85. It was proposed to delete this section as the Guidelines for Use of Nutrition and Health Claims did not
refer to properties in the definition of health claims and this would ensure consistency of the Annex with the
Guidelines.
86. Some delegations pointed out that biologically active substances were not defined and should not be
included in the definition. The Committee agreed that this term should be replaced by “related substances or
components”.
87. It was also agreed to replace “whole diets” with “categories of foods” as claims on whole diets were
excluded.
88. The Delegation of France pointed out that this definition has been inserted in order to cope with the
inclusion of whole diet in the Scope of the Recommendations and this might no longer be required.
89. The Delegation of the United States suggested that the phrase “properties of food" be replaced by the
language of the Guidelines for Use of Nutrition and Health Claims “food or food constituent” throughout the
text.
Evaluation of Scientific Evidence
90. The Delegation of the United States expressed the view that there should be a more detailed description
of the clinical studies used as a basis for the substantiation of health claims, and proposed additional text to
this effect The Delegation therefore proposed to add new text in section 4.1 in order to describe the
requirements for these studies more precisely. The Delegation of Malaysia proposed to include a reference to
epidemiological studies in paragraph 4.1.
91. Some observers expressed the view that it was not always possible to substantiate health claims on the
basis of well designed clinical trials. They were concerned that it might not be feasible and practical to base
all health claims on evidence from human studies, especially as many original health claims were based on
observational studies and epidemiological research. Some observers also pointed out that some common
claims, for example for groups of foods such as vegetables, would be excluded by such provisions.
92. After some discussion, the Committee recognized that it was not possible to complete the review of the
text section by section in view of the issues raised in the discussion and considered how to proceed further.
93. The Delegation of the United States proposed to reorganize the document in order to follow the steps for
the substantiation of health claims, and to include the following in Section 4. Evaluation of Scientific
Evidence: 4.1 Nature, quality and scope of the evidence; 4.2 Evaluation of the total body of relevant
evidence; and 4.3 Special cases.
94. The Delegation of France recalled that the current structure was the outcome of responses to a circular
letter and that a specific section was necessary to define the level of scientific evidence, while expressing
some concern that this might be lost if the document was reorganized. The Delegation pointed out that while
further development of the Section “Step-by-Step Process” might provide more useful information, the main
issue to be addressed was the standard of evidence required to substantiate claims and sought the guidance of
the Committee in order to proceed with the document.
95. The Delegation of Australia expressed the view that the structure of the document should correspond to
the different types of health claims described in the Guidelines for Use of Nutrition and Health Claims and
that the presentation of scientific evidence for substantiation could be also significantly different according to
the type of claim concerned.
96. The Committee could not come to a conclusion on the provisions for scientific evidence or the
reorganization of the text at this stage and agreed that an electronic working group led by France with the
assistance of interested delegations working in English only would revise the document in the light of the
comments received.
ALINORM 08/31/26 11

Status of the Proposed Draft Recommendations on the Scientific Basis of Health Claims
97. The Committee agreed to return the Proposed Draft Recommendations to Step 2/3 for redrafting by the
electronic working group led by France, comments and consideration at the next session.
PROPOSED DRAFT NUTRITIONAL RISK ANALYSIS PRINCIPLES AND GUIDELINES FOR
APPLICATION TO THE WORK OF THE COMMITTEE ON NUTRITION AND FOODS FOR
SPECIAL DIETARY USES AT STEP 4 (Agenda Item 7)8
98. The Committee recalled that a new work proposal on the Establishment and Application of Nutritional
Risk Analysis Principles was approved by the 30th Session of the Commission.
99. The Delegation of Australia introduced the document and explained the structure and the content of the
document. The Delegation indicated that the main definitions were taken from the Codex Procedural Manual
and that two options for the title were proposed. The Delegation pointed out that the purpose of the document
was intended for the application in the framework of the Codex rather than by governments.
100. The Committee expressed appreciation to the Delegation of Australia for the very high quality of
their document.
General Comments
101. The Delegation of Malaysia drew the attention of the Committee to the need for a use of consistent
language in various examples and pointed out that not all saturated fatty acids have the same physiological
effect.
102. The Representative of FAO indicated that WHO/FAO should be the primary if not only source of
scientific advice to CCNFSDU, and that international expert groups might not provide independent and
unbiased scientific advice. FAO and WHO are committed, if requested by CCNFSDU, to hold expert
meetings and consultations on the topics requested and to publish reports in a timely manner. For global risk
assessment only international nutritional reference standards, but not regional or national ones should be
used. For international nutritional risk assessment international databases on food consumption and food
composition will have to be developed. For food safety, e.g. JECFA, the GEMS/food 13 cluster diets are
used for exposure assessment, which might not be appropriate for nutritional risk assessment.
103. In response to the clarification requested by the Delegation of the United States of America
regarding the need for a FAO/WHO expert consultation, the Representative of WHO indicated that the
suggestion was made as the purpose of the draft principles was not clear, whether they were being developed
for internal Codex use or for governments. However, following the explanation by the Delegation of
Australia while introducing the document, it was clear that these principles are being developed for internal
Codex use, but not for the use of the governments. The Representative of WHO explained that for
developing guidance to governments, such as to develop recommendations for an approach to nutritional risk
assessment, it is a standard practice for WHO to have an expert consultation involving external international
experts. The Representative of WHO further noted that WHO is very much aware that Codex Member
States are increasingly expressing the need for strengthening the role of FAO and WHO in providing timely
scientific advice. WHO is ready to ensure timely provision of scientific advice with timely support from
governments. A good example of this was the 2005 Technical Workshop on Nutrient Risk Assessment.
With support from governments, FAO and WHO were able to deliver scientific advice in time. This issue
should also be seen in the light of the development of the Global Initiative for Food related Scientific Advice
(GIFSA) which will support the scientific work of FAO/WHO expert bodies, including various expert
consultations and meetings related to nutrition.
104. The Committee considered the document section by section and in addition to editorial corrections
made the following comments and changes.

8
CX/NFSDU 07/29/7; CX/NFSDU 07/29/7 - Add.1 (comments from the United States, WSRO); CX/NFSDU 07/29/7­
Add.2 (comments from Mexico); CRD 7(comments from the European Community, Indonesia and Philippines)
ALINORM 08/31/26 12

Title
105. The Committee agreed to clarify the title to read “Nutritional Risk Analysis Principles and
Guidelines for Application to the Work of the Committee on Nutrition and Foods for Special Dietary Uses”
as it better addressed the content of the document, and it was consistent with titles of documents elaborated
by other Codex Committees on this matter.
Section 1. Background
106. The Representative of WHO requested a clarification or adding some wording in the second
paragraph of the text to ensure that the joint FAO/WHO expert consultations referred to in the document are
those requested by the CCNFSDU, but not all FAO/WHO expert consultations, as many of the joint
FAO/WHO expert consultations are not only for Codex, but for developing guidelines and recommendations
for the governments, including those on human nutrient requirements, fortification guidelines,
supplementation guidelines.
Section 2. Introduction
107. The Committee noted that it was not clear what the term “attendant” meant in relation to risk,
therefore agreed to delete “attendant” in paragraph 3.
108. The Committee agreed to change “nutritional principles” to “nutritional risk analysis principles” in
paragraph 4 and throughout the document.
109. The Committee agreed that the “favorable impact on health” should be changed to “nutritional or
physiological effect” and placed it in square brackets in footnote 2 to better describe the potential impact of a
related substance.
Section 3. Scope and Application
110. The Committed agreed to combine paragraphs 9 and 10 by deleting the reference to examples in the
first and second bullet of paragraph 9 and combined the first and second bullets of paragraph 10 and moved it
as the third bullet in paragraph 9, and put this bullet in square brackets for further comments and
consideration.
111. The second bullet of old paragraph 12 was amended by deleting “potentially eligible ” and clarifying
that formulating general principles for assessing and managing risk related to food not only to health claims
but also to nutrition claims.
112. Paragraph 13 was deleted as it covered issues that were not related to nutritional risk analysis.
Section IV Definitions
113. The Delegation of the European Community requested clarification regarding the status of the
definitions as presented, indicating that some of these may need to be revised by the Committee to reflect
more clearly nutritional risk assessment.
Section 5. Principles for Nutritional Risk Analysis
114. The Committee deleted the paragraph 16 because Section 1 already covered it.
115. The Committee agreed to combine paragraph 31 and 32 by deleting the first sentence of paragraph
31 and move the second sentence to the end of paragraph 32 and put this sentence into square brackets. The
Delegation of Mexico proposed to add “stability” after “availability” in paragraph 31.
116. The Committee agreed to delete paragraph 33 as nutritional risk analysis was not in the terms of
reference of JECFA.
117. The Committee agreed to consider a new paragraph as proposed by the Delegation of European
Community in CRD 7 clarifying that nutritional risk management decisions should take into account food
habits of different consumers and put this paragraph in square brackets for further comments and
consideration.
ALINORM 08/31/26 13

Section 6. Selection of Risk Assessor by CCNFSDU

118. The Committee noted a proposal that in some cases national expertise might be required, therefore
agreed to amend last sentence of paragraph 38 and put new wording into square brackets.
119. The Delegation of Malaysia expressed its concern with the inclusion of other sources of scientific
advice in addition to FAO/WHO, and indicated that it should be clarified whether “national expertise” was
provided by governments or by other sources.
120. In view of the deletion of some paragraphs, the text was renumbered accordingly.
Status of the Proposed Draft Nutritional Risk Analysis Principles and Guidelines for Application to
the Work of the Committee on Nutrition and Foods for the Special Dietary Uses
121. The Committee recognized that significant progress had been made on the revision of the document
and, despite the fact that a number of paragraphs were left in square brackets, it agreed to advance the
Proposed Draft Nutritional Risk Analysis Principles and Guidelines for Application to the Work of the
Committee on Nutrition and Foods for the Special Dietary Uses to Step 5 for adoption by the 31st Session of
the Codex Alimentarius Commission (see Appendix VI).
DISCUSSION PAPER ON THE PROPOSALS FOR ADDITIONAL OR REVISED NUTRIENT
REFERENCE VALUES FOR LABELLING PURPOSES (Agenda Item 8)9
122. The Committee recalled that an electronic working group coordinated by the Delegation of Republic
of Korea was requested to revise the discussion paper on Nutrient Reference Values (NRVs) for labelling
purposes by addressing the following issues: to set up principles for the establishment of NRVs, and the need
to establish NRVs for different population groups.
123. The Delegation Republic of Korea introduced the revised document, which overviewed the existing
situation and current practices in member countries; criteria for establishing NRVs for food labeling purposes
and use of NRVs by national authorities and the basis for NRVs in different countries. The Delegation drew
the attention of the Committee to the fact that it was very important to reach a firm agreement on the scope of
nutrients and population group(s) to be covered and the use of NRVs before proceeding with further work.
The Delegation also indicated that draft principles for establishing NRVs for general population were
presented in the Appendix to the document and that the Project Document for new work (CRD 14) was
prepared, if the Committee decided to proceed with it.
124. The Committee expressed its appreciation to the Delegation of Republic of Korea for their excellent
work and had a lengthy discussion on the scope of the document and the way to proceed further.
125. The Delegation of the United States, while acknowledging the importance of the elaboration of
NRVs for infants and young children, pointed out that the main priority for the Committee should progress
on the work for NRVs for general population limited only for labeling purposes since the elaboration of
NRVs for infants and young children would require additional preparatory work. This view was supported by
several delegations.
126. The Delegation of the European Community proposed that the revision of NRVs was a very
important work and should be continued in order to establish NRVs for the adult population and also for
infants and young children from 6 to 36 months and was of the view that this work could progress in parallel.
This view was supported by several delegations.
127. Some delegations pointed out that the establishment of principles and NRVs for infants and young
children required the elaboration of a separate set of principles and additional data therefore proposed to start
working on NRVs for adult population and to address infants and young children at a later stage.

9
CX/NFSDU 07/29/8; CRD 8 (comments from European Community, Indonesia, Philippines, IADSA); CRD 14
(Project Document for New Work to Revise Nutrient Reference Values for Vitamins and Minerals prepared by
Republic of Korea); CRD 16 (comments from South Africa).
ALINORM 08/31/26 14

128. The Committee agreed that the scope of the document should be limited to vitamins and minerals
and that the use of NRVs should be limited to food labeling purposes.
129. The Committee noted that it would be very difficult to progress on the elaboration of two sets of
principles and NRVs for adult population and for infants young children at the same time and agreed that this
work would involve a process to develop the general principles for the establishment of NRVs for the general
population as a first step. The Committee agreed that the next step would be a process to review all available
reference values and their scientific basis by the principles agreed upon and, if appropriate, update and
extend the current list of vitamin and mineral NRVs in the Guidelines for Nutrition Labelling. Once the
above was completed, the Committee would establish vitamin and mineral NRVs for labeling for individuals
6 months to 36 months of age. The Committee then begin to work to establish principles that would apply to
NRVs for this age group, using as a basis the principles identified for NRVs for the general population and
modifying them as appropriate. Once those principles were developed, the NRVs for this age group would
be established. The Committee also agreed to amend the Section 3 on Main Aspects to be covered in the
Project Document presented in CRD 14 to that effect.
130. The Committee considered the need for scientific advice for the development of NRVs for infants
and children and after some discussion agreed to amend Section 7 dealing with the identification of scientific
advice in Project Document that the necessity for FAO/WHO scientific advice would be identified at a later
stage during the elaboration of the document.
131. The Observer of NHF proposed to establish an additional NRV for each nutrient, to represent the
population group with the greatest need for it, however the Committee did not support this proposal.
132. The Committee agreed to request the 31st Session of the Commission to approve new work on the
revision of Nutrient Reference Values of Vitamins and Minerals for Food Labeling Purposes. Project
Document for this work is attached to this report as Appendix
133. The Committee agreed that the Delegation of Republic of Korea with assistance of other interested
parties would prepare a revised document, taking into account decisions taken by this session of the
Committee, which would be sent for comments and subsequent consideration by the next session of the
Committee.
DISCUSSION PAPER ON THE PRODUCTION AND PROCESSING STANDARDS REGARDING
THE NUTRITIONAL QUALITY AND SAFETY OF FOODS (Agenda Item 9)10
134. The Committee recalled that at its last session it had agreed that the delegation of Canada would
prepare a document providing more explanations on the development of such guidelines, for consideration at
the current session.
135. The Delegation of Canada introduced the document and recalled that the WHO/FAO Draft Action
Plan for the Implementation of the Global Strategy on Diet, Physical Activity and Health in Action 5, para.
43 addressed to the CCNFSDU stated that the CCNFSDU was to “Review the need for guidelines intended
for governments on the use of sound nutrition principles in the production, processing and formulation of
foods based on population nutrient intake goals of the 2002 Expert Consultation, taking into account
advances in nutrition sciences during the past decade and the General principles for the Addition of Essential
Nutrients to Foods”. The Draft Action Plan stated that such guidelines could assist in the development of
foods suitable for inclusion in diets aimed at reducing risk of chronic diseases e.g. when reducing or
eliminating trans fats in foods, such guidelines could provide advice on more healthful alternatives.
136. The Delegation recalled that the Guidelines for Use by Codex Committees on the Inclusion of
provisions on Nutritional Quality in Food Standards and other Codex Texts developed by the Committee
were adopted by the Commission in 1987 and were included in the CAC Procedural Manual. The major
focus of the Guidelines was on addition of essential nutrients and restoration of nutrient losses in foods. The
Committee started a revision of these guidelines in 1992 in order to address concerns over excessive intakes
of fat, sugars and sodium and inadequate intakes of fibre. Canada had lead on the revision at that time,

10
CX/NFSDU 07/29/9.
ALINORM 08/31/26 15

however the work on the revision was discontinued and the guidelines were withdrawn from the Procedural
Manual in 1997 after the Committee on General Principles and the Executive Committee of the Codex
Alimentarius Commission recognized that many definitions and objectives of the Guidelines were already
covered by the General Principles for the Addition of Essential Nutrients to Foods and that advice on
nutrition policy was outside the mandate of the Committee.
137. The Delegation emphasized that food standards should promote and not impede the development of
foods that are consistent with the Global Strategy. Food standards can clearly address several of the
recommendations for diet in the Global Strategy such as limit energy intake from total fats and shift fat
consumption away from saturated fats to unsaturated fats and towards elimination of trans-fatty acids, limit
intake of free sugars and limit salt (sodium) consumption from all sources and ensure that salt is iodized. The
Delegation therefore was of the view that guidance in the production, processing and formulation of foods
that would address the above recommendations would be useful for consideration both by Codex
Committees and national authorities. Canada pointed out however, that the Committee in deciding how to
proceed on this item, should also consider current and proposed work such as the Draft Nutritional Risk
Analysis Principles and Guidelines for Application by the Committee on Nutrition and the proposed work on
to revise the General Principles for the Addition of Essential Nutrients to Foods and the work of the Codex
Committee on Food Labelling on Modified Standardized Common Names.
138. The Delegation of the European Community while complimenting Canada for their work on the
Discussion Paper indicated that advice on nutrition policy was outside the mandate of the Committee and
that many definitions and objectives of the guidelines were already covered by the General Principles for the
Addition of Essential Nutrients to Foods and that the revision of the general principles for the addition of
essential nutrients to foods is currently under consideration for new work. The Delegation was of the opinion
that the recently adopted guidelines on nutrition and health claims already took into account specific
recommendations on nutritional quality and safety developed in the context of the WHO Global Strategy on
Diet, Physical Activity and Health and that a draft on the establishment and application of principles for
nutritional risk analysis and a discussion paper on the proposals for additional revised nutrient reference
values for labelling purpose were currently under discussion by the Committee, therefore some of the
specific recommendations of the WHO strategy could be taken into account in the above documents that are
currently under discussion.
139. The Delegation of the United States was of the view that many issues in the Guidelines for Use by
Codex Committees on the Inclusion of provisions on Nutritional Quality in Food Standards were already
covered by the General Principles for Addition of Essential Nutrients to Food and that the Committee would
consider its revision on the following agenda item and that several key issues would be addressed during the
elaboration of the Proposed Draft Nutritional Risk Analysis Principles and Guidelines for Application to the
Work of the CNFSDU.
140. In view of these proposals, the Committee agreed to cease the consideration of the discussion paper
and concluded that the revision of the Guidelines for Use by Codex Committees on the Inclusion of
provisions on Nutritional Quality in Food Standards and other Codex Texts was not necessary.
DISCUSSION PAPER ON THE PROPOSAL FOR NEW WORK TO AMEND THE CODEX
GENERAL PRINCIPLES FOR THE ADDITION OF ESSENTIAL NUTRIENTS TO FOODS
(CAC/GL 09-1987) (Agenda Item 10)11
141. The Delegation of Canada introduced the document and indicated that the General Principles were
adopted in 1987 and since then there were changed approaches or philosophies related to controlling the
addition of vitamin and minerals for foods, changes in technologies employed for achieving addition or
enhancement of vitamin and mineral levels in foods and an increased interest in the addition to foods of non-
nutrient bioactive substances. The Delegation proposed new work to revise the General Principles that
would address three separate issues within the Principles: addition or enhancement of the levels of essential
nutrients to foods by indirect methods, including biofortification; discretionary addition of vitamins and
minerals to food to provide consumers with a greater variety of foods with added vitamin and mineral

11
CX/NFSDU 07/29/10.
ALINORM 08/31/26 16

nutrients, including the need for setting maximum and minimum levels of addition and addition of bioactive
substances that are non essential constituents to foods. The Delegation indicated that the project document
for new work was prepared and presented in CX/NFSDU 07/29/10-Add.1 in line with the terms of reference
and Strategic Objectives of the Commission.
142. The Committee expressed its appreciation to the Delegation of Canada for their work and agreed to
concentrate on general comments.
143. The Delegation of the European Community was of the view that the evolving dietary habits of the
population and technological progress accomplished by industry would justify the update of the General
Principles. However it was of the opinion that at a first stage this update should continue to concentrate on
the issues that are obviously within the scope of the current General Principles, namely the direct addition of
nutrient to foods. The Delegation acknowledged the importance of taking into account issues arising from
biofortification in the overall vitamin intake, but was sceptical about the capability of the CCNFSDU to
tackle all the issues that would be relevant to biofortification in the framework of these general principles.
The Delegation was in favour of the suggestion to introduce the concept of discretional fortification,
allowing the addition of essential nutrients for reasons other than those listed in the current General
Principles.
144. Concerning the addition of bioactive substances, the Delegation considered that, at this stage, the
General Principles should continue to consider as a priority the addition of essential nutrients and that the
inclusion of bioactive substances would render difficult to elaborate common principles.
145. As regards discretional fortification, the Delegation considered that restrictions for discretional
fortification should only be justified on the basis of safety and on the possibility to mislead consumers and
that discretionary fortification should be allowed only with sources evaluated for their safety and
bioavailability. The risk of excessive intake of nutrients could be tackled with the establishments of
maximum amounts for nutrients that could be added to foods and these maximum amounts should be
established taking into consideration in particular the tolerable upper intake levels established by scientific
risk assessment and the intakes from the diet. Periodic nutritional surveys should be envisaged in order to
monitor shifts in dietary habits and/or industrial practices, which would need a revision of such levels.
146. Some other delegations noted the availability of new technologies and were in favour for further
development of the document and emphasize importance of these issues for public health.
147. The Delegation of the United States supporting the concerns expressed by the Delegation of the
European Community, indicated that the document described how principles could be applied to new
technologies and pointed out that the last session of Task Force on Foods Derived from Biotechnology had
noted that the General Principles for the Addition of Essential Nutrients to Foods (CAC/GL 9-1987)
elaborated by this Committee were applicable to foods elaborated by these new technologies. The Delegation
also pointed out that the revision of the General Principles might open many controversial areas on which it
would be very difficult to reach an agreement as there was no common understanding on these issues.
148. The Committee noted that the work on the revision might proceed in areas where it could be possible
to get an agreement and requested the Delegation of Canada to prepare a revised document, narrowing its
scope in the light of the comments provided at the current session. The revised document would then be
considered by the next session of the Committee.
OTHER BUSINESS AND FUTURE WORK (Agenda Item 11):
Methods of Analysis in the revised infant formula Standard12
149. The Committee recalled that the Committee on Methods of Analysis and Sampling had not endorsed
the methods proposed for inclusion in the Standard for Infant Formula and Formulas for Special Medical
Purposes Intended for Infants and had addressed some specific questions on several methods (see Agenda
Item 2).

12
CRD 10 (comment of the United States), CRD 15 (comments of the EC), CRD 17 (proposals from the Working
Group held during the session), CRD 18 (proposed mandate of the electronic working group)
ALINORM 08/31/26 17

150. The Delegation of the United States introduced the report of the working group that had met during
the session and included proposals for reply to the questions from the CCMAS. The Delegation indicated that
it had not been possible to come to a conclusion on all issues and to establish a list of methods as this
required careful review of existing methods and delegations would need to consult with their experts at the
national level. It was therefore proposed to establish an electronic working group to consider all remaining
issues.
151. The Delegation of the European Community, recalling the recommendation of CCMAS to replace
microbiological assays with more modern methods, proposed to forward several methods developed by CEN
for the determination of vitamins for endorsement to CCMAS. The Delegation of the United States indicated
that it had also proposed specific methods for nutrients listed in Section 3.1 in the revised Standard for Infant
Formula . However as there was no consensus on these proposals, the Committee agreed that no specific
methods could be sent for endorsement at this stage.
152. The Committee discussed the terms of reference of the working group proposed in CRD 18, and
especially the possibility of revising other methods for special foods and the need for additional information
in addition to the Principles for the Establishment of Codex Methods of Analysis. The Committee however
agreed that the working group should concentrate on the finalisation of the methods applicable to infant
formula, with the understanding that other methods could be considered at a later stage, and agreed on the
following terms of reference.
153. The electronic working group (EWG) should prepare a list of methods of analysis for infant formulae
to be considered at the 30th Session of the CCNFSDU in 2008. In preparing this list, the EWG should:
• Review methods of analysis for provisions listed in Section 3.1 of the Codex Revised Standard for
Infant Formula and Formulas for Special Medical Purposes Intended for Infants;
• Follow the Principles for the Establishment of Codex Methods of Analysis in the Codex Procedural
Manual, including the General Criteria for the Selection of Methods of Analysis;
• The electronic working group, chaired by New Zealand, would be open to all members and
observers, and would work in English.
154. The Committee agreed with the proposal of the Delegation of France to provide some responses to
the questions from CCMAS specified in paragraphs 82-88 of ALINORM 07/30/23, as general agreement
existed on some proposals from the working group listed in CRD 17. After some discussion, the Committee
agreed on the following position.
155. The Delegation of the United States indicated that other responses in CRD 17 contained information
relevant to the CCMAS inquiries and CRD 17 indicates issues have been referred to the electronic working
group.
Paragraphs 82 and 83 (methods for dietary fibre and PER)
156. As Dietary Fibre and PER were not listed in section 3.1 Essential Composition, the Committee did
not recommend including a method for any substance or provision that was not included in section 3.1.
Paragraph 85 (Method for sodium and potassium)
157. The Committee agreed that both the current AOAC method and the ISO 8070IDF 119.2007 method
should be listed.
Paragraph 86 (crude protein)
158. The Committee noted that the AOAC method 991.20 Nitrogen (total) in milk, identical to ISO 8968­
1/2IDF 20-1/2: 2001, specifies a nitrogen conversion factor of 6.38. This method can also be used for
analysis of nitrogen in soy infant formulas with the use on an appropriate conversion factor. The Revised
Standard includes a footnote for use of nitrogen conversion factors for calculation of the protein content of
infant formulas. Consistent with that footnote, the Committee proposed the following wording for the use of
nitrogen conversion factor for insertion in the Description column or footnote to the method.
ALINORM 08/31/26 18

”The calculation of the protein content of infant formulas prepared ready for consumption may
be based on N x 6.25, unless a scientific justification is provided for the use of a different
conversion factor for a particular product. The value of 6.38 is generally established as a
specific factor appropriate for conversion of nitrogen to protein in other milk products, and the
value of 5.71 as a specific factor for conversion of nitrogen to protein in other soy products.
159. The Committee agreed that the other questions from the CCMAS would be considered further at the
next session on the basis of the recommendations of the electronic working group.
Proposal for new work to establish a standard for processed cereal-based foods for underweight infant
and young children13
160. The Delegation of India recalled that the 29th session of the Commission had adopted the Revised
Standard for Processed Cereal-Based Foods for Infants and Young Children. India’s comments related to
minimum cereal content, energy density and protein content in the revised Standard. The delegations of India
and Thailand had reserved their position on the decision of the Commission to adopt a revised Standard. The
Commission agreed to request the Committee on Nutrition and Foods for Special Dietary Uses to evaluate
the need for revising sections 3.2, 3.3 and 3.4 of the adopted standard.
161. The Delegation drew the attention of the Committee to the adverse effects of malnutrition especially
in developing countries of the world, causing a high infant, child and maternal mortality. Further
consequences of malnutrition could lead to high level of anemia, low weight gain during pregnancy, acute
infections and chronic diseases. It also significantly affects cognitive development and learning achievements
of children and this puts additional stress on health care expenditures.
162. A vicious intergenerational cycle of malnutrition commences when a child is born with low birth
weight. While malnutrition is caused by multiple problems including poverty, lack of health care and low
consumption of protective foods such as milk, cereals, fruits and vegetables, the delayed and inadequate
complementary feeding is found to be an important reason for the onset of malnutrition among children of 6
months to 2 years.
163. The Delegation indicated that in India about 46% of children in 0 to 3 years of age group are
underweight and about 30% of children born in the country whose birth weight was reported, had low birth
weight. Micronutrient deficiencies are also wide spread and 79% of children between 6 month to 3 years
suffer from anemia. The Delegation indicated that in developing countries 146 million children under 5 years
are underweight. Of these more than a half live in south Asia and 57 million live in India. The Delegation
also emphasized that about 30000 children die each day and most of these children live in developing
countries. Malnutrition contributes to these deaths.
164. The Delegation of India also pointed out that improving nutritional standards, particularly in the
early years, is crucial for achieving the “Millennium Development Goals”, and that priorities must be altered
for reducing child malnutrition by half by 2015. The delegation stated that while multiple strategies are
required for addressing the problems of under nutrition in children, issues of timely and adequate
complementary feeding with appropriate levels of nutritional density foods are very important.
165. The Delegation of India therefore urged the Committee to start working on a separate standard for
Processed Cereal-Based Foods for Underweight Infants and Young Children so that nutritionally and energy
dense composition in the proposed standard will help to reduce the burden of malnutrition in the developing
countries.
166. The Delegation of the EC, while acknowledging the importance of this problem in developing
countries, was of the view that the proposal for this work came in the beginning of the meeting and that it
was not enough time to study this question in detail. The Delegation indicated that a number of issues such
as nature of standard (regional or world-wide) and products concerned should be clarified. The delegation
indicated that more thorough analysis of the problem was needed and proposed to prepare a more structured
project document on this matter for consideration by the next session of the Committee.

13
CRD 9 (prepared by India).
ALINORM 08/31/26 19

167. The Delegation of Australia questioned whether the existing Codex Guidelines on Formulated
Supplementary Foods for Older Infants and Young Children could help to address this problem.
168. Several delegations and observers supported the spirit of the document and volunteered to join India
to develop the revised version of supporting document containing analysis and proposals on how the
Committee could address this issue.
169. The Committee agreed that the Delegation of India with assistance from other interested parties14
working electronically would revise the document in the light of comments at the current session and prepare
a more structured project document for consideration by the next session of the Committee.
Information from the Committee on Food Labelling
170. The Delegation of Canada, speaking as the Chair of the Committee on Food Labelling (CCFL),
informed the Committee of the decisions taken by the CCFL on eight recommendations contained in the
Draft Action Plan from WHO and FAO on the implementation of the WHO Global Strategy on Diet,
Physical Activity and Health as related to labeling. It was also recalled that a physical working group would
be held prior to the next CCFL session to discuss pending issues (ALINORM 07/30/22, paras. 20-64). The
Delegation expressed the view that there was a need to consider what mechanisms were available for inter-
committee communication and cooperation and seek guidance from WHO and FAO as to what were their
roles, responsibilities and obligations in assisting with the implementation of the Global Strategy in relation
to Codex activities.
171. The Chairperson thanked the Delegation of Canada for this information and recalled that the
Committee was also intensifying its work on nutrition issues identified by the Global Strategy, and
welcomed continued cooperation with the CCFL in order to ensure that Codex standards were consistent
with the Global Strategy.
172. The Delegation of the EC expressed the view that the Committee should consider the Action Plan
and for this purpose establish a physical working group prior to the next session in order to consider
additional issues that may arise from the discussions of the Committee on Food labelling, or any other
relevant nutritional issue relevant to the Global Strategy.
173. The Secretariat recalled that the Committee had complied with the request from the Commission
concerning the implementation of the Global Strategy, as it had replied specifically to the proposals from
WHO related to its mandate and was currently considering specific work of direct relevance to the Global
Strategy. There had been no request for consideration of other issues related to the Global Strategy by the
Commission, by other Committees or by any delegation for inclusion in the Agenda prior to the Committee
or as Other Business when adopting the Agenda, as only a presentation of CCFL work for information
purposes had been mentioned. The Secretariat noted that this Committee and the Committee on Food
Labelling regularly exchanged advice and cooperated quite efficiently, as had been the case regarding Global
Strategy issues of common relevance (NRVs). As regards procedures and mechanisms, any matter directed
by any Codex Committee to another was systematically brought to the attention of that Committee under
Matters Referred, while overall coordination regarding work on the Global Strategy was exercised by the
Commission. The Secretariat also recalled that if a working group was established, it should have a clear
mandate in application of the Guidelines for Physical Working Groups.
174. The Delegation of the United States suggested that in order to focus the discussion, a working group
could consider some issues related to current work which is related to the Global Strategy, such as the
extension of NRVs and substantiation of health claims. The Delegation of the European Community
supported this view and also suggested to consider the issues that may be coming from the discussions of the
CCFL or the Commission.
175. The Chairperson pointed out that in order to avoid confusion, it was important to give a clear
mandate if a working group was established, and recalled that important items of work related to the Global

14
Australia, Brazil, Ghana, Guatemala, Indonesia, Republic of Korea, Malaysia, Mexico, South Africa, Thailand, CI,
IBFAN, ISDI and NHF.
ALINORM 08/31/26 20

Strategy were currently under consideration: the scientific basis of health claims and NRVs for labelling
purposes. Discussion of these issues in a working group prior to the session might facilitate progress in the
Plenary Session, as it had been the case with other issues. Several delegations supported the consideration of
health claims and NRVs in a working group.
176. As regards other issues related to the Global Strategy, the Committee noted that it was not possible at
that stage to anticipate if any questions or requests would be referred to the CCNFSDU from either CCFL or
the Commission. The Committee therefore agreed with the proposal of the Delegation of France to insert a
general reference to other matters related to the WHO Global Strategy as this would allow the working group
to consider any relevant matters if required.
177. After some further discussion, the Committee agreed to convene a physical working group prior to
the next session, with the following mandate:
Within the context of the mandate of CCNFSDU, the Working Group is asked to consider:
• Issues of relevance to the implementation of the Global Strategy on Diet, Physical Activity and
Health which are under consideration by CCNFSDU
o NRVs; Health Claims; and
o any other matters related to the WHO Global Strategy
178. The Committee agreed that the physical Working Group, to be held immediately prior to the 30th
Session, would be co-chaired by France and the Republic of Korea and by the United States and that it would
work in English, French and Spanish.
Other Matters
Correction of report of the 28th session of the Committee
179. The Committee noted that the last sentence in paragraph 160 of ALINORM 07/30/26 should be
deleted as the Delegation of Norway had not supported the proposal on the revision of the Standard for
Processed Cereal-Based Foods for Infants and Young Children (Sections 3.2, 3.3 and 3.4) and that this was
not corrected at the adoption of of the report at the last session of the Committee.
DATE AND PLACE OF THE NEXT SESSION (Agenda Item 12)
180. The Committee was informed that its 30th Session would take place in South Africa from 3 to 7
November 2008, subject to confirmation by the host government and the Codex Secretariat. The Committee
thanked the Delegation of South Africa for its kind offer to host the next Session of the Committee.
ALINORM 08/31/26 21

SUMMARY STATUS OF WORK

Subject Matter Step For Action by Reference in
ALINORM 08/31/26
Draft Revised Standard for Foods for 8 Governments, 31th CAC para. 64 and
Special Dietary Use for Persons Appendix III
Intolerant to Gluten
Draft Advisory Lists of Nutrient 8 Governments, 31th CAC para. 78 and Appendix
Compounds for Use in Foods for IV
Special Dietary Uses Intended for
Infants and Young Children
Guidelines for Use of Nutrition 6 Governments; 30th CCNFSDU para. 41 and Appendix II
Claims: Draft Table of Contents for
Nutrient Contents (Part B Containing
Provisions on Dietary Fibre)
Draft Advisory List of Nutrient 6 Governments, 30th CCNFSDU paras 75-78 and
Compounds for Use in Foods for Appendix V
Special Dietary Uses Intende for
Infants and Young Children: Part D
Advisory List of Food Additives for
Special Nutrient Forms: Provisions
on gum arabic (gum acacia)
Establishment and Application of 5 Governments; 31th CAC; 30th para. 121 and Appendix
Risk Analysis Principles by the CCNFSDU VI
Codex Committee on Nutrition and
Foods for Special Dietary Uses.
Proposed Draft Recommendations on 2/3 France with assistance of para. 97
the Scientific Basis of Health Claims EWG; Governments; 30th
CCNFSDU
Proposal for New Work to Amend the Canada; 30th CCNFSDU paras 141-148
Codex General Principles for the
Addition of Essential Nutrients to
Foods (CAC/GL 09-1987)
Proposal for New Work to Establish a - India with assistance of EWG; paras 160169
Standard for processed cereal-Based 30th CCNFSDU
Foods for Underweight Infant and
Young Children
New work
Additional or Revised Nutrient 1/2/3 61st CCEXEC, 31st CAC; paras 122-133;
Reference Values (NRVs); Republic of Korea with
Project document is available in assistance of EWG;
Appendix VII
Appendix VII of CX/NFSDU Governments; 30th CCNFSDU
08/29/8.
ALINORM 08/31/26 22

LIST OF PARTICIPANTS
LISTE DES PARTICIPANTS
LISTA DE PARTICIPANTES

CHAIRPERSON/PRESIDENT/PRESIDENTE
Dr Rolf Grossklaus
Director and Professor
Federal Institute for Risk Assessment (BfR)
P.O. Box 33 00 13
14191 Berlin,
Germany
Tel: +49 (1888) 4 12 – 32 30
Fax: +49 (1888) 5 29 – 49 65
E-Mail: ccnfsdu@bmelv.bund.de

ASSISTANTS TO THE CHAIRPERSON/ASSISTANT AU PRESIDENT/

ASISTENTE AL PRESIDENTE
Ms Katharina Adler
Federal Ministry of Food, Agriculture
and Consumer Protection
Rochusstraße 1
53123 Bonn
Germany
Tel: +49 (228) 99 4647
Fax: +49 (228) 99 4965
E-Mail: katharina.adler@bmelv.bund.de

MEMBER COUNTRIES/PAYS MEMBRES/ ARGENTINA / ARGENTINE

PAYSES MIEMBROS Prof Maria Luz Martinez

ANGOLA Farm./Lic. En Industrias

Dr Esmeralda Mateus Jùnior Administracion nacional de Medicamentos,

Coordenadora do Sub-Comité de Higiene dos Alimentos

Alimentos y Tecnologia Medica (ANMAT)

Nutrição des Alimentos

Instituto Nacional de Alimentos (INAL)

Comité Nacional para o Código Alimentar em Angola

Estados Unidos 25

Ministério de Agricultura e Desenvolvimento Rural,

7° andar Rua comandante Gika 1101 Ciudad Autonoma de Buenos Aires

527 Luanda Argentina

Angola Tel.: +54 (11) 4340 0800 int 3514

Tel.: +244 912 247965 Fax: +54 (11) 4373 2001

Fax: +244 (2) 2223 23724 E-Mail: mmartin@anmat.gov.ar

E-Mail: secretariado_codex@yahoo.com.br Mrs Elizabeth Miriam Kleiman

Dr Lidia Garcia Júnior Morais Lic. En Nutrición

2ª Secretária Executiva Adjunta do Comité Nacional Secretaria de Agricultura, Ganaderia, Pesca y

para Código Alimentar em Angola Alimentos-SAGPYA

Ministério de Agricultura e Desenvolvimento Rural, Av. Paseo Colón 922 Piso 2 Of. 222

7° andar Rua comandante Gika C1063ACW Buenos Aires

527 Luanda Argentina

Angola Tel.: +54 (11) 4349 2236

Tel.: +244 923 316678 Fax: +54 (11) 4349 2097

Fax: +244 (2) 2223 23724 E-Mail: ekleim@mecon.gov.ar

E-Mail: lidiamorais43@hotmail.com.br

ALINORM 08/31/26 23

AUSTRALIA / AUSTRALIE BARBADOS / BARBADE

Ms Janine Lewis Mrs Cheryl Lewis
Principal Nutritionist Technical Officer
Food Standards Australia New Zealand Barbados National Standards Institution
P.O. Box 7186 Flodden, Culloden Road
Canberra BC ACT 2610 St. Michael
Australia Barbados, West Indies
Tel.: +61 (2) 6271 2245 Tel. : +1809 246 426 3870
Fax: +61 (2) 6271 2278 Fax : +1809 246 436 1495
E-Mail: janine.lewis@foodstandards.gov.au E-Mail : clewis@bnsi.com.bb
Ms Jenny Hazelton BELGIUM / BELGIQUE / BÉLGICA
Manager Public Health Nutrition Standards Pascale De Gryse
Food Standards Australia New Zealand Expert
P.O.Box 7186 Service public fédéral de la Santé Publique, Sécurité de
Canberra B.C.ACT 2610 la Chaîne alimentaire et Environnement
Australia Eurostation Bloc II Place Victor Hugo 40 bte 10
Tel.: +61 (2) 6271 2623 1060 Bruxelles
Fax: +61 (2) 6271 2278 Belgium
E-Mail: jenny.hazelton@foodstandards.gov.au Tel.: +32 (0) 2 524 7368
Mrs Victoria Landells Fax: +32 (0) 2 524 7399
Regulatory Strategist – Health and Nutrition E-Mail : pascale.degryse@health.fgov.be
Fonterra Mr José Bontemps
327 Ferntree Gully Road, Mt Waverly Conseiller scientifique et nutritionnel
3149 Victoria SPADEL
Australia Rue Colonel Bourg 103
Tel.: +61 (3)8541 1327 1030 Bruxelles
Fax: +61 (3) 8541 1462 Belgium
E-Mail: victoria.landells@fonterra.com Tel.: +32 (2) 702 3811
Ms Usha Sriram-Prasad Fax: +32 (2) 702 3812
Australian Government Mr Wim Caers
Department of Agruculture, Fisheries & Forestry Regulatory Affairs Manager
GPO Box 858 Beneo
Canberra 2601 Aandorenstraat 1
Australia ACT 3300 Tienen
Tel.: +61 (2) 6272 3547 Belgium
Fax: +61 (2) 6272 4367 Tel:: +32 (16) 801 483
E-Mail: usha.sp@daff.gov.au Fax: +32 (16) 801 359
Ms Jennifer McDonald E-Mail : wim.caers@beneo-group.com
Australian Government BENIN/BÈNIN
Department of Health and Aging Dr. Denis Mikode
GPO Box 9848 MPD 15 ACT Directeur Alimentation et Nutrition Appliquée
2601 Canberra Secrétaire Permanent du du Comité National duCodex
Australia Alimentarius
Tel:: +61 (2) 6289 7107 BP. 295 Porto Novo
E-Mail: jennifer.macdonald@health.gov.au Benin
AUSTRIA/AUTRICHE Tel.: +229 9595 8422
Dr Fritz Wagner Fax: +229 2021 3963
Federal Ministry for Health, Family and Youth E-Mail: admikode@yahoo.fr
Radetzkystrasse 2 BOLIVIA / BOLIVIE
1030 Vienna Mr Edwin Villegas Villarreal
Austria Handelsattaché
Tel.: +43 (1) 7 11 00 44 26 Wichmannstraße 6
E-Mail: fritz.wagner@bmgfj.gv.at 10787 Berlin
Tel.: +49 (30) 263915 0
Fax: +49 (30) 263915 15
E-Mail: embajada.bolivia@berlin.de
ALINORM 08/31/26 24

BRAZIL / BRÉSIL / BRASIL Ms Christina Zehaluk

Mrs Elisabete Gonçalves Dutra Head, Special Purpose Foods
Technical Assistant Bureau of Nutritional Sciences
National Health Suveillance Agency – Anvisa Food Directorate
SEPN 511 – Bloco A - Edificio Bittar II Health Canada
70750-541 Brasília – DF 251 Sir Frederick Banting Driveway
Brazil 2203A Banting Research Centre Tunneys Pasture
Tel:: +55 (61) 3448 6285 K1A OK9 Ottawa, Ontario
Fax: +55 (61) 3448 6274 Canada
E-Mail: elisabete.goncalves@anvisa.gov.br Tel.: +1 (613) 957 1739
Miss Erika Carvalho Fax: +1 (613) 941 6636
Regulatory Affairs Adviser E-Mail: christina_zehaluk@hc-sc.gc.ca
ABIA – Brazilian Food Manufactures Association Dr Anne MacKenzie
Av Brigadeiro Faria Lima, 1478 – 11° andar Senior Advisor, Vice-President, Programs
01451-001 Sao Paulo Canadian Food Inspection Agency
Brazil 159 Cleopatra Drive
Tel.: +55 (11)5508 7564 K1A OY9 Ottawa, Ontario
Fax: +55 (11) 5508 7503 Canada
E-Mail: erika.carvalho@br.nestle.com Tel.: +1 (613) 221 7084
Mrs Tais Porto Oliveira Bevilaqua Fax: +1 (613) 221 6656
Specialist in Health Surveillance E-Mail: amackenzie@inspection.gc.ca
General Coordination of Food and Nutrition Policy Ms Charmaine Kuran
Ministry of Health National Manager
SEPN 511, Bl. C. Ed. Bittar IV, 4° andar Nutrition and Health Claims
70750-543 Brasilia Consumer Protection Division
Brazil Canadian Food Inspection Agency
Tel.: +55 (61) 3448 8231 159 Cleopatra Drive
Fax: +55 (61) 3448 8228 K1A OY9 Ottawa, Ontario
E,Mail: tais.porto@saude.gov.br Canada
Miss Aline Cristino Figueiredo Tel.: +1 (613) 221 7200
Specialist in Health Surveillance Fax: +1 (613) 221 7295
National Health Surveillance Agency E-Mail: kuranc@inspection.gc.ca
Ministry of Health CHILE/CHILI
SEPN 511, Bl. A, Ed. Bittar II, 2° andar Dr Lorena Rodriguez-Osiac
70750-541 Brasilia Médico Pediatra Magister en Nutrición
Brazil Ministerio de Salud
Tel.: +55 (61) 3448 6352 Mac Iver 459 8° Piss. Dpto. Alimentos y Nutrición
Fax: +55 (61) 3448 6274 Santiago
E-Mail: aline.figueiredo@anvisa.gov.br Chile
CANADA/CANADÁ Tel.: +56 (2) 5740474
Dr Mary L’Abbé E-Mail: lrodriguez@minsal.cl
Director Mrs Gisela Rodriguez Rideau
Bureau of Nutritional Sciences Magister en Ciencias
Food Dirctorate, Health Canada Nestlé
251 Sir Frederick Banting Driveway, 2203 C Roger de Flor 2800 – Las Cones
Ottawa, Ontario Santiago
K1A OL 2 Chile
Canada Tel.: +56 (2) 3384232
Tel.: +1 (613) 948-8476
E-Mail: gisela.rodriguez@cl.netsle.com
Fax: +1 (613) 948 8470
E-Mail: mary_labbe@hc-sc.gc.ca
ALINORM 08/31/26 25

Mr Juan Carlos Sola Alcázar Mr Hongmin Xu

Dietitian Regulatory Director
Abbott, Chile Amway (China) Co.Ltd
Av El Salto 5380 Huechuraba 233 Tianhe N. Road
Santiago 510613 Guangzhou
Chile P. R. China
Tel.: +56 (2) 750 6043 Tel. : +86 (20) 8519 8811
E-Mail: juan.sola@abbott.com Fax : +86 (29) 3891 2807
E-Mail : nmxtiger@163.com
CHINA/CHINE
Prof. Shi An Yin Mr Jian Bo Zhang
Director of the Department of Maternal and Assistant Resercher
Child Nutrition National Institute of Nutrition and Food Safety, China
National Institute for Nutrition and Food Safety 7 Panjiayuan Nanli, Chaoyang district
Chinese Center for Diseases Control and Prevention 100021 Beijing
29 Nan Wei Road, Xuanwu District China
Beijing 100050 Tel.: +86 (10) 8777 6914
P. R. China Fax: +86 (10) 6771 1813
Tel.: +86 (10) 8313 2932 E-Mail: zhjb318@sina.com
Fax: +86 (10) 8313 2021
Mrs Zhaoxia Shi
E-Mail: shianyin@public.bta.net.cn
Shanghai Wyeth Nutritional Co., Ltd.
Dr. Xuejun Zhao Beijing Office
Medical Director Suit 901, 905-909, China Life Tower
Nutricia China Baby Food 16 Chaoyangmenwai Avenue
15th Floor 1504 Westgate Hall Chaoyang District Beijing 100020
1038, Nanjing Road West Tel.: +86 (10) 6580 5237
Shanghai, 200041 Fax: +86 (10) 6580 5399
P. R. China E-Mail: Shis4@wyeth.com
Tel.: +86 (21) 5899 0899 Mr Xudong Zhang
Fax: +86 (21) 5899 5256 Deputy Director
E-Mail: xuejun.zhao@nutricia.com.cn Bureau of Health Supervision
Prof. Kun Wu Ministry of Health,
Public Health Institution 1 Xizhimenwai, Xicheng District
Department Director 100044 Beijing
Nutrition and Food Hygiene Department, China
Harbin Medical University Tel.: +86 (10) 68792594
157, Baojian Road, Nangang Fax: +86 (10) 6879 2408
150086 Harbin E-Mail: zhangxd@moh.gov.cn
P. R. China DENMARK / DANEMARK / DINAMARCA
Tel.: +86 (451) 8750 2826 Ms Anne Scott
Fax : +86 (451) 8750 2885 Master of Food Science an Technology
E-Mail : wukun@public.hr.hl.cn Danish Veterinary and Food Administration
Prof. Zhixu Wang Mørkhøj Bygade 19
Deputy Director 2860 Søborg
Institute of Medical Nutrition and Food Hygiene, Denmark
Qingdao University Medical College Tel : +45 3395 6142
38, Dengzhou Road, Qingdao University Medical E-Mail : ansc@fvst.dk
College Mr Søren Langkilde
266021 Qingdao Master of Biology
P.R. China Danisch Veterinary and Food Administration
Tel.: +86 (532) 8381 2234 Division of Nutritioin
Fax : +86 (532) 8381 2243 Mørkhøj Bygade 19
E-Mail : zhixuwang@tch.qdu.edu.cn 2860 Søborg
Denmark
Tel.: +45 3395 6143
E-Mail: srbl@fvst.dk
ALINORM 08/31/26 26

EGYPT / ÉGYPTE / EGIPTO Ms Ariane Vander Stappen

Prof Abd el Aziz Mohammed Hosni Policy officer
Deputy Permanent Representative of Egypt European Commission
Agricultural Counsellor
Directorate-General SANCO
Embassy of Arab Republic of Egypt
1049 Brussels
Via Salaria 267
Belgium
00199 Rome
Italy Tel.: +32 (2) 2952 158
Tel.: +39 (6) 854 8956 Fax: +32 (2) 2951 735
Fax: +39 (6) 854 2603 E-Mail: ariane.vander-stappen@ec.europa.eu
E-Mail: egypt@agrioffegypt.it Ms Eva Maria Zamora Escribano
ERITREA / ÉRITHRÉE Administrator
Mrs Amleset Hagos European Commission
IYCF Focal Person Rue Froissart 101 – 2/60
Ministry of Health 1040 Brussels
Asmara Belgium
Eritrea Tel :: +32 (2) 299 8682
Tel.: +291 (1) 120297 Fax : +32 (2) 299 8566
Fax: +291 (1) 121614 E-Mail: eva-maria.zamora-escribano@ec.europa.eu
E-Mail: amleset@moh.gob.er Mrs Bernadette Klink-Khachan
ESTONIA / ESTONIE Codex Coordinator
Ms Ursula Siim European Commission
Chief Specialist of the Food Safety Bureau, Food and Rue Froissart 101 – 2/64
Veterinary Department 1040 Brussels
Ministry of Agriculture Belgium
39/41 Lai Street Tel. : +32 (2) 295 7908
15056 Tallinn Fax : +32 (2) 299 8566
Estonia
E-Mail: Bernadette.klink-khachan@ec.europa.eu
Tel.: +372 625 6547
Fax: +372 625 6210 FINLAND / FINLANDE / FINLANDIA
E-Mail: ursula.siim@agri.ee Ms Kaisa Vaihia
Senior Advisor
EUROPEAN COMMUNITY / COMMUNAUTÉ EUROPÉENNE / Ministry of Trade and Industry
COMUNIDAD EUROPEA P.O.Box 32
Mr Basil Mathioudakis 00023 Government, Finland
Head of Unit Tel.: +358 (9) 1606 3536
European Commission Fax: +358 (9) 1606 2670
Rue Froissart 101 E-Mail: kaisa.vaihia@ktm.fi
1049 Brussels Ms Sirpa Sarlio-Lähteenkorva
Belgium
Ministerial Adviser
Tel.: +32 (2) 2959 182
PhD, Adjunct professor
Fax: +32 (2) 2961 735 Ministry of Social Affairs and Health
E-Mail: basil.mathioudakis@ec.europa.eu
Health Department
Ms Helen Lee P.O. Box 33
European Commission 00023 Government, Finland
Directorate-General SANCO Tel.: +358 (9) 16 07 40 35
Rue Froissart 101 Fax: +358 (9) 16 07 41 44
1049 Brussels E-Mail: sirpa.sarlio-lahteenkorva@stm.fi
Belgium
Ms Annika Nurttila
Tel.: +32 (2) 299 8668 Senior Officer
E-Mail : helen.lee@ec.europa.eu
Finnish Food Safety Authority Evira
Mustialankatu 3
00790 Helsinki
Finland
Tel.: +358 (50) 5576414
Fax: +358 (50) 2077 24277
E-Mail: annika.nurttila@evira.fi
ALINORM 08/31/26 27

FRANCE / FRANCIA GERMANY / ALLEMAGNE / ALEMANIA

Mrs Caroline Jayet Dr Pia Noble
Direction générale de la concurrence, de la Federal Ministry of Food,
consommation et de la répression des frances Agriculture and Consumer Protection
Bureau D 3 Rochusstrasse 1
Teledoc 251 53123 Bonn
59 bd Vincent Auriol Germany
75703 Paris 13e Tel.: +49 (228) 99 46 65
France Fax: +49 (228) 99 49 65
Tel. : +33 (1) 4497 2911 E-Mail: pia.noble@bmelv.bund.de
Fax : +33 (1) 4497 3048
Dr. Claudia Dietrich
E-Mail : caroline.jayet@dgccrf.finances.gouv.fr
Federal Ministry of Food,
Mr Pascal Audebert Agriculture and Consumer Protection
Point de Contact du Codex alimentarius en France Rochusstrasse 1
Premier Ministre 53123 Bonn
Secrétariat général des Affaires européennes Germany
2, boulevard Diderot Tel.: +49 (228) 99 46 65
75572 Paris Cedex 12 Fax: +49 (228) 99 49 65
France E-Mail: Claudia.dietrich@bmelv.bund.de
Tel.: +33 (1) 44 87 16 03
Dr. Joachim Bollmann
Fax: +33 (1) 44 87 16 04
Federal Ministry of Food,
E-Mail: pascal.audebert@sgae.gouv.fr
Agriculture and Consumer Protection
Mrs Murielle Clémenté Rochusstrasse 1
Ministère de la Santé de la jeunesse et des sports, 53123 Bonn
DGS, Bureau alimentation et nutrition Germany
14, Avenue Duquesne Tel.: +49 (228) 99 3784
75350 Paris Fax: +49 (228) 99 3743
France E-Mail: joachim.bollmann@bmelv.bund.de
Tel.: +33 (1) 4056 4332
Mrs Ingrid Kundoch
Fax: +33 (1) 4056 5412
Bundesministerium für Wirtschaft und Technologie
E-Mail: murielle.clemente@sante.gouv.fr
Villemombler Str. 76
Mrs Françoise Costes 53123 Bonn
Association de la Transformation Laitière Française Germany
ATLA Tel.: +49 (1888) 615 3513
42 Rue de Châteaudun Fax: +49 (1888) 615 2765
75314 Paris Cedex 09 E-Mail: ingrid.kundoch@bmwi.bund.de
France
Ms Anke Weissenborn
Tel.: +33 (1) 4970 7269
Bundesinsitut für Risikobewertung
Fax: +33 (1) 4280 6362
Federal Institute for Risk Assessment
E-Mail: trs@atla.asso.fr
Thielallee 88-92
Mrs Catherine Vigreux 14195 Berlin
Société Roquette Freres Germany
Route de la Gorgue Tel.: +49 (30) 8412 3812
62136 Lestrem Fax: +49 (30) 8412 3715
France E-Mail: anke.weissenborn@bfr.bund.de
Tel. : +33 (3) 2163 3763
Mrs Renate Scherer
Fax : +33 (3) 2163 3850
Lebensmittelchemikerin
E-Mail : catherine.vigreux@roquette.com
Chemisches Landes- und Staatliches
Mr Jean-Claude Attale Veterinäruntersuchungsamt
Regulatory Affairs Director Joseph-König-Straße 40
Cargill Texturizing Solutions 48147 Münster, Germany
Tel:: +33 (1) 3061 3741 Tel.: +49 (251) 98 21 - 2 28
Fax: +33 (1) 3904 6799 Fax: +49 (251) 98 21 - 2 50
E-Mail : jean.claude_attale@cargill.com E-Mail: scherer@cvua.nrw.de
ALINORM 08/31/26 28

Ms Katrin Woese
Norbert Pahne
Landesamt für Verbraucherschutz Sachsen-Anhalt
Diätverband e.V.
Fachbereich Lebensmittelsicherheit
Godesberger Allee 142-148

Freiimfelder Str. 66-67

53175 Bonn
06112 Halle/Saale
Germany
Germany
Tel.: +49 (228) 308 5110

Tel.: +49 (345) 564 3434

Fax: +49 (228) 308 5150

Fax: +49 (345) 564 3403

E-Mail: diaetverband@t-online.de
E-Mail: katrin.woese@lav.ms.sachsen-anhalt.de
Dr. Gerda Jost

Mrs Sofia Beisel

Manager Corporate & Regulatory Affairs

Dipl. Oec. troph.

Milupa GmbH

Deutsche Zöliakie-Gesellschaft e.V.

Bahnstr. 14 -30

Filderhauptstraße 61
61381 Friedrichsdorf

70599 Stuttgart
Germany

Germany
Tel.: +49 6172 991423

Tel.: +49 (711) 459981

Fax: +49 6172 991250

Fax: +49 (711) 459981-50

E-Mail: gerda.jost@milupa.de

Mrs Stefanie Rams

Mrs Constanze Hiepler

Manager Scientific and Regulatory Affairs

Diätverband e.V.

Bund für Lebensmittelrecht und Lebensmittelkunde e.V.

Association of Manufacturers of Dietetic Foods

Godesberger Allee 142-148

Godesberger Allee 142-148

53175 Bonn, Germany

53175 Bonn

Tel.: +49 (288) 8199 3146

Germany

Fax: +49 (228) 8199 3246

Tel.: +49 (228) 30851-0

E-Mail: srams@bll-online.de
Fax: +49 (228) 30851-50

Mrs Gertrud Granel

E-Mail. hiepler@diaetverband.de

Fachbverband der Stärke Industrie e.V.

GHANA
Königstraße 57
Ms Maria Lovelace-Johnson

53115 Bonn
Head, Food Safety Management Unit

Germany
Food and Drugs Board

Tel.: +49 32 2212 07261

P.O.Box CT 2783

Fax: +49 30 8871 3398-19

Accra

E-Mail: g.granel@verbaende-jess.de
Ghana

Tel.: +233 (20) 8115619

Dr Gert Krabichler
Fax: +233 (21) 660389

Capsugel – a division of Pfizer

E-Mail: mariluv2004@hotmail.com

10, rue Timken

GREECE / GRÈCE /GRECIA

France

Mrs Magdalini Zika

Tel.:

Pharmacist

Fax: +33 3 8941 4811

Hellenic Food Authority (EFET)

E-Mail: gert.krabichler@pfizer.com
124 Kifisias Av. & 2

Dr Michael Packert
Iatridou Str. Ampelokipi

Südzucker AG
11526 Athens

Gottlieb-Daimler-Str- 12
Greece

68165 Mannheim
Tel.: +30 210697 1554

Tel.: +49 (621) 421 573

Fax: + 30 210697 1501

Fax_ +49 (621) 421 574

E.Mail: mzika@efet.gr

E-Mail: michael.packert@suedzucker.de

ALINORM 08/31/26 29

GUATEMALA Dr G.S. Toteja

Ing. Ana Marroquin Deputy Director General (Senior grade)
Asistente Codex Alimentarius Guatemala Indian Council of Medical Research
Miembro del Comite del Codex sobre Nutricion y Ansari Nagar
Alimentos para Regimenes Especiales (CCNFSDU) New Delhi 110029
Ministerio de Agricultura, Ganaderia y Alimentación India
7a. Avenida 12-90 zona 13 Tel.: +91 (11) 2658 8762
Edificio Infoagro, 2do nivel, oficina 4 Fax: +91 (11) 2658 8762
01013 Guatemala E-Mail: gstoteja@yahoo.com
Guatemala Mr Yogesh Kumar Verma
Tel.: +502 2413 7466 Food Regulatory Affairs Manager
Fax: +502 2434 4619 Confederation of Indian Industry
E-Mail: ana.marroquin@maga.gob.gt 23, Lodhi Road Institutional Area
Dr Antonio Ferraté de la Riva 110003 New Delhi
Coordinador Nacional Codex Alimentarius Guatemala India
Ministerio de Agricultura, Ganaderia y Alimentación Tel.: +91 9971 552655
7a. Avenida 12-90 zona 13 E-Mail: vermayk@indiatimes.com
Edificio Infoagro, 2do nivel, oficina 4 INDONESIA / INDONÈSIE/INDONESIA
01013 Guatemala Ms Sri Irawati Susalit
Guatemala Director for Food Standardization
Tel.: +502 2413 7466 National Agency for Drug and Food Control
Fax: +502 2434 4619 Jalan Percetakan Negara No 23
E-Mail: antonio.ferrate@maga.gob.gt Jakarta 10560
HUNGARY / HONGRIE / HUNGRÌA Indonesia
Dr Éva Barna Tel.: +62 (21) 4287 5584
Head of Department Fax: +62 (21) 4287 5780
National Institute for Food Safety and Nutrition E-Mail: iras48@yahoo.com
Gyáli út 3/a Mrs Tetty Helfery Sihombing
1097 Budapest Head of Subdirectorate of Certain Food
Hungary National Agency of Drug and Food Control
Tel.: +36 (1) 476 6444 Jl. Percetakan Negara No.23
Fax: +36 (1) 215 5369 10560 Jakarta
E.Mail: barna.eva@oeti.antsz.hu Indonesia
INDIA / INDE Tel:: +62 (21) 4287 5584
Ms Pradeep Bolina Fax: +62 (21) 4287 5780
Joint Secretary to the Government of India E-Mail: tettyhelfery@yahoo.com
Ministry of Women and Child Development IRAQ
Shastri Bhawan, Dr. Rajendra Prasad Road, Dr Mohsin AL-Delfi
110001 New Delhi Director, Diet Therapy Department
India Nutrition Health Institute, Ministry of Health
Tel.: +91 (11) 2338 1654 A’adamiya Baghdad
Fax: +91 (11) 2307 0480 Baghdad
E-Mail: jspb-wcd@nic.in Republic of Iraq
Mr Shaminder Pal Singh Tel.: +964 7901 731620
Head – FICCI Codex Cell, E-Mail: mohsinaldelfi@yahoo.com
Federation of Indian Chambers of Commerce & Industry
Confederation of Indian Food Trade & Industry,
Federation House, Tansen Marg
110001 New Delhi
India
Tel.: +91 124 4539231
Fax: +91 124 4539200
E-Mail: shamindr@gmail.com
ALINORM 08/31/26 30

IRELAND / IRELANDE / IRLANDA Dr Ciro Impagnatiello

Ms Joan Regan Ministero delle Politiche Agricole Alimentari e Forestali
Assistant Principal Officer Via XX Settembre, 20
Dept. of Health and Children 00187 Rome
Hawkins House Italy
Hawkins Street Tel.: +39 (6) 4665 6046
2 Dublin Fax: +39 (6) 4880 273
Ireland E-Mail: c.impagnatiello@politicheagricole.it
Tel.: +353 (1) 6 35 42 47 JAPAN / JAPON / JAPÓN
Fax: +353 (1) 6 35 45 52 Dr Chieko Ikeda
E-Mail: Joan_regan@health.irlgov.ie Director
Dr Mary Flynn Office of International Food Safety
Chief Specialist Public Health Nutrition Department of Food Safety, Pharmaceutical and Food
Food Safety Authority of Ireland Safety Bureau
Abbey Court Minister of Health, Labour and Welfare
Lower Abbey Court 1-2-2 Kasumigaseki Chiyoda-ku
1 Dublin 100-8916 Tokyo
Japan
Ireland
Tel.: +81 (3) 3595 2326
Tel.: +353 (1) 817 1315
Fax: +81 (3) 3503 7965
Fax: +353 (1) 817 1215
E-Mail: codexj@mhlw.go.jp
E-Mail: mflynn@fsai.ie
Mr Katsuhiro Chosho
ISRAEL/ISRAË/
Deputy Director
Dr Ziva Stahl
Office of Health Policy on newly developed Foods
Director, Nutrition Department
Standards and Evaluation Division,
Ministry of Health
Department of Food Safety,
20 King David Street
Pharmaceutical and Food Safety Bureau, Ministry of
91010 Jerusalem
Health, Labour and Walfare
Israel
1-2-2 Kasumigaseki, Chiyoda-ku
Tel:: +972 (2) 622 8855
100-8916 Tokyo
Fax: +972 (2) 624 7173
Japan
E-Mail: ziva.stahl@moh.health.gov.il
Tel.: +81 (3) 3595 2327
ITALY/ITALIE/ITALIA Fax: +81 (3) 3501 4867
Dr Lucia Guidarelli E-Mail: codexj@mhlw.go.jp
Senior Officer
Mr Hiroaki Hamano
Dietetics and Nutrition Unit
Technical Advisor
Ministero della Salute
Japan Health Food and Nutrition Food Association
P. za Marconi, 25
2-7-27, Sadohara-cho, Ichigaya, Shinjuku-ku
00144 Roma
162-0842 Tokyo
Italy
Japan
Tel.: +39 (6) 5994 6828
Tel.: +81 (3) 3268 3134
Fax: +39 (6) 5994 6119
Fax: +81 (3) 3268 3136
E-Mail: l.guidarelli@sanita.it
E_Mail: hiroaki.hamamo@danisco.com
Mrs Brunella Lo Turco
Mr Yasuki Matsui
Ministero dellePolitiche AgricoleAlimentari e Forestali
Office of Health Policy on newly developed Foods
Via XX Settembre, 20
Standards and Evaluation Division, Department of Food
00187 Rome
Safety,
Italy
Pharmaceutical and Food Safety Bureau, Ministry of
Tel.: +39 (6) 46656041
Health, Labour and Walfare
Fax: +39 (6) 4880273
1-2-2 Kasumigaseki, Chiyoda-ku
E-Mail: qpa6@politicheagricole.it
100-8916 Tokyo
Dr. SSA Anna Paonessa Japan
AIPA (Italian Association of Food Industries) Tel.: +81 (3) 3595 2327
Corso di Porta Nuova 34 Fax: +81 (3) 3501 4867
20121 Milano, Italy E-Mail: codexj@mhlw.go.jp
Tel.: +39 (2) 65 41 84
Fax: +39 (2) 65 48 22
ALINORM 08/31/26 31

Mr Masahiro Miyazako JORDAN / JORDANIE / JORDANIA

Associate Director Dr Fuad Daas
International Affairs Division, Food Safety and Food Control Assit. Director
Consumer Affairs Bureau, Ministry of Agriculture, Jordan Food and Drug Administration
Forestry and Fisheries Food Control Directorate
1-2-1 Kasumigaseki, Chiyoda-Ku 3rd Circle – Jabal Amman-
100-8950 Tokyo PO Box 811 951
Japan 11181 Amman
Tel. : +81 (3) 3502 8732 Jordan
Fax : +81 (3) 3507 4232 Tel. : +962 6460 2019
E-Mail : masahiro_miyazako@nm.maff.go.jp Fax : +962 6562 6325
Dr Hiroshi Tsuchita E-Mail : fuad.daas@jfda.jo
Technical Advisor Ms Feryal Hishmeh
Japanese National Committee of IDF Nutritionist
Nyugyo-kaikan Jordan Food and Drug Administration
1-14-19 Kudankita, Chiyoda-ku Drug Control Directorate
102-0073 Tokyo 3rd Circle – Jabal Amman-
Japan PO Box 811 951
Tel.: +81 (3) 3264 3731 11181 Amman
Fax: +81 (3) 3264 3732 Jordan
Mr Tsuyoshi Urano Tel. : +962 795 247127
Section Chief Risk Assessment Division Fax : +962 4618425
Food Safety Commission Secretariat E-Mail: ferial.hishmeh@jfda.jo
Prudential Tower 6F KENYA / KENIA
2-13-10 Nagatacho, Chiyuda-ku Mrs Anne Mbugua
Tokyo 100-8989, Japan Chief Nutrition Officer
Tel. : +81 (3) 5251 9169 Kenyatta National Hospital
Fax. +81 (3) 3591 2236 P.O.Box 20723 Nairobi
E-Mail : codex@cao.go.jp 254 Nairobi
Dr Kazuhiko Yamada Kenya
Director Tel.: +254 2726300
Divison of Applied Food Research, E-Mail: annmbugua2003@yahoo.com
National Institute of Health and Nutrition KOREA, REPUBLIC OF / CORÉE, RÉPUBLIQUE DE / COREA,
1-23-1, Toyama, Shinjuku-ku REPUBLICA DE
162-8636 Tokyo Dr Oran Kwon
Japan Director
Tel.: +81 (3) 3203-5721 Devision of Health/Functional Food Standards
Fax: +81 (3) 3202 3278 Center for Nutrition & Functional Foods
E-Mail: peaceboy@nih.go.jp Korea Food and Drug Administration
194 Tongil-No, Eunpyoung-Gu
Dr Hiroshi Yoshikura 122-704 Seoul
Adviser Korea
Department of Food Safety, Pharmaceutical and Food Tel.: +82 (2) 380 1316
Safety Bureau Fax: +82 (2) 359 0025
Ministry of Health, Labour and Welfare E-Mail: orank@kfda.go.kr
1-2-2 Kasumigaseki, Chiyoda-ku
Prof Namsoo Chang
100-8916 Tokyo
Ewha Womans University, Dept. of Nutritional Science
Japan
11-1 Daehyun-dong, Seodaemun-ku
Tel.: +81 (3) 3595 2326
120750 Seoul
Fax: +81 (3) 3501 7965
Korea
E-Mail: codexj@mhlw.go.jp
Tel.: +82 (2) 3277 3468
Fax: +82 (2) 3277 2862
E-Mail: nschang@ewha.ac.kr
ALINORM 08/31/26 32

Adj. Prof. Hae-Rang Chung MACEDONIA, THE FMR YUG RP / MACÉDONIA L’EX RÈP
Ewha Womans University YOUG / MACEDONIA LA EX REP YUG
Dept. of Nutritional Science Dr Arsim Agushi
11-1 Daehyun-dong, Seodaemun-ku Head of Unit for Quality Insurance
120-750 Seoul Ministry of Health
Korea Food Directorate
Tel.: +82 (2) 886 0243 Str. “50-ta Divizija” Nr 6
Fax: +82 (2) 6008 6878 1000 Skopje
E-Mail: chunghr@empal.com Macedonia
Dr Jung-Ah Byun Tel.: + 389 (2) 3296 430
Science Officer Fax: +389 (2) 3296 823
Daejeon Regional Food & Drug Administration E-Mail: arsimagusi@yahoo.com
120 Seonsa-ro, Seo-Gu
MALAYSIA / MALASIE / MALASIA
302-828 Daejeon
Ms Rokiah Don
Korea
Senior Principal Assitant Director (Nutrition)
Tel.: +82 (42) 480 8786
Family Health Development Division
Fax: +82 (42) 480 8790
Department of Public Health
E-Mail: junga68@kfda.go.kr
Ministry of Health Malaysia
Ms Eunju Lee Level 7, Block E 10, Parcel E
Deputy Director Federal Government Administrative Centre
Nutritional Evaluation Team 62590 Putrajaya
Korea Food and Drug Administration Malaysia
#194 Tongil-Ro, Eunpyeong-Gu Tel.: +60 (3) 8883 4083
122-704 Seoul Fax: +60 (3) 8883 6175
Korea E-Mail: rokiah@moh.gov.my
Tel.: +82 (2) 380 1678
Ms Norrani Eksan
Fax: +82 (2) 359 0867
Senior Principal Assistant Director
E-Mail: Eunju@korea.kr
Food Safety and Quality Division
Miss So Yoon Yun Department of Public Health
Senior Researcher Ministry of Health Malaysia
Korea Food and Drug Administration Level 3, Block E 7, Parcel E
#194 Tongil-Ro, Eunpyeong-Gu Federal Government Administrative Centre
122-704 Seoul 62590 Putrajaya
Korea Malaysia
Tel.: +82 (2) 380 1317 Tel.: +60 (3) 8883 3511
Fax: +82 (2) 359 0025 Fax: +60 (3) 8883 3815
E-Mail: ysy0614@kfda.go.kr E-Mail: norrani@moh.gov.my
LITHUANIA / LITUANIE / LITUANIA Dr Tangavelu Thiagarajan
Ms Indre Chmieliauskaite Regional Manager
Head of Department Malaysian Palm Oil Board
National Nutrition Centre of Ministry of Health 3516 International Court, N.W.
Kalvariju 153 20008 Washington D.C.
LT-08221 Vilnius USA
Lithuania Tel.: +1 (202) 572 9719
Tel:: +370 5277 8919 Fax: +1 (202) 572 9783
Fax: +370 5277 8713 E-Mail: mpobtas@aol.com
E-Mail: indre@rmc.lt
ALINORM 08/31/26 33

MEXICO / MEXIQUE / MÉXICO Miss Zully Corona

Mr Javier Luna Research and Development/Regulatory Affairs
Subdirector Ejucativo de Seguimiento de Proyectos de Grupo Bimbo Mexico
Fomento Prolongacion Paseo de la Reforma No. 1000
Comisión de Fomento Sanitario Col. Peña Blanca Sasnta Fe. Deleg. Alvaro Obregón
Comisión Federal para la Protección contra riesgos 01210 Mexico D.F.
Sanitarios Secretaría de Salud Mexico
Monterrey #33 5° Piso, Colonia Roma, Delegación Tel. : +52 (55) 5268 6600 ext. 6367
Cuautémoc Fax : +52 (55) 5268 6602
06700 Ciudad de México E-Mail : zcorozur@grupobimbo.com
México MONGOLIA / MONGOLIE
Tel.: +52 (55) 5080 5200, ext: 1401 Ms Batsaikhan Enkhtungalag
E-Mail: javierluna@salud.gob.mx Head, Nutrition & Food Safety team,
Mrs Martha Galicia Secretary of the National Codex Team
Consultant Nutrition Research Center, Public Health Institute
Consejo Mexicano de la Industria de Productos de Of the Ministry of Health
Consumo A.C. Peace Avenue-17, Bayanzurkh District
Seneca 65 211049 Ulaanbaatar
Col. Chapultepec Polanco Mongolia
11560 Ciudad de México Tel.: +976 (11) 455600
México Fax: +976 (11) 458645
Tel.: +52 (55) 5280 4335 E-Mail: dulaanuul@hotmail.com
Fax: +52 (55) 5280 4335 MOROCCO / MAROC / MARRUECOS
E-Mail: mgalicia@conmexico.com.mx Mr Moha Bouchebcheb
Miss Claudia Jaquez Chef de Service
Coordinadora de Asuntos Regulatorios Nutricionales Direction de la Protection des Végétaux, des Contrôles
Abbot Laboratories de México S.A. De C.V. Techniques et de la Répression des Fraudes
Av. Coyoacán No 1622, Colonia del Valle, Delegación Ministére de l’Agriculture, du Développement Rural et
Benito Juarez des Pêches Maritimes
03100 Ciudad de México Avenue My Ismail, B.P. 183,
México 46000, Safi
Tel:: +52 (55) 5726 4700 Maroc
Fax: +52 (55) 5726 4601 Tel.: +212 2462 8953
E-Mail: claudia.jaquez@abbott.com E-Mail: bchebm@menara.ma
Ms Delia Altamirano Dr Mustapha Mahfoudi
Directora de Asuntos Regulatorios Physician
Pepsico Internacional Ministry of Health
Bosques de Durazno #67 Piso 9 Direction de la Population
Col. Bosques de las Lomas Ministère de la Santé
11700 Diudad de México Km 4.5 Route de Casablanca
México 46000 Rabat
Tel.: +52 (55) 2582 4746 Maroc
Fax: +52 (55) 2582 4746 Tel. : +212 3729 9834
E-Mail: delia.altamirano@pepsico.com.mx Fax: +212 3729 9834
Dr Pedro Gutiérrez E-Mail: mmahfoudi@yahoo.fr
Director de Investigación Mr Jamal Ennassir
Instituto Nacional de Pediatría LOARC
Av. Insurgentes sur No 3700 Letra C, 1er Piso Torre, 25, rue Niehakra Rahal
Col. Insurgentes Cuicuilco, Delegación Coyoacán 20000 Casablanca
04530 Ciudad de México Morocco
México Tel:: +212 2230 2196
Tel:: +52 (55) 1084 0906 Fax: +212 2230 1972
Fax: +52 (55) 1084 3883 E-Mail: ennassir-jamal@yahoo.fr
E-Mail: pedrogtzca@prodigy.net.mx
ALINORM 08/31/26 34

MOZAMBIQUE
NIGERIA / NIGÉRIA
Mrs Francisca Barrote Cabral Mr Dennis Onyeagocha
Chief od Information Unit in SETSAN Mozambique Deputy Director
Food Security and Nutrition Secretariat Foods and Drug Services Dept.
Ministerio da Agriculture Federal Ministry of Health
2396 Maputo Federal Secretariat Complex Phase III
Mozambique 900244 Abuja
Tel. : +258 82 3943820 Tel.: +234 (9) 8033 147808
E-Mail : fcabral@setsan.org.mz E-Mail: dennyo_2003@yahoo.com
NETHERLANDS / PAYS BAS / PAÍSES BAJOS Mr Chris Ojembe
Mr Bas Van der Heide Chief Dept. of Food and Drug Services
Senior Policy Officer Federal Ministry of Health
Ministry of Health, Welfare and Sports Federal Secretariat
Nutrition, Health Protection and Prevention Department 900244 Abuja
P.O.Box 20350 Nigeria
2500 EJ The Haque Tel.: +234 (9) 8033 004551
The Netherlands NORWAY / NORVÈGE / NORUEGA
Tel.: +31 (70) 340 5619 Mrs Turid Ose
Fax: +31 (70) 340 5554 Senior Adviser
E-Mail: b.vd.heide@minvws.nl Norwegian Food Safety Authority
Dr Jaap Schrijver P.O.Box 383
2381 Brumunddal
Manager Regulatory Affairs Baby Foods
Norway
Royal Numico N.V.
Tel.: +47 2321 67 42
Schipol Boulevard 105
Fax: +47 2321 68 01
P.O.Box 75538 E-Mail: tuose@mattilsynet.no
1118 ZN Schipol Airport
The Netherlands Dr Linda Granlund
Tel.: +31 (20) 456 9466 Nutrition Manager
Fax: +31 (20) 456 8466 NBL/Mills DA
E-Mail: jaap.schrijver@numico.com Sofienberggata 19, POB 4644 Sofienberg
0506 Oslo
NEW ZEALAND / NOUVELLE-ZÉLANDE / NUEVA ZELANDA
Norway
Ms Jenny Reid
Tel.: + 47 9901 9418
Assistant Dirctor
Fax: +47 2238 2380
New Zealand Food Safety Authority
E-Mail: linda.granlund@mills.no
PO Box 2835
Level 4, Televom Building South Tower Prof Helle Margrete Meltzer
86 Jervais Quay Norwegian Institute of Public Health
6001 Wellington P.Box 4404 Nydalen
New Zealand 0403 Oslo
Tel.: +64 (4) 463 2582 Norway
Fax: +64 (4) 463 2583 Tel.: +47 2204 2337
E-Mail: jenny.reid@nzfsa.govt.nz Fax: +47 2204 2243
E-Mail: heme@fhi.no
Mr David Roberts
Programme Manager (Nutrition) PHILIPPINES / FILIPINAS
New Zealand Food Safety Authority Ms Maria Victoria Pinion
P.O.Box 2835 Nutritionist-Dietitian
Wellington Bureau of Food and Drugs – Department of Health
New Zealand Civic Drive Filinvest Corporate City,
E-Mail: david.roberts@nzfsa.govt.nz Alabang, Muntinlupa City
1770 Muntinlupa
Philippines
Tel.: +63 (2) 8425606
Fax: +63 (2) 8425606
E-Mail: vdpinion@yahoo.com.ph
ALINORM 08/31/26 35

Mrs Flerida Villamor

Dr. Luis Salino

#3 Magdalost.
Advisor

Real Vill. 2
Ministry of Agriculture Rural Development and Fisheries

Project 8
Rua Padre António Vieira, 1

Quezon City
1099-073 Lisbon

Philippines
Portugal

Tel.: +63 8418152

Tel.: +351 (21) 3819305

Fax: +63 8418194

Fax: +351 (21) 3866650

E-Mail: lida.villamor@bms.com
E-Mail: lsalino@gpp-pt

POLAND / POLOGNE / POLONIA Mr Kari Töllikkö

Prof Hanna Kunachowicz

Principal Administrator

Head of Department of Nutritional Value of Food

General Secretariat of the Council of the European Union

Products
The Portuguese Presidency

National Food and Nutrition Institute

Rue de la Loi 175

Powsinska 61/63
1048 Bruxelles

02903 Warsaw
Belgium

Poland
Tel.: +32 (2) 281 7841

Tel.: +48 (22) 5509 708

Fax: +32 (2) 281 6198

Fax: +48 (22) 8423 741

E-Mail : kari.tollikko@consilium.europa.eu

E-Mail: h.kunachowicz@izz.waw.pl
Mrs Pilar Velazquez

Dr Katarzyna Stos
Administrattor

Head of Food and Nutrition Safety Laboratory Unit

The Portuguese Presidency

National Food and Nutrition Institute

Rue de la Loi 175

61/63 Powsinska
1048 Bruxelles

02-903 Warsaw
Belgium

Poland
Tel.: +32 (2) 281 6628

Tel:: +48 (22) 842 2171

Fax: +32 (2) 281 7928

Fax: +48 (22) 842 1103

E-Mail: pilar.velazquez@consilium.europa.eu

E-Mail: k.stos@izz.waw.pl
SERBIA
Prof Janusz Ksiazyk
Prof Ivan Stankovic

Head, Dept. Pediatrics

Institute of Bromatology, Faculty of Pharmacy

Children’s Memorial Health Insitute

University of Belgrade

Dzieci Polskich 20
Vojvode Stepe 450

04-730 Warsaw
11000 Belgrade

Poland
Serbia

Tel.: +48 (22) 815 1216

Tel.: +381 (11) 3870 379 ext. 345

Fax: +48 (22) 815 1212

Fax: +381 (11) 3972 840

E-Mail: j.ksiazyk@czd.pl
E-Mail : istank@eunet.yu

PORTUGAL SINGAPORE / SINGAPOUR / SINGAPUR

Dr Dirce Silveira
Ms Lee San Lim

Senior Technician
Head, Pre-Market Approval Branch

Ministry of Health/Instituto Nacional de Saúde

Agri-Food and Veterinary Authority

Dr.Ricardo Jorge
5, Maxwell Road

Av. Padre Cruz

18-00 Tower Block, MND Complex

1649-016 Lisbon
069110 Singapore

Portugal
Singapore

Tel.: +351 (21) 751 9354

Tel.: +65 6325 8553

Fax: +351 (21) 752 6400

Fax: +65 6324 4563

E-Mail: dirce.silveira@insa.min-saude.pt
E-Mail: lim_lee_san@ava.gov.sg

ALINORM 08/31/26 36

SLOVAK REPUBLIC / SLOVAQUIE / ESLOVAQUIA SUDAN / SOUDAN / SUDÁN

Dr Iveta Truskova Mr Awad Mohamed Ahmed Sokrab
Public Health Authority of Slovak Republic Technical Affairs Administration Director
Ministry of Health FSR Sudanese Standards and Metrology Organization
Trnavska 52 Street Baledia
82645 Bratislava P.O.Box 13573
Slovak Republic Khartoum
Tel.: +421 (2) 444 55643 Sudan
Fax: +421 (2) 444 55643 Tel :: +249 (91) 501 6974
E-Mail: truskova@uvzsr.sk Fax : +249 (183) 774 852
E-Mail : awadsokrab@hotmail.com
SOUTH AFRICA / AFRIQUE DE SUD / SUDÁFRICA
Mrs Lynn Moeng Mr Ismail Ahmed Al Kamish
National Department of Health Food Control
Private Bag X828, Federal Ministry of Health
0001 Pretoria P.O.303 Khartoum
South Africa Sudan
Tel.: +27 (12) 312 0072 Tel.: + 249 91224 7820
Fax: +27 (12) 312 3112 Fax: +249 15514 5620
E-Mail: MoengL@health.gov.za E-Mail: kamish2005@hotmail.com
Mrs Andiswa Ngqaka SWEDEN / SUÈDE / SUECIA
National Department of Health Mrs Kristina Lagestrand Sjölin
Private Bag X828, Principal Administrative Officer
0001 Pretoria National Food Administration
South Africa Food Standards Department
Tel.: +27 (12) 312 0873 Box 622
Fax: +27 (12) 312 3112 SE-75126 Uppsala
E-Mail: NgqakA@health.gov.za Sweden
Tel.: +46 (18) 175500
Mrs Anne Pringle
Fax: +46 (18) 105848
Health Products Association
E-Mail: codex@slv.se
P.O.Box 68068
Bryanston 2021 Mrs Ingrid Lindeberg
South Africa Senior Administrative Officer
Tel.: +27 (11) 317 8300 National Food Administration
Fax: +27 (11) 317 8547 Box 622
E-Mail: anne@sportron.co.za SE-751 26 Uppsala
Sweden
SPAIN / ESPAGNE / ESPAÑA
Tel.: +46 (18) 175500
Ms Almudena Rollán
Fax: +46 (18) 105848
Spanish Food Safety and Nutrition Agency
E-Mail: codex@slv.se
Alcalá, no 56
28071 Madrid SWITZERLAND / SUISSE / SUIZA
Spain Ms Elisabeth Nellen-Regli
Tel.: +34 (91) 3380 710 Resp. for Food for special dietary uses
Fax: +34 (91) 3380 169 Swiss Federal Office of Public Health
E-Mail: arollan@wanadoo.es Schwarzenburgstr. 165
Ms Myriam Garcia Cofrades 3003 Bern
Secretaria General Switzerland
Asociacón Nacional de Fabricantes de Productos de Tel.: +41 (31) 322 9560
Dietética Infantil Fax: +41 (31) 322 9574
E-Mail: elisabeth.nellen@bag.admin.ch
Diego de León, 44
28006 Madrid
Spain
Tel:: +34 915 301801
Fax: +34 915 301 801
E-Mail : mgarcia.andi@telefonica.net
ALINORM 08/31/26 37

Dr Dirk Cremer Dr Noppadon Adjimatera

Global Regulatory Affairs Manager The Federation of Thai Industries
DSM Nutritional Products Queen Sirikit National Conventions Center, Zone C,
P.O.Box 3255, Bldg. 241/421 4th Floor
4002 Basel 60 New Rachadapisek Road, Klontoey
Switzerland Bangkok 10110
Tel.: +41 (61) 687 3276 Thailand
Fax: +41 (61) 688 1635 Tel.: +66 (2) 624 6860
E-Mail: dirk.cremer@dsm.com Fax: +66 (2) 624 6801
Dr. Marquard Imfeld E-Mail: noppadon.adjimatera@intl.pepsico.com
Senior Consultant Mr Manat Larpphon
Bioresco Ltd. Standards Officer,
Bundesstraße 29 Office of Commodity and System Standards
4054 Basel National Bureau of Agricultural Commodity and Food
Switzerland Standards
Tel.: +41 (61) 273 7706 4th Floor, Ministry of Agriculture and Cooperatives
Fax: +41 (61) 273 7703 3 Rajdamnern Nok Avenue
E-Mail: marquard.imfeld@bioresco.ch Bangkok 10200
Hervé Nordmann Thailand
Scientific & Regulatory Affairs Tel.: +66 (2) 283 1600 ext. 1186
Ajinomoto Co. Inc. Fax: +66 (2) 280 3899
En Crochet 1 E-Mail: mlarpphon@yahoo.com
CH 1143 Apples UNITED KINGDOM / ROYAUME-UNI / REINO UNIDO
Switzerland Ms Claire Boville
Tel.: +41 (21) 800 3763 Food Standards Agency
Fax: +41 (21) 800 4087 Aviation House
E-Mail: herve.nordmann@asg.ajinomoto.com 125, Kingsway
Dr Philippe Pittet London, WC2B 6NH
United Kingdom
Deputy Head Regulatory Affairs
Tel.: +44 (20) 7276 8168
Nestec Ltd.
Fax: +44 (20) 7276 8193
Avenue Nestlé 55
E-Mail: claire.boville@foodstandards.gsi.gov.uk
1800 Vevey
Switzerland Dr Bindiya Shah
Tel.: +41 (21) 924 4264 Food Standards Agency
Aviation House
Fax: +41 (21) 924 4547
125, Kingsway
E-Mail: philippe.pittet@nestle.com
London, WC2B 6NH
THAILAND / THAÏLANDE / TAILANDIA United Kingdom
Dr Songsak Srianujata Tel.: +44 (20) 7276 8168
Senior Advisor, Fax: +44 (20) 7276 8193
Institute of Nutrition, Mahidol University E-Mail: Bindiya.shah@foodstandards.gsi.gov.uk
Salaya, Putthamonthon
Nakhonpathom 73170 Mrs Sue Hattersley
Thailand Food Standards Agency
Tel.: +66 (2) 640 0461 ext. 112 Aviation House
Fax: +66 (2) 640 0465 125, Kingsway
E-Mail: rassn@mahidol.ac.th London, WC2B 6NH
United Kingdom
Ms Patchanee Intaraluk
Tel.: +44 (20) 7276 8168
Food Control Division
Fax: +44 (20) 7276 8193
Food and Drug Administration
E-Mail: sue.hattersley@foodstandards.gsi.gov.uk
Ministry of Public Health
Tiwanond Road
Nonthaburi 11000
Thailand
Tel:: +66 (2) 590 7030
Fax: +66 (2) 591 8460
E-Mail: meefood@health.moph.go.th
ALINORM 08/31/26 38

UNITED STATES OF AMERICA / ÉTATS-UNIS D'AMÉRIQUE Mrs Edith Kennard

ESTADOS UNIDOS DE AMÉRICA International Issues Analyst
Dr Barbara O. Schneeman U.S. Codex Office
Director, Office of Nutritional Products Food Safety and Inspection Service
Labeling and Dietery Supplements U. S. Department of Agriculture

Center for Food Safety & Applied Nutrition Room 4861 – South Building

U.S. Food and Drug Administration (HFS-800)

1400 Independence Avenue S.W.

5100 Paint Branch Parkway

Washington, DC 20250

College Park, MD 20740

USA

USA
Tel.: +1 (202) 205-7760

Tel.: +1 (301) 436 2373

Fax: +1 (202) 720 3157

Fax: +1 (301) 436 2636

E-Mail: edith.kennard@usda.gov

E-Mail: barbara.schneeman@fda.hhs.gov
Non-Government Advisors
Dr Allison A. Yates Mr Michael Auerbach

Director Senior Science Advisor

Beltsville Human Nutrition Research Center Corporate Regulatory Affairs

Agricultural Research Center Danisco A/S

U:S. Department of Agriculture

565 Taxter Road – Suite 590

10300 Baltimore Avenue

Elmsford, NY 10523

Bldg 307C, Rm. 117

USA

Beltsville, MD 20705
Tel.: +1 (800) 255 6837

USA
Fax: +1 (914) 592 1407

Tel.: +1 (301) 504-8157

E-Mail: michael.auerbach@danisco.com

Fax: +1 (301) 504-9381

Dr Sukh D. Bassi

E-Mail: allison.yates@ars.usda.gov
Chief Science Officer

Dr Sue A. Anderson
Vice President

Team Leader, Regulations and Review Team

MGP Ingredients, Inc.

Infant Formula and Medcical Foods Staff

1300 Main Street

Office of Nutritional Products, Labeling and Dietary

P.O.Box 130

Supplements
Atchison, Kansas 66002

Center for Food Safety & Applied Nutrition

USA

Food and Drug Administration (HFS-850)

Tel:: +1 (913) 360-5246

5100 Paint Branch Parkway

Fax: +1 (913) 360-5746

College Park, MD 20740

E-Mail: sukh.bassi@mgpingredients.com

USA
Ms Melanie Fairchild-Dzanis

Tel.: +1 (301) 436 1450

Regulatory Director

Fax: +1 (301) 436 2636

Nestlé Nutrition, Nestlé USA

E-Mail: sue.anderson@fda.hhs.gov
800 No Brand Blvd

Ms Nancy T. Crane
Glendale, California 91203,

Regulatory Review Scientist

USA

Office of Nutritional Products, Labeling and Dietary

Tel.: +1 (818) 549 5868

Supplements
Fax: +1 (818) 549 5704

Center for Food Safety & Applied Nutrition

E-Mail: melanie.fairchild@us.nestle.com

Food and Drug Administration (HFS-850)

Dr Mary H. Hager,

5100 Paint Branch Parkway

Director, Regulatory Affairs

College Park, MD 20740

The American Dietetic Association

USA
1120 Connecticut Av. NW, Suite 480

Tel.: +1 (301) 436 1450

Washington DC 20036,

Fax: +1(301) 436 2636

USA

E-Mail: nancy.crane@fda.hhs.gov
Tel.: +1 (202) 775 8277

Fax: +1 (202) 775 8284

E-Mail: mhager@eatright.org

ALINORM 08/31/26 39

Dr William C. MacLean
INTERNATIONAL NON-GOVERNMENTAL
Consultant
ORGANIZATIONS
1800 Upper Chelsea Road AAC – ASSOCIATION DES AMIDONNERIES ET CEREALES
Columbus, Ohio 43212 Mr Marcel Feys
USA AAC
Tel.: +1 (614) 486 6170 Avenue des Arts 43
E-Mail: William.maclean@earthlink.net 1040 Brussels
Ms Mardi K. Mountford Belgium
Executive Vice President Tel. : +32 (2) 289 6760
International Formula Council Fax : +32 (2) 513 5592
1100 Johnson Ferry Road, E-Mail : aaf@aaf-eu.org
Suite 300 ASPPG– ASSOCIATION OF THE EUROPEAN SELF­
30342 Atlanta, Georgia MEDICATION INDUSTRY
USA Dr Rose Schraitle
Tel.: +1 (404) 252 3663 Association of the European Self-Medication Industry
Fax: +1 (404) 252 0774 7, Avenue de Tervuren
E-Mail: mmountford@kellencompany.com B-1040 Brussels
Charlene J. Rainey Belgium
President Tel.: +32 2735 5130
Food Research, Inc. Fax: +32 2735 5222
575 Anton Boulevard, Suire 300 E-Mail: info@aesgp.be
Costa Mesa, California 92626
AIDGUM
USA
Prof John Lupien
Tel:: +1 (949) 497 6066
via Aventina 30
Fax: +1 (714) 523-2556
00153 Rome
E-Mail: charlierainey@sbcglobal.net
Italy
ZAMBIA / ZAMBIE Tel.: +39 (6) 5725 0042
Mrs Agnes Aongola E-Mail: john@@jrlupien.net
Nutrition Specialist
Mr Gontran Dondain
Ministry of Health HQ
President AIDGUM
Haile Selassie Rd, Ndeke House, Box 32588
129, Chemin de Croisset
10101 Lusaka
BP 4151
Zambia
76723 Rouen Codex 3
Tel.: +260 (1) 253179-82
France
Fax: +260 (1) 253173
Tel.: +33 232 831818
E-Mail: aaongola@yahoo.com
AOECS - ASSOCIATION OF EUROPEAN COELIAC
ZIMBABWE / ZIMBABUE
SOCIETIES
Mr Munyaradzi Livingstone Musiyambiri
Mrs Hertha Deutsch
Chief Government Analyst
Chair of AOECS-WG Codex, Labelling and Symbol
Government Analyst Laboratory
AOECS Association of European Coeliac Societies
Ministry of Health & Child Welfare
Anton Baumgartner Strasse 44/C5/2302
P.O.Box CY 231
1230 Vienna, Austria
Causeway
Tel.: +43 (1) 667 1887
Harare
Fax: +43 (1) 667 1887
Zimbabwe
E-Mail: hertha.deutsch@utanet.at
Tel.: +263 (4) 792026/7 / +263 11 874588
Fax: +263 (4) 708527 CEFS – COMITÉ EUROPÉEN DES FABRICANTS DE SUCRE
E-Mail: musiml@africaonline.co.zw Oscar Ruiz de Imaña
Head of Scientific and Regulatory Affairs
CEFS- Comité Européen des Fabricants de Sucre
Avenue de Tervuren 182
1150 Brussels
Belgium
Tel. : +32 (2) 762 0760
Fax : +32 (2) 771 0026
E-Mail : oscar.ruiz@cefs.org
ALINORM 08/31/26 40

Mrs Camille Perrin Dr Mark Mansour

Scientific Regulatory Affairs Assistant-Manager Partner
CEFS- Comité Européen des Fabricants de Sucre Foley & Ladner LLP
Avenue de Tervuren 182 300 K Street, NW
1150 Brussels Suite 500
Belgium 20007 Washington, DC
Tel. : +32 (2) 762 0760 USA
Fax : +32 (2) 771 0026 Tel.: +1 (202) 672 5585
Camille.perrin@cefs.org Fax: +1 (202) 672 5399
CIAA E-Mail: mmansour@foley.com
Ms Elena Colgalniceanu Mr John Venardos
Manager Consumer Information Diet & Health Vice President, Worldwide Regulatory & Government
CIAA
Affairs
43 Avenue des Arts
Herbalife International of America, Inc.
1040 Brussels
1800 Century Park East
Belgium
Tel : +32 (2) 514 1111 90067 Century City, CA
Fax : +32 (2) 511 2905 USA
E_Mail :e.cogalniceanu@ciaa.eu Tel.: +1 (310) 203 7746
Fax: +1 (310) 557 3916
CONSUMER INTERNATIONAL
E-Mail: johnv@herbalife.com
Mrs Goski Alabi
Consumer Advocacy Centre EFLA - EUROPEAN FOOD LAW ASSICIATION
Lecturer/Research and Conference Coordinator Mr Matias Cortes
Institute of Professional Studies Member
P.O.Box 149, Legon EFLA
Accra Rue de la Loi 235
Ghana 1040 Brussels
Tel. : +233 (27) 748 2339 Belgium
Fax: +233 (21) 513 3539 Tel. : +32 (2) 230 4845
E-Mail : goskia@yahoo.com Fax : +32 (2) 230 8206
CRN - COUNCIL FOR RESPONSIBLE NUTRITION E-Mail : efla_aeda@hotmail.com
Dr. John Hathcock EHPM – EUROPEAN FEDERATION OF ASSOCIATIONS OF
Vice President, International & Scientific Affairs HEALTH PRODUCT MANUFACTURERS
Council fo Responsible Nutrition Dr Derek Shrimpton
1828 L Street, NW Scientific Advisor
Suite 900 EHPM
20036 Washington, DC Rue de l’association 50
USA 1000 Brussels
Tel: +1 (202) 776 7955 Belgium
Fax: +1 (202) 204 7980 Tel.: +32 (2) 209 1145
E-Mail: jhathcock@crnusa.org Fax: +32 (2) 223 3064
Mr Byron Johnson E-Mail: secretariat@ehpm.be
Industry Relations Director Mr Peter van Doorn
Access Business Group/Nutrilite EHPM
7575 Fulton Street East Rue de l’association 50
49355 Ada, MI 1000 Brussels
USA Belgium
Tel: +1 (616) 787 7577 E-Mail: peter.van.doorn@mcohealth.nl
Fax: +1 (616) 787 5625
E-Mail: byron.johnson@accessbusinessgroup.com
ALINORM 08/31/26 41

IADSA - INTERNATIONAL ALLIANCE OF DIETARY / FOOD Dr Boris Pimentel

SUPPLEMENT ASSOCIATIONS Secretariat
Mr Simon Pettman International Alliance of Dietary/Food Supplement
Executive Director Associations (IADSA)
International Alliance of Dietary/Food Supplement Rue de l’Association 50
Associations (IADSA) 1000 Brussels
Rue de l’Association 50 Belgium
1000 Brussels Tel.: +32 (2) 209 1155
Belgium Fax: +32 (2) 223 3064
Tel.: +32 (2) 209 1155 E-Mail: secretariat@iadsa.be
Fax: +32 (2) 223 3064 Mrs Penny Viner
E-Mail: secretariat@iadsa.be Secr International Alliance of Dietary/Food Supplement
Mr David Pineda Ereño Associations (IADSA)
Manager Regulatory Affairs Rue de l’Association 50
International Alliance of Dietary/Food Supplement 1000 Brussels
Associations (IADSA) Belgium
Rue de l’Association 50 Tel.: +32 (2) 209 1155
1000 Brussels Fax: +32 (2) 223 3064
Belgium E-Mail: secretariat@iadsa.be
Tel.: +32 (2) 209 1155 Mr Peter F. Zambetti
Fax: +32 (2) 223 3064 Global Business Development Manager
E-Mail: secretariat@iadsa.be Dietary Supplements
Ms Kaori Nakajima CAPSUGEL
Secretariat Rue de l’Association 50
International Alliance of Dietary/Food Supplement 1000 Brussels
Associations (IADSA) Belgium
Rue de l’Association 50 Tel.: +32 (2) 209 1155
1000 Brussels Fax: +32 (2) 223 3064
Belgium E-Mail: secretariat@iadsa.be
Tel.: +32 (2) 209 1155
IBFAN - INTERNATIONAL BABY FOOD ACTION
Fax: +32 (2) 223 3064
NETWORK
E-Mail: secretariat@iadsa.be Mr Mosadeq Sahebdin
PhD Hirobumi Ohama Coordinator
Scientific Advisor Institute for Consumer Protection
International Alliance of Dietary/Food Supplement 2nd Floor, Hansrod Building, Jummah Mosque t
Associations (IADSA) Post Louis
Rue de l’Association 50 Mauritius
1000 Brussels Tel.: +230 210 4433
Belgium Fax: +230 211 4436
Tel.: +32 (2) 209 1155 E-Mail: mosadeq53@intnet.mu
Fax: +32 (2) 223 3064 ICA – INTERNATIONAL CO-OPERATIVE ALLICANCE
E-Mail: secretariat@iadsa.be Mr Kazuo Onitake
Ms Hideko Ikeda Head of Unit, Safety Policy service
Scientific Advisor Japanese Consumers’ Co-operative Union (JCCU)
International Alliance of Dietary/Food Supplement Co-op Plaza, 3-29-8
Associations (IADSA) Shibuya, Shubuya-ku,
Rue de l’Association 50 150-8913 Tokyo
1000 Brussels Japan
Belgium Tel.: +81 (3) 5778 8109
Tel.: +32 (2) 209 1155 Fax: +81 (3) 5778 8002
E-Mail: kazuo.onitake@jccu.coop
Fax: +32 (2) 223 3064
E-Mail: secretariat@iadsa.be
ALINORM 08/31/26 42

ICBA - INTERNATIONAL COUNCIL OF BEVERAGES ICGMA – INTERNATIONAL COUNCIL OF GROCERY

ASSOCIATIONS MANUFACTURERS ASSOCIATIONS
Mrs Helen Falco Mr Robert Earl
Technical Advisor Senior Director Nutrition Policy
International Council of Beverages Associations ICGMA
3-3-3 Nihonbashi-Muromachi Chuo-ku 1350 I Street, NW
103-0022 Tokyo 2005 Washington, DC
Japan USA
Tel.: +81 (3) 3270 7300 Tel:: +1 (202) 639 5970
Fax: +81 (3) 3270 7306 Fax : +1 (202) 639 5991
E-Mail: hefalco@na.ko.com E-Mail : rearl@greaonline.org
Mr Hiromi Ohta
Dr Kenneth Falci
Technical Advisor
Senior Director
Japan Soft Drinks Association
Scientific Regulatory Operations
3-3-3 Nihonbashi-Muromachi Chuo Kuo
Kellogg Company
Tokyo
235 Porter Street
Japan
49014 Battle Creek, MI
Tel.: +81 (3) 3270 7300
USA
Fax: +81 (3) 3270 7306
Tel. : +1 (269) 961 3632
E-Mail: hiromi_ohta@suntory.co.jp
Fax : +1 (269 660 4549
Dr. Shuji Iwata
E-Mail : ken.falci@kellogg.com
Technical Adviser
Japan Soft Drinks Association Mrs Phyllis Tanaka
3-3-3 Nihonbashi-Muromachi Chuo Kuo Vice President
Tokyo Scientific and Regulatory Affairs
Japan Food Policy
Tel.: +81 (3) 3270 7300 Food & Consumer Products of Canada
Fax: +81 (3) 3270 7306 885 Don Mills Road, Suite 301
E-Mail: shuji_iwata@suntory.co.jp M3CIV9 Toronto ON
Canada
ICGA – INTERNATIONAL CHEWING GUM ASSOCIATION
Tel.: +1 (416) 510 8024 extern 2246
Mr Jean Savigny
Fax : +1 (416) 510 8043
General Counsel
E-Mail : phyllist@fcpc.ca
c/o Keller and Heckman
523 avenue Louise IDACE - ASSOCIATION DES INDUSTRIES DES ALIMENTS
1050 Brüssel DIÉTÉTIQUES DE L'UNION EUROPÉENNE
Belgium Dr Andrée Bronner
Tel.: +32 (2) 645 5071 Association des Industries des Aliments Diététiques de
Fax: +32 (2) 645 5050 l’Union Européenne (IDACE)
E-Mail: savigny@khlaw.be 194 Rue de Rivoli
Mr Christophe Leprêtre 75001 Paris, France
Manager Technical and Regulatory Affairs Tel.: +33 (1) 5345 8787
c/o Keller and Heckman Fax: +33 (1) 5345 8780
523 avenue Louise E-Mail:andree.bronner@idace.org
1050 Brüssel Ms Leoniek Robroch
Belgium Food LegislatioinOfficer
Tel.: +32 (2) 645 5078 Association des Industries des Aliments Diététiques de
Fax: +32 (2) 645 5050 l’Union Européenne (IDACE)
E-Mail: leptretre@khlaw.be 194 Rue de Rivoli
75001 Paris, France
Tel.: +33 (1) 5345 8787
Fax: +33 (1) 5345 8780
E-Mail:andree.bronner@idace.org
ALINORM 08/31/26 43

Mrs Ruth Birt IFT - INSTITUTE OF FOOD TECHNOLOGISTS

Scientific an Regulatory Affairs Prof. Rosemary Walzem
Association des Industries des Aliments Diététiques de Associate Professor
l’Union Européenne (IDACE) Texas A&M University
194 Rue de Rivoli Department of Poultry Science and Department of
75001 Paris, France Nutrition and Food Science
Tel.: +33 (1) 5345 8787 College Station, TX 77845
Fax: +33 (1) 5345 8780 USA
E-Mail:andree.bronner@idace.org Tel.: +1 979-845-7537
Fax: +1 979-845-1921
IDF - INTERNATIONAL DAIRY FEDERATION E-Mail: rwalzem@poultry.tamu.edu
Ms Katrin Lehmann, Ph.d. Ms Gloria Brooks-Ray
Technical Manager Dairy in Nutrition
Exponent Food and Chemicals Practice
Verband der Deutschen Milchwirtschaft e.V.
P.O.Box 97
Meckenheimer Allee 137
Mountain Lakes NJ 07046
53115 Bonn
Germany USA
Tel.: +49 (228) 982 4316 Tel.: +1 (973) 334 4652
Fax: +49 (228) 982 4320 E-Mail: gbrooksray@exponent.com
E-Mail : k.Lehmann@vdm-deutschland.de IGTC – INTERNATIONAL GLUTAMATE TECHNICAL
Ms Marieke Lugt COMMITTEE
Food Legislation Officer Mrs Yoko Ogiwara
Corporate Food Safety & Dairy Affairs Scientific Advisor
Friesland Foods Ajinomoto Co., Inc.
P.O.Box 124 Hatchobori 3-9-5 Chuo-ku
7940 AC Meppel 104-0032 Tokyo
The Netherlands Japan
Tel.: +81 (80) 3258 1900
Tel.: +31 (522) 276 354
Fax: +81 (3) 5250 8403
Fax: +31 (522) 276 475
E-Mail: yoko_ogiwara@ajinomoto.com
E-Mail: marieke.lugt@frieslandfoods.com
Mr Joerg Seifert ILSI – INTERNATIONAL LIFE SCIENCES INSTITUTE
Technical Director Dr Eric Hentges
International Dairy Federation Executive Director, ILSI North America
One Thomas Cirle, NW, 9th Floor
Diamant Building
20005 Washington DC
80, Boulevard Auguste Reyers
USA
1030 Brussels
Tel.: +1 (202) 659 0074
Belgium Fax: +1 (202) 659 3617
Tel.: +32 2 706 8643 E-Mail: ehentges@ilsi.org
Fax: +32 2 733 0413
E-Mail: jseifert@fil-idf.org Ms Victoria Betteridge
Group Manager Regulatory Affairs
Ms Sandra Tuijtelaars Tate & Lyle PLC
Nutrition Officer Sugar Quay
International Dairy Federation Lower Thames Street
Diamant Building London EC 3 R 6 DQ
80, Boulevard Auguste Reyers United Kingdom
1030 Brussels Tel.: +44 (20) 7977 6295
Belgium E-Mail: victoria.betteridge@tateandlyle.com
Tel.: +32 (2) 706 8650
Fax: +32 (2) 733 0413
E-Mail: STuijtelaars@fil-idf.org
ALINORM 08/31/26 44

Prof Dr Julie Jones Prof Barry V. McCleary

ILSI Technical Director & Joint Managing Director
College of St Catherine Megazyme International Ireland Limited
St Paul, MN Bray Business Park
4030 Valentine Ct Bray, Co. Wicklow
55112 Arden Hills MN Ireland
USA Tel.: +353 (1) 286 1220
Tel.: +1 (651) 636 2275 Fax: +353 (1) 286 1264
Fax: +1 (651) 636 2394 E-Mail: barry@megazyme.com
E-Mail: jmjones@stkaate.edu Mr Kazuo Sueki
Ms Olive Misa Director, Scientific Information
Regional Corporate Relations Director-Asia ILSI Japan
Abbott Nutrition International Kojimachi R K Bldg. 2.6.7
Abbott Kojimachi, Chiyoda-ku
102 EDSA corner Madison Street 102-0083 Tokyo
Mandaluyong City Japan
Philippines Tel.: +81 (3) 5215 3535
Tel.: +63 (2) 6874236 Fax: +81 (3) 5215 3537
Fax: +63 (2) 6340041 E-Mail: ksueki@ilsijapan.org
E-Mail: maolivia.misa@abbott.com Dr Kazuyoshi Namba
Dr Loek Pijls Morinaga Milk Industriy Co.Ltd
Senior Scientist 1-83-5-Chome, Higashihara
ILSI Europe Zama-city, Kanagawa-Pref. 228-8583
Av. E. Mounier 83, Box 6 Japan
1200 Brussels Tel.: +81 (46) 252 3057
Belgium Fax: +81 (46) 252 3077
Tel.: +32 (2) 771 0014 E-Mail: k_namba@morinagamilk.co.jp
Fax: +32 (2) 762 0044
ISDI - INTERNATIONAL SPECIAL DIETARY FOODS
E-Mail: lpijls@ilsieurope.be
INDUSTRIES
Dr Susan Potter Mrs Tova Almlöf
Vice President, Health and Nutrition Sciences Scientific and Regulatory Affairs
Tate & Lyle International Special Dietary Foods Industries (ISDI)
2200 East Eldorado Street 194 Rue de Rivoli
Decatur, IL 62525 75001 Paris, France
USA Tel.: +33 (1) 5345 8787
Tel.: +1 (127) 421 2565 Fax: +33 (1) 5345 8780
Fax: +1 (127) 421 2936 E-Mail: andree.bronner@isdifederation.org
E-Mail: susan.potter@tateandlyle.com Ms Lisa Craig
Ms Julie Scott Scientific and Regulatory Affairs
European Regulatory Compliance Manager International Special Dietary Foods Industries (ISDI)
National Starch Food Innovation 194 Rue de Rivoli
Greencourts Business Park 75001 Paris, France
333 Styal Road Tel.: +33 (1) 5345 8787
Manchester M22 5LW Fax: +33 (1) 5345 8780
United Kingdom E-Mail: andree.bronner@isdifederation.org
Tel:: +44 (161) 435 3241 Ms Marie-Odile Gailing
Fax: +44 (161) 435 3244 Scientific and Regulatory Affairs
E-Mail: julie.scott@nstarch.com International Special Dietary Foods Industries (ISDI)
194 Rue de Rivoli
75001 Paris, France
Tel.: +33 (1) 5345 8787
Fax: +33 (1) 5345 8780
E-Mail: andree.bronner@isdifederation.org
ALINORM 08/31/26 45

Mr Peter Van Dael WGPAT- WORKING GROUP ON PROLAMIN ANALYSIS AND

Scientific and Regulatory Affairs TOXICITY
International Special Dietary Foods Industries (ISDI) Dr Martin Stern
194 Rue de Rivoli Professor of Paediatrics
75001 Paris, France University Children's Hospital
Tel.: +33 (1) 5345 8787 Hoppe-Seyler-Strasse 1
Fax: +33 (1) 5345 8780 72076 Tübingen, Germany
E-Mail: andree.bronner@isdifederation.org Tel.: +49 (7070) 298 3781
Fax: +49 (7070) 295 477
Ms Amandine Devergies E-Mail: martin.stern@med.uni-tuebingen.de
Scientific and Regulatory Affairs
International Special Dietary Foods Industries (ISDI) INTERNATIONAL GOVERNMENTAL ORGANIZATIONS
194 Rue de Rivoli
75001 Paris, France WHO - WORLD HEALTH ORGANIZATION
Tel.: +33 (1) 5345 8787 Dr Chizuru Nishida
Fax: +33 (1) 5345 8780 Scientist
E-Mail: andree@bronner@isdifederation.org Department of Nutrition for Health and Development
IUNS – INTERNATIONAL UNION OF NUTRITIONAL (NHD)
SCIENCES WHO
Prof Dr Ibrahim Elmadfa 20. Avenue Appia
President-elect IUNS 1211 Geneva 27
Institute of Nutritional Sciences (Director) University of Switzerland
Vienna Tel.: +41 (22) 791 3317/3455
Althanstraße 14 Fax: +41 (22) 791 4156
1090 Vienna E-Mail: nishidac@who.int
Austria Dr Lisa Rogers
Tel.: +43 (1) 4277 54911 Technical Officer, Micronutrient Unit
Fax: +43 (1) 4277 9549 Department of Nutrition for Health and Development
E-Mail: ibrahim.elmadfa@univie.ac.at (NHD)
NHF – NATIONAL HEALTH FEDERATION WHO
Mr Scott C. Tips 20, Avenue Appia
President & General Legal Counsel 1211 Geneva
National Health Federation Switzerland
PO Box 688 Tel:: +41 (22) 791 1957
Monrovia, California 91017 Fax: +41 (22) 791 4156
USA E-Mail: rogersl@who.int
Tel.: +1 (626) 357 2182 Prof John Cummings
Fax: +1 (626) 303 0642 WHO Temporary Adviser
E-Mail: scott@rivieramail.com Professor of Experimental Gastroenterology, Pathology
Mr Paul Anthony Taylor and Neuroscience
Chairman Ninewells Hospital and Medical School
National Health Federation Dundee
PO Box 688 DD 1 9SY
Monrovia, California 91017 United Kingdom
USA Tel.: +44 (1) 382 632425
Tel.: +1 (626) 357 2182 Fax: +44 (1) 382 633952
Fax: +1 (626) 303 0642 E-Mail: j.h.cummings@dundee.ac.uk
Dr Robert Verkerk
National Health Federation
PO Box 688
Monrovia, Califonia 91017
USA
Tel.: +44 (0) 1306 646551
Fax: +44 (0) 1306 646552
E-Mail: robert.verkerk@ntlworld.com
ALINORM 08/31/26 46

FAO – FOOD AND AGRICULTURE ORGANIZATION OF THE Food Standards Officer

UNITED NATIONS Joint FAO/WHO Food Standards Programme

Mrs Ute Ruth Charrondiere

Viale delle Terme di Caracalla

NutritionOfficer
00153 Rome

FAO
Italy

Viale delle Terme di Caracalla

Tel.: +39 (06) 57 05 39 67

00153 Rome
Fax: +39 (06) 57 05 45 93

Italy
E-Mail: jeronimas.maskeliunas@fao.org

Tel.: +39 (6) 570 56134

Ms Selma Doyran

Fax: +39 (6) 570 54593

Senior Food Standards Officer’

E-Mail: ruth.charrondiere@fao.org
Joint FAO/WHO Food Standards Programme

Viale delle Terme di Caracalla

GERMAN SECRETARIAT
00153 Rome

Mr Georg Müller

Italy

Federal Ministry of Food,

Tel.: +39 (06) 57 05 58 26

Agriculture and Consumer Protection

Fax: +39 (06) 57 05 45 93

Rochusstraße 1

E-Mail: Selma.Doyran@fao.org

53123 Bonn, Germany

Tel.: +49 (228) 99 33 87

Dr Jinjing Zhang

Fax: +49 (228) 99 49 65

Volunteer

E-Mail: ccnfsdu@bmelv.bund.de
Codex Secretariat

Viale delle Terme di Caracalla

Mrs Ursula Siebert

00153 Rome

Federal Ministry of Food,

Italy

Agriculture and Consumer Protection

Tel.: +39 (6) 57054922

Rochusstraße 1

Fax: +39 (6) 57054593

53123 Bonn, Germany

E-Mail: jinjing.zhang@fao.org

Tel.: +49 (228) 99 33 87

Fax: +49 (228) 99 49 65

E-Mail: ccnfsdu@bmelv.bund.de

Mrs Beate Trautmann

Federal Ministry of Food,

Agriculture and Consumer Protection

Rochusstraße 1

53123 Bonn, Germany

Tel.: +49 (228) 99 33 87

Fax: +49 (228) 99 49 65

E-Mail: ccnfsdu@bmelv.bund.de

Mrs Sonja Braun

Federal Ministry of Food,

Agriculture and Consumer Protection

Rochusstraße 1

53123 Bonn, Germany

Tel.: +49 (228) 99 33 87

Fax: +49 (228) 99 49 65

E-Mail: ccnfsdu@bmelv.bund.de

Mr Peter Braun

Federal Ministry of Food,

Agriculture and Consumer Protection

Rochusstraße 1

53123 Bonn, Germany

Tel.: +49 (228) 99 33 87

Fax: +49 (228) 99 49 65

E-Mail: ccnfsdu@bmelv.bund.de

CODEX SECRETARIAT
Dr Jeronimas Maskeliunas
ALINORM 08/31/26, Appendix II page 47

APPENDIX II

GUIDELINES FOR THE USE OF NUTRITION CLAIMS:

DRAFT TABLE OF CONDITIONS FOR NUTRIENT CONTENTS (PART B CONTAINING

PROVISIONS ON DIETARY FIBRE)

(At Step 6 of the Procedure)

COMPONENT CLAIM CONDITIONS

B. NOT LESS THAN

Dietary Fibre Source 3 g per 100 g or 1.5 g per 100 kcal
or [10 % of recommended intake] per
serving*
[(liquid foods: 1.5 g per 100 ml)]

High 6 g per 100 g or 3 g per 100 kcal

or [20 % of recommended intake] per
serving*
[(liquid foods: 3 g per 100 ml)]

*
Serving size [and recommended intake] to be determined at national level.

Definition and properties of dietary fibre:

DEFINITION:
Dietary fibre means carbohydrate polymers1 with a degree of polymerisation (DP) not lower than 3, which
are neither digested nor absorbed in the small intestine. A degree of polymerisation not lower than 3 is
intended to exclude mono- and disaccharides. It is not intended to reflect the average DP of a mixture.
Dietary fibre consists of one or more of:
• Edible carbohydrate polymers naturally occurring in the food as consumed,
• carbohydrate polymers , which have been obtained from food raw material by physical,
enzymatic or chemical means,.
• synthetic carbohydrate polymers.

1
When derived from a plant origin, dietary fibre may include fractions of lignin and/or other compounds when
associated with polysaccharides in the plant cell walls and if these compounds are quantified by the AOAC gravimetric
analytical method for dietary fibre analysis : Fractions of lignin and the other compounds (proteic fractions, phenolic
compounds, waxes, saponins, phytates, cutin, phytosterols, etc.) intimately "associated" with plant polysaccharides are
often extracted with the polysaccharides in the AOAC 991.43 method. These substances are included in the definition
of fibre insofar as they are actually associated with the poly- or oligo-saccharidic fraction of fibre. However, when
extracted or even re-introduced into a food containing non digestible polysaccharides, they cannot be defined as dietary
fibre. When combined with polysaccharides, these associated substances may provide additional beneficial effects.
ALINORM 08/31/26, Appendix II page 48

Properties:
Dietary fibre generally has properties such as:

• Decrease intestinal transit time and increase stools bulk

• Fermentable by colonic microflora
• Reduce blood total and/or LDL cholesterol levels
• Reduce post-prandial blood glucose and /or insulin levels.
With the exception of non-digestible edible carbohydrate polymers naturally occurring in foods as consumed
where a declaration or claim is made with respect to dietary fibre, a physiological effect should be
scientifically demonstrated by clinical studies and other studies as appropriate. The establishment of criteria
to quantify physiological effects is left to national authorities.

RECOMMENDATIONS TO CODEX COMMITTEES USING THIS DEFINITION OF

DIETARY FIBRES
Codex Committees, when making use of this definition, may wish to consider that:
• Food safety requirements should be met by the substances purporting to be presented as
source of dietary fibres;
• The physiological effects listed in the definition may vary with the substances present in
the foods and the justification for the use of the nutrition and health claims must
accommodate this diversity;
• If the dietary fibre does not derive from plants, it may be appropriate to consider, when
establishing labelling provisions, that consumers in many countries generally regard foods
designated as sources of dietary fibre as having a plant origin.
Methods of Analysis for Dietary Fibre1

Name Quantified compounds Reference Type Chapter2

AOAC 991.43 Soluble + insoluble Lee et al Enzymatic- 32.1.17
polysaccharides (including gravimetric
RS 3)+ lignin
AOAC 985.29 Soluble + insoluble Prosky et al. 1992 Enzymatic- 45.4.07
polysaccharides ( including gravimetric
RS 3)+ lignin
AOAC 994.13 Soluble + insoluble Theander et al. Enzymatic- 45.4.11
polysaccharides (including chemical
RS 3)+ lignin
AOAC 995.16 beta-glucans McCleary & Codd, Enzymatic 32
1991
AOAC 2002.02 Resistant starch and algal McCleary & Enzymatic 45.4.15
fibre Monaghan, 2002

1
As presented in CX/NFSDU 04/3-Add.1.
2
Official Methods of Analysis of AOAC International. 17th edition. Volume II. Horwitz, editor.
ALINORM 08/31/26, Appendix II page 49

Name Quantified compounds Reference Type Chapter2

AOAC 999.03 Fructans (oligofructans, McCleary & Enzymatic & 45.4.06B
inulin derivatives, Blakeney, 1999 colorimetric
fructooligosaccharides) McCleary et al.,
2000
AOAC 997.08 Fructans (oligofructans, Hoebregs, 1997 Enzymatic & 45.4.06A
inulin derivatives, HPAEC
fructooligosaccharides)
AOAC 2001.02 Trans-galacto­ De Slegte HPAEC-PAD 45.4.12
oligosaccharides
AOAC 2001.03 Total dietary fibre in foods Enzymatic 45.4.13
containing resistant gravimetric and
maltodextrin Liquid
chromatography
AOAC 2000.11 Polydextrose Craig et al. 2001 HPAEC 45.6.06C

All the above methods are approved AOAC techniques. These methods have the advantage of being used
world-wide as well as being easily used in routine analysis.

The AOAC 985.29 and 991.43 are the general methods for measuring ‘total dietary fibre’ in most foods. The
other methods can be used for complementary assessment of other fibre components/fractions not measured
by the general methods due to their solubility in aqueous alcohol or for analysis of certain foods or raw
materials for which the standard methods may be less suitable. The methods for total or soluble+insoluble
dietary fibre give satisfactory results for foods that contain neither added non-digestible oligosaccharides
(e.g. FOS) nor resistant starch3 fractions RS1 and RS2 which are not measured by these AOAC method.
The AOAC 991.43 includes part of the resistant starch fractions (retrograded starches, RS3). Therefore, in
order to include total RS, it is necessary to analyse RS independently and correct for the RS in the fibre
residue.
The Englyst method, which is not used world-wide, is complicated and may therefore be less suitable for
routine analysis. However, this or similar methods may be necessary in some foods difficult to analyse with
the routine methods, e.g. infant formula.

3
Resistant starch (RS) is defined as the fraction of starch not absorbed in the small intestine. It consists of physically
enclosed starch (RS1), certain types of raw starch granules (RS2) and retrograded amylose (RS3). Modified starches
used as food additives may also be partially resistant (RS4).
ALINORM 08/31/26, Appendix III page 50

APPENDIX III
DRAFT REVISED CODEX STANDARD FOR FOODS FOR SPECIAL DIETARY USE FOR

PERSONS INTOLERANT TO GLUTEN

(At Step 8 of the Procedure)

1. SCOPE
1.1 This standard applies to foods for special dietary uses that have been formulated, processed or
prepared to meet the special dietary needs of people intolerant to gluten.
1.2 Foods for general consumption which by their nature are suitable for use by people with gluten
intolerance may indicate such suitability in accordance with the provisions of section 4.3.
2. DESCRIPTION
2.1 Definitions
The products covered by this standard are described as follows:
2.1.1 Gluten-free foods
Gluten-free foods are dietary foods
a) consisting of or made only from one or more ingredients which do not contain wheat (i.e., all Triticum
species, such as durum wheat, spelt, and kamut), rye, barley, oats1 or their crossbred varieties, and the
gluten level does not exceed 20 mg/kg in total, based on the food as sold or distributed to the consumer,
and/or
b) consisting of one or more ingredients from wheat (i.e., all Triticum species, such as durum wheat,
spelt, and kamut), rye, barley, oats1 or their crossbred varieties, which have been specially processed

to remove gluten, and the gluten level does not exceed 20 mg/kg in total, based on the food as sold or

distributed to the consumer.

2.1.2 Foods specially processed to reduce gluten content to a level above 20 up to 100 mg/kg
These foods consist of one or more ingredients from wheat (i.e., all Triticum species, such as durum wheat,
spelt, and kamut), rye, barley, oats1 or their crossbred varieties, which have been specially processed to
reduce the gluten content to a level above 20 up to 100 mg/kg in total, based on the food as sold or
distributed to the consumer.
Decisions on the marketing of products described in this section may be determined at the national level.
2.2 Subsidiary Definitions
2.2.1 Gluten
For the purpose of this standard, "gluten" is defined as a protein fraction from wheat, rye, barley, oats1 or
their crossbred varieties and derivatives thereof, to which some persons are intolerant and that is insoluble
in water and 0.5M NaCl.
2.2.2 Prolamins
Prolamins are defined as the fraction from gluten that can be extracted by 40 - 70% of ethanol. The
prolamin from wheat is gliadin, from rye is secalin, from barley hordein and from oats1 avenin.
It is however an established custom to speak of gluten sensitivity. The prolamin content of gluten is
generally taken as 50%.
3. ESSENTIAL COMPOSITION AND QUALITY FACTORS
3.1 For products referred to in 2.1.1 a) and b), the gluten content shall not exceed 20 mg/kg in the food as
sold or distributed to the consumer.

1
Oats can be tolerated by most but not all people who are intolerant to gluten. Therefore, the allowance of oats that are
not contaminated with wheat, rye or barley in foods covered by this standard may be determined at the national level.
ALINORM 08/31/26, Appendix III page 51

3.2 For products referred to in 2.1.2 the gluten content shall not exceed 100 mg/kg in the food as sold or
distributed to the consumer.
3.3. Products covered by this standard substituting important basic foods, should supply approximately the
same amount of vitamins and minerals as the original foods they replace.
3.4 The products covered by this standard shall be prepared with special care under Good Manufacturing
Practice (GMP) to avoid contamination with gluten.
4. LABELLING
In addition to the general labelling provisions contained in the General Standard for the Labelling of
Prepackaged Foods (CODEX STAN 1-1985) and the General Standard for the Labelling of and Claims for
Prepackaged Foods for Special Dietary Uses (CODEX STAN 146-1985), and any specific labelling
provisions set out in a Codex standard applying to the particular food concerned, the following provisions
for the labelling of “gluten-free foods” shall apply:
4.1 The term "gluten-free" shall be printed in the immediate proximity of the name of the product in the
case of products described in section 2.1.1.
4.2 The labelling of products described in section 2.1.2 should be determined at the national level.
However these products must not be called gluten-free. The labelling terms for such products should
indicate the true nature of the food, and shall be printed in the immediate proximity of the name of the
product.
4.3 A food which, by its nature, is suitable for use as part of a gluten-free diet, shall not be designated
“special dietary”, “special dietetic” or any other equivalent term. However, such a food may bear a
statement on the label that “this food is by its nature gluten-free” provided that it complies with the
essential composition provisions for gluten-free as set out in section 3.1 and provided that such a statement
does not mislead the consumer. More detailed rules in order to ensure that the consumer is not misled may
be determined at the national level.
5. METHODS OF ANALYSIS AND SAMPLING
5.1 General outline of the methods
• The quantitative determination of gluten in foods and ingredients shall be based on an
immunologic method or other method providing at least equal sensitivity and specificity.
• The antibody used should react with the cereal protein fractions that are toxic for persons
intolerant to gluten and should not cross-react with other cereal proteins or other constituents of
the foods or ingredients.
• Methods used for determination should be validated and calibrated against a certified reference
material,, if available.
• The detection limit has to be appropriate according to the state of the art and the technical
standard. It should be 10 mg gluten/kg or below.
• The qualitative analysis that indicates the presence of gluten shall be based on relevant methods
(e.g. ELISA-based methods, DNA methods).
5.2 Method for determination of gluten
Enzyme-linked Immunoassay (ELISA) R5 Mendez Method.
ALINORM 08/31/26, Appendix IV 52

APPENDIX IV

DRAFT ADVISORY LISTS OF NUTRIENT COMPOUNDS FOR USE IN FOODS FOR SPECIAL

DIETARY USES INTENDED FOR INFANTS AND YOUNG CHILDREN

(At Step 8 of the Procedure)

1. PREAMBLE

These lists include nutrient compounds, which may be used for nutritional purposes in foods for special
dietary uses intended for infants and young children in accordance with 1) the criteria and conditions of use
identified below and 2) other criteria for their use stipulated in the respective standards. In addition, the
sources from which the nutrient compound is produced may exclude the use of specific substances where
religious or other specific dietary restrictions apply. As noted in the respective standards, their use may either
be essential or optional.

2. CRITERIA FOR THE INCLUSION AND DELETION OF NUTRIENT COMPOUNDS FROM

THE ADVISORY LISTS

2.1 Nutrient compounds that are to be added for nutritional purposes to foods for infants and young children
may be included in the Lists only if:

(a) they are shown to be safe and appropriate for the intended use as nutrient sources for infants and
young children

(b) it is demonstrated by appropriate studies in animals and/or humans that the nutrients are biologically
available

(c) the purity requirements of the nutrient compounds conform with the applicable Specifications of
Identity and Purity recommended by the Codex Alimentarius Commission, or in the absence of such
specifications, with another internationally recognised specification. If there is no internationally
recognised specification, national purity requirements that have been evaluated according to or
similar to a FAO/WHO process may be considered

(d) the stability of nutrient compound(s) in the food(s) in which it is (they are) to be used can be
demonstrated

(e) the fulfilment of the above criteria shall be demonstrated by generally accepted scientific criteria.

2.2 Nutrient compounds may be added to the Lists based on the criteria above. Nutrient compounds shall be
deleted from the Lists if they are found no longer to meet the above criteria. If a country proposes to add or
delete a nutrient compound to/from a list, the country should provide information that addresses how the
nutrient compound satisfies/does not satisfy the criteria in Section 2.1.

3. Optional ingredients

The Optional Ingredients sections in Codex standards for foods for infants and young children do not
identify all optional ingredients that may be considered for use in foods for special dietary uses intended for
infants and young children. Optional ingredients added for nutritional purposes to foods for special dietary
uses intended for infants and young children should meet the criteria specified in Section 2.1. They should
also meet the provisions for optional ingredients in the respective Codex standard for foods for infants and
young children.
ALINORM 08/31/26, Appendix IV 53

A: ADVISORY LIST OF MINERAL SALTS AND TRACE ELEMENTS FOR USE IN FOODS FOR
SPECIAL DIETARY USES INTENDED FOR INFANTS AND YOUNG CHILDREN

Purity Requirements Use in Codex Food Standards

Nutrient Source by Applicable to Infants and Young Children
CAC1 internation IF FUF4 PCBF5 CBF6 FSMP7
al and/or for
national Sec. A2 Sec. B3 infants
bodies and
young
children
1. Source of Calcium (Ca)

1.1 Calcium √ JECFA √ √ √ √ √ √

carbonate (1981) (1973),
Ph Int,
FCC, USP,
NF, Ph
Eur, BP,
DAB
1.2 Calcium √ JECFA √ √ √ √ √ √
chloride (1979) (1975),
FCC, USP,
Ph Eur, JP,
BP, DAB
1.3 Tricalcium √ JECFA √ √ √ √ √ √
dicitrate (1979) (1975),
(Calcium citrate) FCC, USP,
DAC
1.4 Calcium √ JECFA √ √ √ √ √ √
gluconate (1999) (1998),
Ph Int,
FCC, USP,
Ph Eur, BP,
DAB
1.5 Calcium FCC, Ph √ √ √ √ √ √
glycerophosphate Eur,
Ph Franc

1
CAC = Codex Alimentarius Commission
2
IF Sect. A = Section A of the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants
3
IF Sect. B = Section B of the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants
4
FUF = Follow-up Formula
5
PCBF = Processed Cereal Based Food for Infants and Young Children
6
CBF = Canned Baby Food
7
FSMP = Food for Special Medical Purposes other than Infant Formula
ALINORM 08/31/26, Appendix IV 54

1.6 Calcium L­ √ JECFA √ √ √ √ √ √

lactate (1978) (1974),
FCC, USP,
Ph Eur (tri­
and penta­
hydrate),
BP, DAB
1.7 Calcium √ JECFA √ √ √ √ √ √
hydroxide (1979) (1975),
FCC, USP,
Ph Eur, BP
1.8 Calcium oxide √ JECFA - √ - √ √ √
(1979) (1975),
FCC, DAC
1.9 Calcium √ JECFA √ √ √ √ √ √
dihydrogen (1997) (1996),
phosphate Ph Int,
(Calcium FCC
phosphate,
monobasic)
1.10 Calcium √ JECFA √ √ √ √ √ √
hydrogen (1979) (1975),
phosphate FCC, USP,
(Calcium Ph Eur, BP,
phosphate, DAB
dibasic)
1.11 Tricalcium JECFA √ √ √ √ √ √
diphosphate (1973),
(Calcium Ph Int,
phosphate, FCC, BP
tribasic)
1.12 Calcium √ JECFA - √ - - - √
sulphate (1979) (1975),
Ph Int,
FCC, Ph
Eur
(dihydrate),
DAB
2. Source of Iron (Fe)

2.1 Ferrous DAB - √ - √ √ √

carbonate,
stabilised with
saccharose
2.2 Ferrous Ph Int, √ √ √ √ √ √
fumarate FCC, USP,
Ph Eur, BP
ALINORM 08/31/26, Appendix IV 55

2.3 Ferrous √ JECFA √ √ √ √ √ √

gluconate (2001) (1999),
FCC, USP,
Ph Eur,
DAB, BP

2.4 Ferrous lactate √ JECFA √ √ √ √ √ √

(1991) (1989),
FCC, NF
2.5 Ferrous √ JECFA √ √ √ √ √ √
sulphate (2001) (1999),
Ph Int,
FCC, USP,
Ph Eur, BP,
DAB
2.6 Ferric √ JECFA √ √ √ √ √ √
ammonium (1987) (1984),
citrate FCC, DAC
2.7 Ferric citrate FCC √ √ √ √ √ √

2.8 Ferric FCC √ √ √ √ √ √

diphosphate
(pyrophosphat
e)

2.9 Hydrogen FCC, DAB - √ - √ √ √

reduced iron

2.10 Electrolytic FCC - √ - √ √ √

iron

2.11 Carbonyl iron FCC - √ - √ √ √

2.12 Ferric Ph Helv, - √ - √ √ √

saccharate DAB, ÖAB

2.13 Sodium ferric FCC - √ - √ √ √

diphosphate
2.14 Ferrous citrate FCC, √ √ √ √ √ √
FSANZ
2.15 Ferrous
succinate MP, MI, √ √ √ √ √ √
FSANZ
2.16 Ferrous JECFA
bisglycinate (2003) √ √ √ √ √ √
ALINORM 08/31/26, Appendix IV 56

2.17 Ferric FCC - - - √ - -

orthophosphat
e
3. Source of Magnesium (Mg)

3.1 Magnesium JECFA √ √ √ √ √ √

hydroxide (1979),
carbonate USP, BP,
DAB
3.2 Magnesium √ JECFA √ √ √ √ √ √
chloride (1979) (1979),
FCC, USP,
Ph Eur (­
4,5­
hydrate),
BP, DAB
3.3 Magnesium √ JECFA √ √ √ √ √ √
gluconate (2001) (1998),
FCC, DAC
3.4 Magnesium Ph Eur, - √ - √ √ √
glycero- BPC
phosphate
3.5 Magnesium √ JECFA √ √ √ √ √ √
hydroxide (1979) (1975),
Ph Int,
FCC, USP,
Ph Eur, BP,
DAB
3.6 Magnesium √ JECFA - √ - √ √ √
lactate (1987) (1983)
(Mg-DL-
Lactate,
Mg-L-
Lactate)
3.7 Magnesium JECFA √ √ √ √ √ √
oxide (1973),
Ph Int,
FCC, USP,
Ph Eur, BP,
DAB
3.8 Magnesium √ JECFA √ √ √ √ √ √
hydrogen (1985) (1982),
phosphate FCC, DAB
Magnesium
phosphate,
dibasic)
3.9 Trimagnesium √ JECFA √ √ √ √ √ √
phosphate (1981) (1982),
(Magnesium FCC
phosphate,
tribasic)
ALINORM 08/31/26, Appendix IV 57

3.10 Magnesium Ph Eur √ √ √ √ √ √

sulphate (heptahydr
ate), FCC,
USP, JP,
BP, DAB,
DAC
3.11 Magnesium Ph Eur, - √ - - - √
acetate DAC

3.12 Magnesium USP, DAC √ √ √ √ √ √

salts of citric
acid

3.13 Magnesium JECFA √ √ √ √ √ √

carbonate (1973),
FCC, USP,
Ph Eur, BP,
DAB
4. Source of Sodium (Na)

4.1 Sodium √ JECFA √ √ √ - - √

carbonate (1979) (1975),
FCC, USP,
NF,
Ph Eur, BP,
DAB
4.2 Sodium √ JECFA √ √ √ - - √
hydrogen (1979) (1975),
carbonate Ph Int,
(Sodium FCC, USP,
bicarbonate) Ph Eur, BP,
DAB
4.3 Sodium Ph Int, √ √ √ - - √
chloride FCC, USP,
Ph Eur, JP,
BP, DAB
4.4 Trisodium JECFA √ √ √ - - √
citrate (1975),
(Sodium Ph Int,
citrate) FCC, USP,
Ph Eur, BP,
DAB
4.5 Sodium √ JECFA √ √ √ - - √
gluconate (1999) (1998),
FCC, USP,
DAC
4.6 Sodium L­ √ JECFA √ √ √ - - √
lactate (1978) (1974),
FCC, USP,
Ph Eur, BP,
DAB
ALINORM 08/31/26, Appendix IV 58

4.7 Sodium √ JECFA √ √ √ - - √

dihydrogen (1995) (1963),
phosphate FCC, USP,
(Sodium Ph Eur
phosphate, (dihydrate)
monobasic)
4.8 Disodium JECFA √ √ √ - - √
hydrogen (1975),
phosphate Ph Int,
(Sodium FCC, USP,
phosphate, BP
dibasic)
4.9 Trisodium JECFA √ √ √ - - √
phosphate (1975),
(Sodium FCC, DAC
phosphate,
tribasic)
4.10 Sodium √ JECFA √ √ √ - - √
hydroxide (1979) (1975),
Ph Int,
FCC, USP,
NF, Ph
Eur, JP,
BP, DAB
4.11 Sodium JECFA
sulphate (2000), √ √ √ - - √
Ph Int,
FCC, USP,
Ph Eur, BP,
DAB,
FSANZ
5. Source of Potassium (K)

5.1 Potassium √ JECFA √ √ √ - - √

carbonate (1979) (1975),
FCC, USP,
Ph Eur,
DAC
5.2 Potassium √ JECFA √ √ √ - - √
hydrogen (1979) (1975),
carbonate FCC, USP,
(Potassium Ph Eur, BP,
bicarbonate) DAB
5.3 Potassium √ JECFA √ √ √ √ √ √
chloride (1983) (1979),
Ph Int,
FCC, USP,
Ph Eur, BP,
DAB
ALINORM 08/31/26, Appendix IV 59

5.4 Tripotassium JECFA √ √ √ √ √ √

citrate (1975),
(Potassium Ph Int,
citrate) FCC, USP,
Ph Eur, BP,
DAB
5.5 Potassium √ JECFA √ √ √ √ √ √
gluconate (1999) (1998),
FCC, USP,
DAC
5.6 Potassium FCC - √ - √ √ √
glycero­
phosphate
5.7 Potassium L­ √ JECFA √ √ √ √ √ √
lactate (1978) (1974),
FCC, DAB
5.8 Potassium √ JECFA √ √ √ - - √
dihydrogen (1979) (1982),
phosphate FCC, NF,
(Potassium Ph Eur, BP,
phosphate, DAB
monobasic)
5.9 Dipotassium √ JECFA √ √ √ - - √
hydrogen (1979) (1982),
phosphate FCC, BP
(Potassium
phosphate,
dibasic)
5.10 Potassium √ JECFA √ √ √ - - √
phosphate, (1979) (1982)
tribasic
5.11 Potassium √ JECFA √ √ √ - - √
hydroxide (1979) (1975),
FCC, NF,
Ph Eur, JP,
BP, DAC
6. Source of Copper (Cu)

6.1 Cupric FCC, USP √ √ √ √ √ √

gluconate
(Copper
gluconate)
6.2 Cupric sulphate √ JECFA √ √ √ √ √ √
(Copper (1981) (1973),
sulphate) FCC, USP,
Ph Eur,
DAB
6.3 Cupric MI √ √ √ √ √ √
carbonate
ALINORM 08/31/26, Appendix IV 60

6.4 Cupric citrate FCC, USP √ √ √ √ √ √

7. Source of Iodine (I)

7.1 Potassium Ph Int, √ √ √ √ √ √
iodide FCC, USP,
Ph Eur, BP,
DAB
7.2 Sodium iodide Ph Eur, √ √ √ √ √ √
USP, BP,
DAB
7.3 Potassium √ JECFA √ √ √ √ √ √
iodate (1991) (1988),
FCC
7.4 Sodium iodate FCC - √ - √ √ √

8. Source of Zinc (Zn)

8.1 Zinc acetate USP, Ph √ √ √ √ √ √
Eur
(dihydrate)
8.2 Zinc chloride USP, Ph √ √ √ √ √ √
Eur, JP,
BP, DAB
8.3 Zinc gluconate FCC, USP, √ √ √ √ √ √
DAC
8.4 Zinc lactate FCC √ √ √ √ √ √

8.5 Zinc oxide Ph Int, √ √ √ √ √ √

FCC, USP,
Ph Eur, BP,
DAB
8.6 Zinc sulphate FCC, USP, √ √ √ √ √ √
Ph Eur, BP
8.7 Zinc carbonate USP, BP - √ - - - √
(hydroxide
carbonate)
9. Source of Manganese (Mn)
9.1 Manganese(II) FCC √ √ √ √ √ √
chloride

9.2 Manganese(II) FCC √ √ √ √ √ √

citrate

9.3 Manganese(II) FCC - √ - √ √ √

glycero­
phosphate
ALINORM 08/31/26, Appendix IV 61

9.4 Manganese(II) FCC, USP, √ √ √ √ √ √

sulphate Ph Eur
(monohydr
ate)
9.5 Manganese(II) FCC √ √ √ √ √ √
gluconate
9.6 Manganese(II) MI √ √ √ √ √ √
carbonate
10. Source of Selenium (Se)
10.1 Sodium MI √ √ √ √ - √
selenate

10.2 Sodium Ph Eur, √ √ √ √ - √

selenite USP, MP,
MI
10.3 Sodium DVFA - √ - - - √
hydrogen
selenite
11. Chromium (Cr III)
11.1 Chromium USP, MI - √ - - - √
(III) sulphate

11.2 Chromium USP, MI - √ - - - √

(III) chloride

12. Molybdenum (Mo VI)

12.1 Sodium Ph Eur - √ - - - √
molybdate (dihydrate),
BP, DAB
12.2 Ammonium FCC, USP - √ - - - √
molybdate

13. Fluoride (F)

13.1 Sodium FCC, USP, - √ - - - √
fluoride Ph Eur, BP,
DAB
13.2 Potassium FCC, DAB - √ - - - √
fluoride
13.3 Calcium DAB - √ - - - √
fluoride
ALINORM 08/31/26, Appendix IV 62

B: ADVISORY LIST OF VITAMIN COMPOUNDS FOR USE IN FOODS FOR SPECIAL

DIETARY USES INTENDED FOR INFANTS AND YOUNG CHILDREN

Purity Requirements Use in Codex Food Standards

Nutrient Source by Applicable to Infants and Young Children
CAC1 internation IF FUF4 PCBF5 CBF6 FSMP7
al and/or for
national Sec. A2 Sec. B3 infants
bodies and
young
childre
n
1. Vitamin A

1.1 all trans Retinol FCC √ √ √ √ √ √

(vitamin
A), USP,
Ph Eur
(vitamin A)
1.2 Retinyl acetate FCC √ √ √ √ √ √
(vitamin
A), USP,
Ph Eur
(vitamin
A),
Jap Food
Stan
1.3 Retinyl FCC √ √ √ √ √ √
palmitate (vitamin
A), USP,
Ph Eur
(vitamin
A),
Jap Food
Stan
2. Provitamin A

2.1 Beta-Carotene √ JECFA √ √ √ √ √ √

(1991) (1987),
FCC, USP,
Ph Eur, Jap
Food Stan

1
CAC = Codex Alimentarius Commission
2
IF Sect. A = Section A of the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants
3
IF Sect. B = Section B of the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants
4
FUF = Follow-up Formula
5
PCBF = Processed Cereal Based Foods for Infants and Young Children
6
CBF = Canned Baby Food
7
FSMP = Food for Special Medical Purposes other than Infant Formula
ALINORM 08/31/26, Appendix IV 63

3. Vitamin D

3.1 Vitamin D2 Ph Int, FCC, √ √ √ √ √ √

= Ergocalciferol USP, Ph
Eur, Jap
Food Stan,
DAB
3.2 Vitamin D3 = Ph Int, FCC, √ √ √ √ √ √
Cholecalcifer USP, Jap
ol Food Stan,
BP, DAB
4. Vitamin E

4.1 D-alpha­ √ JECFA √ √ √ √ √ √

Tocopherol (2001) (2000),
FCC, USP,
NF, Ph Eur
4.2 DL-alpha- √ JECFA √ √ √ √ √ √
Tocopherol (1989) (1986),
FCC, USP,
NF, Ph Eur,
Jap Food
Stan
4.3 D-alpha- FCC, USP, √ √ √ √ √ √
Tocopheryl NF,
acetate Ph Eur
4.4 DL-alpha- FCC, USP, √ √ √ √ √ √
Tocopheryl NF,
acetate Ph Eur, BP
4.5 D-alpha- FCC, USP, - √ - - - √
Tocopheryl acid Ph Eur
succinate
4.6 DL-alpha- NF, MP, MI, - √ - - - √
Tocopheryl acid USP, Ph Eur
succinate
4.7 DL-alpha- FCC, - √ - - - √
Tocopheryl USP
polyethylene
glycol 1000
succinate
5. Vitamin C

5.1 L-Ascorbic acid JECFA √ √ √ √ √ √

√ (1981) (1973),
Ph Int, FCC,
USP, Ph
Eur, JP, Jap
Food Stan,
BP, DAB
ALINORM 08/31/26, Appendix IV 64

5.2 Calcium-L­ √ (1983) JECFA √ √ √ √ √ √

ascorbate (1981),
FCC, USP,
Ph Eur
5.3 6-Palmitoyl-L­ JECFA √ √ √ √ √ √
ascorbic acid (1973),
(Ascorbyl FCC, USP,
palmitate) NF,
Ph Eur, Jap
Food Stan,
BP, DAB
5.4 Sodium-L­ JECFA √ √ √ √ √ √
ascorbate (1973),
FCC, USP,
Ph Eur, Ph
Franc, Jap
Food Stan,
DAC
5.5 Potassium-L­ FCC √ √ √ √ √ √
ascorbate
6. Vitamin B1

6.1 Ph Int, √ √ √ √ √ √
Thiaminchlori FCC, USP,
de Ph Eur, Jap
hydrochloride Food Stan,
DAB
6.2 Thiamin Ph Int, √ √ √ √ √ √
mononitrate FCC, USP,
Ph Eur, Jap
Food Stan,
DAB
7. Vitamin B2

7.1 Riboflavin √ (1991) JECFA √ √ √ √ √ √

(1987),
Ph Int, FCC,
USP, Ph
Eur, JP, Jap
Food Stan,
BP, DAB
7.2 Riboflavin-5’­ √ (1991) JECFA √ √ √ √ √ √
phosphate (1987),
sodium USP, Ph
Eur, JP, Jap
Food Stan,
BP, DAB
ALINORM 08/31/26, Appendix IV 65

8. Niacin

8.1 Nicotinic acid Ph Int, FCC, √ √ √ √ √ √

amide USP, Ph
(Nicotinamide) Eur, Jap
Food Stan,
BP, DAB
8.2 Nicotinic acid Ph Int, FCC, √ √ √ √ √ √
USP, Ph
Eur, Jap
Food Stan,
BP, DAB
9. Vitamin B6

9.1 Pyridoxine Ph Int, FCC, √ √ √ √ √ √

hydrochloride USP, Ph
Eur, Jap
Food Stan,
DAB
9.2 Pyridoxal 5­ MI, FCC, √ √ √ √ √ √
phosphate USP
10. Folic acid

10.1 N-Pteroyl-L- Ph Int, FCC, √ √ √ √ √ √

glutamic acid USP, Ph
Eur, Jap
Food Stan
10.2 Calcium-L­ JECFA - √ - - - √
methyl-folate (2005)
11. Pantothenic acid

11.1 Calcium-D­ FCC, USP, √ √ √ √ √ √

pantothenate Ph Eur, Jap
Food Stan,
DAB
11.2 Sodium-D­ Jap Food √ √ √ √ √ √
pantothenate Stan, DAB

11.3 D-Panthenol/ FCC, USP, √ √ √ √ √ √

Ph Eur
11.4 DL-Panthenol FCC, USP, √ √ √ √ √ √
Ph Eur
12. Vitamin B12

12.1 Cyanocobalamin Ph Int, FCC, √ √ √ √ √ √

USP, Ph
Eur, BP,
DAB
ALINORM 08/31/26, Appendix IV 66

12.2 Hydroxo­ Ph Int, USP, √ √ √ √ √ √

cobalamin NF,
Ph Eur
(hydro­
chloride)
13. Vitamin K1

13.1 Phytomenadione Ph Int, FCC √ √ √ √ √ √

(2-Methyl-3­ (vitamin K),
phytyl-1,4­ USP, Ph Eur,
naphthoquinone/ BP
Phylloquinone/
Phytonadione)
14. Biotin

14.1 D-Biotin FCC, USP, √ √ √ √ √ √

Ph Eur
ALINORM 08/31/26, Appendix IV 67

C: ADVISORY LIST OF AMINO ACIDS AND OTHER NUTRIENTS FOR USE IN FOODS FOR
SPECIAL DIETARY USES INTENDED FOR INFANTS AND YOUNG CHILDREN

Purity Requirements Use in Codex Food Standards

Nutrient Source by Applicable to Infants and Young Children
CAC1 internation IF FUF4 PCBF5 CBF6 FSMP7
al and/or for
national Sec. A2 Sec. B3 infants
bodies and
young
children
1. Amino acids8

1.1 L-Arginine FCC, USP, √ √

Ph Eur, BP,
DAB

only for improving the nutritional quality of the protein (when the protein is

1.2 L-Arginine FCC, USP, √ √

hydrochloride Ph Eur,
BP, DAB
1.3 L-Cystine FCC, USP, √ √
Ph Eur
1.4 L-Cystine MI √ only for improving the
√
dihydrochlorid
nutritional quality of the

e
protein (when the

1.5 L-Cysteine DAB √ protein is nutritionally √

nutritionally inadequate for its intended use)

inadequate for its

intended use)
1.6 L-Cysteine FCC, Ph √ √
hydrochloride Eur

1.7 L- Histidine
FCC, USP,
√ √
Ph Eur,

DAB

1.8 L- Histidine FCC, Ph √ √

hydrochloride Eur, DAB
1.9 L-Isoleucine
FCC, USP,
√ √
Ph Eur,

DAB

1.10 L-Isoleucine FCC, USP √ √

hydrochloride

1
CAC = Codex Alimentarius Commission
2
IF Sect. A = Section A of the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants
3
IF Sect. B = Section B of the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants
4
FUF = Follow-up Formula
5
PCBF = Processed Cereal Based Foods for Infants and Young Children
6
CBF = Canned Baby Food
7
FSMP = Food for Special Medical Purposes other than Infant Formula
8
As far as applicable, also the free, hydrated and anhydrous forms of amino acids, and the hydrochloride, sodium, and potassium
salts of amino acids may be used for FSMP.
ALINORM 08/31/26, Appendix IV 68

1.11 L-Leucine FCC, USP, √ √

Ph Eur,
DAB
1.12 L-Leucine MI, FCC, √ √
hydrochloride USP

1.13 L-Lysine USP √ √

only for improving the nutritional quality of the protein (when the
1.14 L-Lysine FCC, USP, √ √
monohydrochl Ph Eur,
oride DAB
1.15 L-Methionine Ph Int, √ √

protein is nutritionally inadequate for its intended use)

FCC, USP,
Ph Eur,
DAB
1.16 L- FCC, USP, √ only for improving the √
Phenylalanine Ph Eur nutritional quality of the
1.17 L-Threonine FCC, USP, √ protein (when the protein √
Ph Eur, is nutritionally inadequate
DAB for its intended use)
1.18 L-Tryptophan FCC, USP, √ √
Ph Eur,
DAB
1.19 L-Tyrosine FCC, USP, √ √
Ph Eur,
DAB
1.20 L-Valine FCC, USP, √ √
Ph Eur,
DAB
1.21 L-Alanine FCC, USP, - √ - - - √
Ph Eur,
DAB
1.22 L-Arginine L- FP - √ - - - √
aspartate

1.23 L-Aspartic FCC, USP, - √ - - - √

acid Ph Eur

1.24 L-Citrulline USP, DAC - √ - - - √

1.25 L- Glutamic JECFA - √ - - - √

acid (1987),
FCC, USP,
Ph Eur
1.26 L-Glutamine FCC, USP, - √ - - - √
DAB
1.27 Glycine FCC, USP, - √ - - - √
Ph Eur
ALINORM 08/31/26, Appendix IV 69

1.28 L-Ornithine MI, FCC - √ - - - √

1.29 L-Ornithine DAB - √ - - - √

monohydrochl
oride
1.30 L-Proline FCC, USP, - √ - - - √
Ph Eur,
DAB
1.31 L-Serine USP, Ph - √ - - - √
Eur, DAB
1.32 N-Acetyl-L­ USP, Ph - √ - - - √
cysteine Eur, DAB

1.33 N-Acetyl-L­ FCC - - - - - √

methionine not for
infants
1.34 L-Lysine FCC, USP, - √ - - - √
acetate MP; Ph Eur
1.35 L-Lysine L- Jap Food - √ - - √
Aspartate Stan
1.36 L-Lysine L- Jap Food - √ - - - √
glutamate Stan
dihydrate
1.37 Magnesium L- Ph Eur - √ - - - √
aspartate
1.38 Calcium L- √ JECFA, - √ - - - √
glutamate (1991) FCC,
FSANZ,
Jap Food
Stan
1.39 Potassium L­ JECFA, - √ - - - √
glutamate FCC,
FSANZ,
Jap Food
Stan
2. Carnitine

2.1 L-Carnitine FCC, USP, √ √ √ √ √ √

Ph Eur
2.2 L-Carnitine FCC √ √ √ √ √ √
hydrochloride
2.3 L-Carnitine FCC, Ph Eur √ √ √ - - √
tartrate
3. Taurine

3.1 Taurine USP, JP √ √ √ - - √

ALINORM 08/31/26, Appendix IV 70

4. Choline

4.1 Choline FCC, USP √ √ √ √ √ √

4.2 Choline FCC, √ √ √ √ √ √

chloride DAC, DAB

4.3 Choline citrate NF √ √ √ √ √ √

4.4 Choline DAB √ √ √ √ √ √

hydrogen
tartrate
4.5 Choline FCC, NF, √ √ √ √ √ √
bitartrate DAB
5. Inositols

5.1 Myo-Inositol FCC, DAC √ √ √ √ √ √

(=meso-
Inositol)
6. Nucleotides

6.1 Adenosine 5­ FSANZ √ √ √ - - √

mono­
phosphate
(AMP)
6.2 Cytidine 5­ FSANZ, √ √ √ - - √
mono- Jap Food
phosphate Stan
(CMP)
6.3 Guanosine 5­ JECFA √ √ √ - - √
mono­ (1985)
phosphate
(GMP)
6.4 Inosine 5­ JECFA √ √ √ - - √
monophos­ (1974)
phate (IMP)
6.5 Disodium FSANZ, Jap √ √ √ - - √
Uridine 5­ Food Stan
monophosphate
salt
6.6 Disodium FCC, √ √ √ - - √
Guanosine 5­ JECFA,
monophosphate FSANZ, Jap
salt Food Stan
6.7 Disodium FCC, √ √ √ - - √
Inosine 5­ JECFA,
monophosphate FSANZ, Jap
salt Food Stan
ALINORM 08/31/26, Appendix IV 71

D: ADVISORY LIST OF FOOD ADDITIVES FOR SPECIAL NUTRIENT FORMS

For reasons of stability and safe handling, some vitamins and other nutrients have to be converted
into suitable preparations, e.g. gum arabic coated products, dry rubbed preparations. For this
purpose, the food additives included in the respective specific Codex standard may be used. In
addition, the following food additives may be used as nutrient carriers:

Maximum Level in
INS no. Additive/ Carrier Ready-to-use Food for
infants and young
children
(mg/kg)
(a) 551 Silicon dioxide 10

(b) 421 Mannitol (for vitamin B12 dry rubbing, 10

0,1% only)
(c) 1450 Starch sodium octenyl succinate 100

(d) 301 Sodium L-ascorbate (in coating of 75

nutrient preparations containing
polyunsaturated fatty acids)

Abbreviations:

BP = British Pharmacopoeia
BPC = British Pharmaceutical Codex
DAB = Deutsches Arzneibuch
DAC = Deutscher Arzneimittel-Codex
DVFA = Danish Veterinary and Food Administration
FCC = Food Chemicals Codex
FSANZ = Food Standards Australia New Zealand
FU = Farmacopoea Ufficiale della Republica Italiana
JP = The Pharmacopeia of Japan
Jap Food Stan = Japanese Food Standard
MI = Merck Index
MP = Martindale Pharmacopoeia
ÖAB = Österreichisches Arzneibuch
Ph Eur = Pharmacopoeia Europaea
Ph Franç = Pharmacopée Française
Ph Helv = Pharmacopoeia Helvetica
Ph Int = International Pharmacopoeia
USP = The United States Pharmacopoeia
ALINORM 08/31/26, Appendix V 72

APPENDIX V

PROPOSED DRAFT ADVISORY LIST OF NUTRIENT COMPOUNDS FOR USE IN FOODS

FOR SPECIAL DIETARY USES INTENDED FOR INFANTS AND YOUNG CHILDERN

(At Step 6 of the Procedure)

D: ADVISORY LIST OF FOOD ADDITIVES FOR SPECIAL NUTRIENT FORMS

Maximum Level in
INS no. Additive/ Carrier Ready-to-use Food for
infants and young children
[mg/kg]

[(a) 414 Gum arabic (gum acacia) [10] or [100]]

ALINORM 08/31/26, Appendix VI 73

APPENDIX VI

PROPOSED DRAFT NUTRITIONAL RISK ANALYSIS PRINCIPLES AND GUIDELINES FOR

APPLICATION TO THE WORK OF THE COMMITTEE ON NUTRITION AND FOODS FOR

SPECIAL DIETARY USES

(At Step 5 of the Procedure)

SECTION 1 – BACKGROUND

1. The Working Principles for Risk Analysis for Application in the Framework of the Codex Alimentarius
(hereafter cited as “Working Principles”) has established general guidance on risk analysis to Codex
Alimentarius. These Working Principles were adopted in 2003 and published in this Procedural
Manual.

2. The objective of the Working Principles is “to provide guidance to the Codex Alimentarius Commission
and the joint FAO/WHO expert bodies and consultations so that food safety and health aspects of Codex
standards and related texts are based on risk analysis”. By its reference to health aspects in addition to
food safety, the objective provides clearer direction for risk analysis to apply to nutritional matters that
are within the mandate of the Codex Alimentarius Commission and its subsidiary bodies.

SECTION 2 – INTRODUCTION

3. Codex nutritional risk analysis addresses nutrients1 and related substances2 and the risk to health from
their inadequate and/or excessive intake. Nutritional risk analysis applies the same general approach as
traditional food safety risk analysis to consideration of excessive intakes of nutrients and related
substances. However, unlike many constituents of food that are the subject of traditional food safety
risk analysis such as food additives, chemical (pesticide and veterinary drug) residues inherent
constituents such as allergens, nutrients and related substances are inherent constituents that are
biologically essential (in the case of essential nutrients) or in other ways potentially favourable to
health. Nutritional risk analysis therefore adds a new dimension to traditional risk analysis by also
considering risks directly posed by inadequate intakes., microbiological pathogens, contaminants and

4. The [Nutritional Risk Analysis Principles and Guidelines for Application to the Work of the Committee
on Nutrition and Foods for Special Dietary Uses] presented in this document (hereafter cited as
“Nutritional Risk Analysis Principles”) are subsidiary to and should be read in conjunction with the
Working Principles.

These Nutritional Risk Analysis Principles are framed within the three-component structure of the Working
Principles, but with an added initial step to formally recognize Problem Formulation as an important
preliminary risk management activity.

5. Consistent with their important role in providing scientific advice to the Codex Alimentarius
Commission and its subsidiary bodies, FAO and WHO and their joint expert consultations [and expert
bodies] are acknowledged as the primary source of nutritional risk assessment advice to Codex

1
Nutrient is defined by Codex General Principles for the Addition of Essential Nutrients to Foods (CAC/GL 09-1987)
to mean:
Any substance normally consumed as a constituent of food:
(a) which provides energy; or
(b) which is needed for growth and development and maintenance of healthy life; or
(c) a deficit of which will cause characteristic biochemical or physiological changes to occur.
Essential nutrient means any substance normally consumed as a constituent of food which is needed for growth and
development and the maintenance of healthy life and which cannot be synthesized in adequate amounts by the body.
2
[A related substance is an inherent constituent of food (other than a nutrient) that has a [potential] nutritional or
physiological effect. ]
ALINORM 08/31/26, Appendix VI 74

Alimentarius. This role however, does not preclude the choice of other sources of scientific advice such
as appropriate international expert groups or organizations if and when justified.

SECTION 3 – SCOPE AND APPLICATION

6. [The Nutritional Risk Analysis Principles are established to guide the Codex Alimentarius Commission
and its subsidiary bodies - primarily but not exclusively the Codex Committee on Nutrition and Foods
for Special Dietary Uses (CCNFSDU) - in applying nutritional risk analysis to their work. This
guidance potentially extends beyond CCNFSDU since the Committee is also mandated, in accordance
with its 4th term of reference, “to consider, amend if necessary, and endorse provisions on nutritional
aspects” of foods including those resulting from application of nutritional risk analysis that are
developed by other Codex subsidiary bodies. ]

7. Nutritional risk analysis considers the risk of adverse health effects from inadequate and/or excessive
intakes of nutrients and related substances, and the predicted reduction in risk from proposed
management strategies. In situations that address inadequate intakes, such a reduction in risk might be
referred to as [one form of] a nutritional benefit.

8. The food constituents of primary interest in nutritional risk analysis are inherent components of food
and/or intentionally added to food [and are identified as:

• nutrients that may reduce the risk of inadequacy and those that may increase the risk of adverse
health effects; or

• related substances2 that may increase the risk of adverse health effects at excessive intake and may
also reduce the risk of other adverse health effects at lower intake;

• [nutrients that increase the risk of adverse health effects that exist in a food matrix with a nutrient(s)
or related substance(s) associated with reduction of the risk of inadequacy or adverse health effects
at lower intake];].

9. Where appropriate, the application of quantitative nutritional risk analysis may guide decision making
on quantitative content provisions for nutrients and related substances in certain Codex texts.

10. Nutritional risk analysis should be as quantitative as possible, although a qualitative risk-based approach
drawing on the principles of nutritional risk analysis could assist the development of Codex texts in such
situations as:

• formulating general principles related to nutritional composition (e.g. principles for the addition of
nutrients to foods);

• formulating general principles for assessing or managing risks related to foods for which a nutrition
or health claim has been requested;

• managing risks by labelling advice in relation to consumption of foods of certain nutrient-related3

composition, including foods for special dietary use; and

• advising on risk-risk analysis (e.g. risk associated with a significantly reduced or entirely avoided
consumption of a nutritious, staple food in response to a dietary hazard such as a contaminant
present in that food.

3
For the purpose of these Nutritional Risk Analysis Principles, the descriptive term ‘nutrient-related’ refers to one or
more nutrients and/or related substances, as the case may be.
ALINORM 08/31/26, Appendix VI 75

SECTION 4 – DEFINITIONS

11. The Definitions of Risk Analysis Terms Related to Food Safety in this Procedural Manual provide
suitable generic definitions of risk analysis, risk assessment, risk management, risk communication and
risk assessment policy. When applied in a nutritional risk analysis context, these high-level risk analysis
terms should be prefaced by ‘nutritional’ and their existing definitions appropriately adapted by
replacement of relevant existing terms and definitions with those listed below.

12. However, other Definitions of Risk Analysis Terms Related to Food Safety have been modified to
reference inadequate intake as a nutritional risk factor. Some new terms also have been defined to
provide further clarity. The modified or newly developed subsidiary definitions are as follows:

Nutritional risk – A function of the probability of an adverse health effect associated with inadequate
or excessive intake of a nutrient or related substance and the severity of that effect, consequential to a
nutrient-related hazard(s) in food.

Adverse health effect4 – A change in the morphology, physiology, growth, development, reproduction
or life span of an organism, system, or (sub)population that results in an impairment of functional
capacity, an impairment of the capacity to compensate for additional stress, or an increase in
susceptibility to other influences.

Nutrient-related3 hazard – A nutrient or related substance in food that has the potential to cause an
adverse health effect depending on inadequate or excessive level of intake.

Nutrient-related hazard identification – The identification of a nutrient-related hazard in a particular

food or group of foods.

Nutrient-related hazard characterization – The qualitative and/or quantitative evaluation of the

nature of the adverse health effects associated with a nutrient-related hazard.

Dose response assessment – The determination of the relationship between the magnitude of intake of
(or exposure to) (i.e. dose) a nutrient or related substance and the severity and/or frequency of
associated adverse health effects (i.e. response).

Upper level of intake4 – the maximum level of habitual intake from all sources of a nutrient or related
substance judged to be unlikely to lead to adverse health effects in humans.

Highest observed intake4 – the highest level of intake observed or administered as reported within a
stud(ies) of acceptable quality. It is derived only when no adverse health effects have been identified.

Intake (Exposure) assessment – The qualitative and/or quantitative evaluation of the likely intake of a
nutrient or related substance from food as well as intake from other relevant sources such as food
supplements.

Nutrient-related risk characterization – The qualitative and/or quantitative estimation, including

attendant uncertainties, of the probability of occurrence and severity of known or potential adverse
health effects in a given population based on nutrient-related hazard identification, nutrient-related
hazard characterization and intake assessment.

Bioavailability5 – The proportion of the ingested nutrient or related substance that is absorbed and
utilised through normal metabolic pathways. Bioavailability is influenced by dietary factors such as

4
.A Model for Establishing Upper Levels of Intake for Nutrients and Related Substances. Report of a joint FAO/WHO
technical workshop 2005, WHO, 2006.
5
Gibson R.S. The role of diet- and host-related factors in nutrient bioavailability and thus in nutrient-based dietary
requirement estimates. Food and Nutrition Bulletin 2007;28(suppl):S77-100.
ALINORM 08/31/26, Appendix VI 76

chemical form, interactions with other nutrients and food components, and food processing/preparation;
and host–related intestinal and systemic factors.

Homeostatic mechanism4 – A mechanism effected through a system of controls activated by negative

feedback that allow the maintenance of normal body functions in the presence of a variable nutrition
environment.

SECTION 5 – PRINCIPLES FOR NUTRITIONAL RISK ANALYSIS

13. Nutritional risk analysis comprises three components: risk assessment, risk management and risk
communication. Particular emphasis is given to an initial step of Problem Formulation as a key
preliminary risk management activity.

PRELIMINARY NUTRITIONAL RISK MANAGEMENT ACTIVITIES

14. Preliminary nutritional risk management activities should have regard to the particular sections in the
Working Principles titled General Aspects of Risk Analysis, and Risk Assessment Policy.

Nutritional Problem Formulation4

15. Nutritional Problem Formulation is necessary to identify the purpose of a nutritional risk assessment and
is a key component of preliminary nutritional risk management activity because it fosters interactions
between risk managers and risk assessors to help ensure common understanding of the problem and the
purpose of the risk assessment.

16. Such considerations should include whether a nutritional risk assessment is needed and if so:

• the priority it should be accorded;

• who should conduct and be involved in the nutritional risk assessment, nutritional risk management
and nutritional risk communication processes;

• the need for development of nutritional risk assessment policy;

• how the nutritional risk assessment will provide the information necessary to support the nutritional
risk management decision;

• whether data are available to embark on an evaluation of nutritional risks;

• what level of resources are available; and

• the timeline for completing the assessment.

17. Specific information to be gathered for nutritional problem formulation may include:

• a detailed inventory of prior knowledge;

• identification of the (sub)populations to be the focus for the risk assessment, geographical areas or
consumer settings to be covered;

• relevant route(s) of exposure; and

• the health endpoints to be considered.

ALINORM 08/31/26, Appendix VI 77

NUTRITIONAL RISK ASSESSMENT

18. The risk assessment section of the Codex Working Principles for Risk Analysis for Application in the
Framework of the Codex Alimentarius is generally applicable to nutritional risk assessment. Additional
nutritional risk assessment principles to consider within the Codex framework are identified below.

Nutrient-Related Hazard Identification and Hazard Characterization

19. These two steps are often globally relevant because they are based on available scientific and medical
literature that contribute data from diverse population groups. This global relevance for characterization
of hazard does not, however, preclude the possibility of a (sub)population-specific hazard.

20. Nutritional risk assessment should take into consideration the nutrient-related hazard(s) posed by both
inadequate and excessive intakes. This may include consideration of hazard(s) posed by excessive
intakes of accompanying risk-increasing nutrients in the food vehicle(s) under consideration.

21. Nutrient-related hazard identification and characterization should recognize current methodological
differences in assessment of nutritional risk of inadequate and excessive intakes, and scientific advances
in these methodologies.

22. Nutrient-related hazard characterization should take into account homeostatic mechanisms for essential
nutrients, and limitations in the capacity for homeostatic adaptations. It may also take into account
bioavailability including factors affecting the bioavailability of nutrients and related substances such as
different chemical forms.

23. Nutrient reference standards that may be used to characterize nutrient-related hazard(s) related to
adequacy include measures of average requirement. Some globally applicable nutrient reference
standards for average requirement have been published by FAO/WHO. Official regional and national
nutrient reference standards are also available and have been periodically updated to reflect scientific
advances. These are more likely to relate to nutrients than to related substances.

24. Nutrient reference standards that may be used to characterize nutrient-related hazard(s) related to
excessive intakes include upper levels of intake. Some globally applicable reference standards of upper
level of intake have been published by FAO/WHO. In addition, the establishment of international upper
levels of intake and highest observed intake that build on recommendations4 may be considered in the
future. Some periodically-updated nutrient reference standards are available from regional and national
authorities. For some related substances, such standards developed from a systematic review of the
evidence are available only in the peer-reviewed scientific literature.

25. The assessment of inadequate and excessive levels of intake of particular nutrients and related
substances should take into account the availability of all such scientifically determined reference
sources, as appropriate. When using such reference standards for nutrient and related substances in
nutritional risk assessment, the basis for their derivation should be explicitly described.

Nutrient-Related Intake Assessment and Risk Characterization

26. These two steps are generally specific to the (sub)population(s) under consideration for risk assessment.
The populations relevant to Codex consideration are populations at large in Codex member countries or
particular subpopulation groups in these countries defined according to physiological parameters such as
age or state of health.

27. Nutrient-related intake assessment and risk characterization should be applied within a total diet context.
Where feasible, it would typically involve the evaluation of the distribution of habitual total daily
intakes for the target population(s). This approach recognizes that nutrient-related risks are often
ALINORM 08/31/26, Appendix VI 78

associated with total intakes from multiple dietary sources, including fortified foods, food supplements6,
and in the case of certain minerals, water. [It may also take into account the bioavailability and stability
of nutrients and related substances in the foods consumed.]

NUTRITIONAL RISK MANAGEMENT

28. The risk management section of the Codex Working Principles for Risk Analysis for Application in the
Framework of the Codex Alimentarius is generally applicable to nutritional risk management.
Additional nutritional risk management principles to consider within the Codex framework are
identified below.

29. Nutritional risk management can be effected through quantitative measures or qualitative guidance
elaborated in Codex texts. Such risk management could involve decisions about nutrient composition,
consideration of the suitability of foods containing risk-increasing nutrients for certain purposes or
(sub)populations, labelling advice intended to mitigate nutritional risks to public health, and formulation
of relevant general principles.

[Nutritional risk management decisions should take into account the actual, or likely, impact on
consumers’ behaviour, such as dietary patterns and preparation practices, which are cultural habits, in
order to anticipate possible product substitutions and to ensure an overall risk reduction.]

30. Nutritional risk assessment policy should be articulated as appropriate for the selected risk assessor
prior to the conduct of the nutritional risk assessment.

NUTRITIONAL RISK COMMUNICATION

31. The risk communication section of the Codex Working Principles for Analysis for Application in the
Framework of the Codex Alimentarius is generally applicable to nutritional risk communication.

SECTION 6 – SELECTION OF RISK ASSESSOR BY CCNFSDU

32. Consistent with their important role in providing scientific advice to Codex Alimentarius and its
subsidiary bodies, FAO and WHO are acknowledged as the primary source of nutritional risk
assessment advice to Codex Alimentarius. However, this role does not preclude the choice of other
sources of advice such as appropriate international expert groups or organizations [as well as national
relevant expertise,] if and when justified.

33. All requests for risk assessment advice should be accompanied by terms of reference and where
appropriate risk assessment policy to provide guidance to the risk assessor. These parameters should be
established by the relevant Codex subsidiary body.

SECTION 7 – REVIEW PROCESS

34. These Nutritional Risk Analysis Principles should be reviewed by CCNFSDU at appropriate intervals
after implementation to ensure currency and consistency with [good regulatory practice] and subsequent
to any future amendments to the Codex Working Principles.

6
Codex Guidelines for Vitamin and Mineral Food Supplements (CAC/GL 55 – 2005) define food supplements as
sources in concentrated forms of those nutrients or related substances alone or in combinations, marketed in forms such
as capsules, tablets, powders solution, etc., that are designed to be taken in measured small unit quantities but are not in
a conventional food form and whose purpose is to supplement the intake of nutrients or related substances from the diet.
ALINORM 08/31/26, Appendix VII 79

APPENDIX VII

PROJECT DOCUMENT OF A PROPOSAL FOR NEW WORK TO REVISE NUTRIENT

REFERENCE VALUES OF VITAMINS AND MINERALS (CAC/GL 2-1985)

1. PURPOSE AND THE SCOPE OF THE PROPOSED NEW WORK

Section 3.4.4 of the Codex Guidelines for Nutrition Labelling (CAC/CL 2-1985, Rev. 1-1993) provides that
numerical information on vitamins, minerals and protein should be expressed as a percentage of the
reference labeling value referred to as “Nutrient Reference Value” (NRV). Since the first introduction of
this guideline in 1985, Section 3.4.4 was amended once in 1993 following the Report of a Joint FAO/WHO
Consultation on Recommended Allowances of Nutrients for Food Labelling Purposes (Helsinki, Finland, 12­
16 September 1988). At that time, it was indicated that the definition and review of these values was on
ongoing process, subject to revision according to new scientific data by the Committee of Food Labelling
(CCFL). The CCFL also recognized a need for general principles to guide the choice and amendment of
NRVs, and had requested the advice of the Committee on Nutrition and Foods for Special Dietary Uses in
this respect (ALINORM 93/40)

Currently the list of NRVs in Codex Guidelines for Nutrition Labelling covers 9 vitamins (A, D, C, thiamin,
riboflavin, niacin, B6, folic acid and B12), 5 minerals (Calcium, Magnesium, Iron, Zinc, Iodine) and protein,
which were in general based on the Reference RDAs for adult men. These values are indicated as a basis
for expressing nutrient content in nutrition labeling of food supplements in the Codex Guidelines for Vitamin
and Mineral Food Supplements (CAC/GL 55-2005). Also the Codex Guidelines for Use of Nutrition and
Health Claims (CAC/GL 23-1997, Rev. 1-2004) indicates NRVs as a basis for criteria for nutrition and
health claims.

At the 25th Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSUD)
agreed that the current list of NRVs in the Codex Guidelines for Nurition Labelling was incomplete and
required additions and updates. It was also pointed out that a set of principles should be developed for the
establishment of NRVs taking into account the experience of member countries in the establishment of
reference values for the purpose of labelling.

The purpose of the proposed new work is to develop the science-based general principles for establishing
NRVs and to revise the list of NRVs in the Codex Guidelines for Nutrition Labelling, taking full account of
the prior work related to nutrient reference values.

2. ITS RELEVANCE AND TIMELINESS

WHA Resolution 57.17 endorsing the Global Strategy requested the Codex Alimentarius Commission to
continue to give full consideration within the framework of its operational mandate, to measures which it
might take to contribute towards the improvement of health standards of foods consistent with the aims and
objectives of the Global Strategy.

Accordingly, the 28th Session of the Commission agreed to ask WHO and FAO to prepare a document
 ALINORM 08/31/26, Appendix VII 80

focused on actions that could be taken by Codex including specific proposals for new work for consideration
by the CCNFSDU and the CCFL. At its 29th Session of the Commission, it was agreed to complete a
document containing concrete proposals for possible actions by Codex and to circulate for comments and
consideration by the CCNFSDU and CCFL.

The CCNFSDU and CCFL had discussed extensively the proposals for actions and both Committees agreed
for CCNFSDU to revise the NRVs of vitamins and minerals in the Guidelines for Nutrition Labelling
(ALINORM 07/30/26). Therefore the proposal of this new work is timely as well as relevant.

3. THE MAIN ASPECTS TO BE COVERED

This work would involve a process to develop the general principles for establishment of vitamin and

mineral NRVs for the general population as a first step.

The next step would be a process to review all available reference values and their scientific basis by the
principles agreed upon and, if appropriate, update and extend the current list of vitamin and mineral NRVs in
the Guidelines for the Nutrition Labelling.

Once the above is completed, the Committee would establish vitamin and mineral NRVs for labelling for
individuals 6 months to 36 months of age. The Committee could then beginn to work to establish principles
that would apply to NRVs for this age group, using as a basis the principles identified for NRVs for the
general population and modifying them as appropriate. Once those principles are developed, the NRVs for
this age group would be established.

4. AN ASSESSMENT AGAINST THE CRITERIA FOR THE ESTABLISHMENT OF

WORK PRIORITIES

Consumer protection from the point of view of health, food safety, ensuring fair practices in the food trade
and taking into account the identified needs of developing countries: This proposed new work would
provide Codex and national/regional authorities principles to be used in establishing NRVs, thus assisting
in establishing appropriate level of protection for consumers. The project could particularly assist countries
that have limited experience with NRVs, particularly for selecting NRVs for labelling purposes.

Diversification of national legislations and apparent resultant or potential impediments to international

trade: This proposed new work would provide internationally-recognized scientific general principles that
Codex and national/regional authorities may use to carry out establishing NRVs for labelling purposes. Such
internationally-agreed principles can help ensure consistent approaches for establishing NRVs for labelling
purposes.

Scope of work and establishment of priorities between the various sections of the work: The scope of the
work relates to work previously undertaken by Codex on a high priority basis.

• Work already undertaken by other organizations in this field: This proposed new work is consistent with,
complements, and builds upon work already undertaken by CCFL.

5. RELEVANCE TO THE CODEX STRATEGIC OBJECTIVES

ALINORM 08/31/26, Appendix VII 81

This proposal is consistent with the following strategic goals presented in the Codex Strategic Plan 2008­

2013:

Promoting Sound Regulatory Frameworks (Activity 1.3);

Promoting Widest and Consistent Application of Scientific Principles and Risk Analysis (Activities 2.3).

6. INFORMATION ON THE RELATION BETWEEN THE PROPOSAL AND OTHER

EXISTING CODEX DOCUMENTS

The Codex Guidelines on Nutrition Labelling (CAC/GL 2-1985, Rev. 1-1993) and Codex Guidelines for
Vitamin and Mineral Food Supplements (CAC/GL 55-2005) indicate the NRVs as a basis for expressing
nutrient content in nutrition labelling of all foods including conventional foods and food supplements. The
Codex Guidelines for Use of Nutrition and Health Claims (CAC/GL 23-1997, Rev. 1-2004) also indicates
NRVs as a basis for criteria for nutrition and health claims.

7. IDENTIFICATION OF ANY REQUIREMENT FOR AND AVAILABILITY OF EXPERT

SCIENTIFIC ADVICE.

Scientific advice from FAO/WHO could be identified at a later stage.

8. IDENTIFICATION OF ANY NEED FOR TECHNICAL INPUT TO THE STANDARD

FROM EXTERNAL BODIES SO THAT THIS CAN BE PLANNED FOR

None foreseen.

9. THE PROPOSED TIME-LINE FOR COMPLETION OF THE NEW WORK, INCLUDING THE
START DATE, THE PROPOSED DATE FOR STEP 5 AND THE PROPOSED DATE FOR
ADOPTION BY THE COMMISSION: THE TIME FRAME FOR DEVELOPING GUIDELINE
SHOULD NOT NORMALLY EXCEED FIVE YEARS

Activity Step/date

The CCNFSDU agrees the work to be undertaken Nov, 2007

Commission approves New Work July 2008

Step 5 2009/2010

Adoption by the Commission 2011/2012